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ENGLISH SUMMARY 
Selecting the level of ventilator support is difficult, with patients responding in 
different ways to reduction or increase of support. Providing adequate level 
of support is necessary to avoid over-assistance and the risk of inducing 
ventilator induced lung injuries (VILI), while avoiding respiratory distress or 
respiratory muscle failure. This thesis described previous clinical and 
technological solutions to assist physicians in selecting the adequate level of 
support. These solutions have focused on guidelines or rule-based systems 
to set ventilator support. A few technological solutions have integrated 
physiological models to describe patients’ response to changes in mechanical 
ventilation, allowing simulation of patient response. One of these is INVENT, 
which integrates models of pulmonary gas-exchange, blood acid-base and 
oxygenation status, body buffering, and lung mechanics. INVENT describes 
patients in controlled ventilation modes, which represents a limitation as the 
majority of patients are ventilated in assisted ventilation modes. The aim of 
this PhD thesis is to integrate a model of respiratory control into the set of 
models included in the INVENT system in order to enable description of 
patients in assisted ventilation modes i.e. spontaneously breathing patients, 
on changes in the level of ventilator support.  
The thesis reviews the appropriate models for inclusion in INVENT, verifying 
that they have the correct level of abstraction to allow bedside use, and a 
model of respiratory control is selected. This model is described, and 
integrated into the set of models included in INVENT. To adequately integrate 
the model of respiratory control, the model was modified to allow calibration 
and simulate down-regulation of ventilation. Two additional models were 
included to quantify muscle function and effective compliance.  
A sensitivity analysis is performed to examine the behavior of the respiratory 
control model and identify potential patient-specific model parameters, and a 
method of parameter estimation presented. The models of INVENT including 
the respiratory control model are then evaluated prospectively in two clinical 
protocols including patients ventilated in assisted controlled ventilation 
(ACV), and pressure support ventilation (PSV). These clinical studies 
evaluated the models ability to describe patient response to 5 different levels 
of tidal volume or pressure support. Model simulated values of respiratory 
frequency (fR), arterial pH (pHa), and end-tidal CO2 (FECO2) compared well 
with measured values, giving low bias and narrow limits of agreement.  
In summary, this PhD thesis presents a set of models which allows the 
description and simulation of patients’ response to changes in the level of 
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ventilator support. Two prospective clinical studies showed that it is possible 
to describe and simulate patients’ response to changes in ventilator support. 
 
DANSK RESUME 
Det er svært at vælge niveauet af respiratorstøtte, da patienter kan reagere 
forskelligt på sænkning eller øgning i støtte. Det er nødvendigt at give det 
rette niveau af støtte for at mindske risici for over-støtte og respiratorinduceret 
lunge skade (ventilator induced lun ginjury - VILI) men i modsat fald også 
undgå besvært med vejtrækningen og udmattelse af de respiratoriske 
muskler. Denne PhD-afhandling beskriver tidligere kliniske og teknologiske 
løsninger til at støtte læger i at vælge hensigtsmæssig respiratorstøtte. Disse 
løsninger har fokuseret på guidelines eller regelbaserede systemer til at 
indstille respiratorstøtte. Enkelte teknologiske løsninger har integreret 
fysiologiske modeller med det formål at beskrive patienters reaktion på 
ændringer i respiratorindstillinger og hermed muliggjort at patienters reaktion 
kan simuleres. Et af disse systemer er INVENT, som integrerer modeller af 
pulmonær gasudveksling, blodets syre-base kemi og iltning, kroppens 
bufferegenskaber, og det respiratoriske systems mekaniske egenskaber. 
INVENT kan beskrive patienter der ventileres i et kontrolleret 
ventilationsmodus. Dette udgør en begrænsning for systemet, da flertallet af 
patienter ventileres i et støttet ventilationsmodus. Målet med denne PhD-
afhandling er at integrere en model af respiratorisk kontrol med de 
eksisterende modeller i INVENT for at muliggøre en beskrivelse af patienter 
i støtte ventilationsmodi, det vil sige patienter som har spontan respiration, 
ved ændring i respiratorstøtte.   
PhD-afhandlingen redegør for egnede modellers inklusion i INVENT, 
verificerer at modellerne har det rette abstraktionsniveau der muliggør 
praktisk klinisk brug, og en model af respiratorisk kontrol udvælges. Denne 
model beskrives og integreres med de eksisterende modeller i INVENT. For 
at kunne integrere modellen hensigtsmæssigt med de eksisterende, er 
modellen blevet modificeret så den kan kalibreres og simulere sænkning af 
ventilation. To yderligere modeller er blevet inkluderet til at kvantificere 
respiratorisk muskelfunktion og effektiv lungeeftergivelighed. 
I PhD-studiet udføres en sensitivitetsanalyse som undersøger modellen af 
respiratorisk kontrol og identificerer potentielle patientspecifikke 
modelparametre og en metode til estimering af modelparametre udvikles. 
Efterfølgende evalueres INVENTs modeller inklusive modellen af 
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respiratorisk kontrol prospektivt i to kliniske protokoller som inkluderer 
patienter i assisted controlled ventilation (ACV) og pressure support 
ventilation (PSV). Disse klniske studier evaluerer modellernes evne til at 
beskrive patienters reaktion på 5 forskellige niveauer af åndedrætsvolumen 
eller trykstøtte. Modellernes simulerede værdier af åndredrætsfrekvens (fR), 
arteriel pH (pHa) og slutekspiratorisk CO2 fraktion (FECO2) er 
sammenlignelige med målte værdier med resulterende små bias og snævre 
limits of agreement. 
Kort opsummeret præsenterer denne PhD-afhandling et sæt af modeller som 
muliggør beskrivelse og simulation af patienters reaktion på ændringer i iveau 
af respiratorstøtte. To prospektive kliniske studier viste at det er muligt at 
beskrive og simulere patienters reaktion på ændringer i respiratorstøtte. 
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CHAPTER 1. CLINICAL AND 
TECHNICAL BACKGROUND 
  
1.1. INTRODUCTION 
Mechanical ventilation is a life-sustaining therapy for patients residing in 
intensive care. It is used to reduce the work required to breathe, to promote 
CO2 removal, and to aid in O2 delivery to the tissues, maintaining adequate 
blood acid-base and oxygenation status. There are two major modes of 
mechanical ventilation, control and assisted, with the difference between 
these depending upon patients’ ability to initiate a breath. In controlled modes 
of ventilation, breaths are primarily triggered by the ventilator and not the 
patient. This means that the patients’ respiratory frequency is decided by the 
physician and set on the ventilator along with inspired oxygen and either 
ventilator volume or pressure. In contrast, in assisted modes, breaths are 
primarily triggered by patient effort. As a result, patients decide their own 
respiratory frequency with the physician deciding the appropriate level of 
inspired oxygen and either volume or pressure support.  
Selecting the appropriate settings for mechanical ventilation is a difficult 
process. Patients’ are highly heterogeneous and have different abnormalities 
in various physiological systems including pulmonary gas-exchange, blood 
acid-base, respiratory drive, metabolism, and circulation. Optimizing 
mechanical ventilation requires understanding of the individual patient’s 
physiological state. To aid in this process, physiological models of numerous 
of these physiological systems have been included in a decision support 
system (DSS) to advice upon appropriate mechanical ventilation (1). This set 
of physiological models was shown to describe patient response to changes 
in ventilation (2-5), but the models included in these systems have limited 
application. The system can only describe patients in controlled ventilation 
modes (6). Since the majority of patients on mechanical ventilation are in 
assisted ventilation modes, this represents a real limitation (7-10). 
Describing patients in assisted ventilation is more complex than describing 
controlled ventilation. During assisted ventilation, patients are spontaneously 
breathing, which is a physiological process that involves additional 
physiological systems (e.g. respiratory chemoreflex, cerebrospinal fluid acid-
base status). Models describing spontaneous breathing, i.e. respiratory 
control, have been used to describe the respiratory response of subjects to 
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hypoxia and hypercapnia following induced abnormalities in blood acid-base 
status (11-13). It may therefore be possible to integrate a model of respiratory 
control into the above mentioned set of physiological models and in doing so 
help provide a description of patients in assisted ventilator modes. The aim 
of this PhD thesis is to improve a set of physiological models, in order to add 
the functionality necessary to describe patients ventilated in assisted 
ventilation modes. To do so, the physiological models are required to be 
complex enough to capture patients’ response to changes in the level of 
ventilator support, while at the same time being simple enough to be tunable 
to the individual patient at the bedside. The selection of appropriate models 
is therefore not trivial, and this thesis describes the selection criteria of 
appropriate models of respiratory control. The respiratory control model that 
best meets the selection criteria is selected and integrated into the set of 
physiological models. This integrated set of models is then prospectively 
evaluated in patients on mechanical ventilation in assisted ventilation modes, 
at different levels of ventilator support.  
1.2. DESCRIPTION OF THE MAJOR VENTILATOR MODES 
The primary objectives of mechanical ventilation are to unload the respiratory 
muscles, and promote removal of CO2 and delivery of O2, keeping adequate 
blood acid-base and oxygenation status. To meet these objectives, selection 
of appropriate ventilator settings is necessary. This process starts with 
selection of the ventilation mode, which depends upon patients’ state of 
consciousness. In passive patients (i.e. heavily sedated or/and paralyzed), 
the ventilator takes over the respiratory muscles’ workload, as patients cannot 
generate spontaneous breathing effort. In active patients (i.e. awake or 
slightly sedated), the ventilator may unload the respiratory muscles with 
patients generating spontaneously breathing effort. This section describes 
general aspects of controlled and assisted ventilation modes. The two most 
common assisted ventilation modes are explained, as these modes are used 
during the clinical studies performed as part of this PhD thesis. 
1.2.1. CONTROLLED VENTILATION MODES 
During controlled ventilation modes the ventilator delivery of breaths is 
typically triggered mechanically by the ventilator, with the expiratory phase of 
the respiratory cycle relying on the elastic recoil of the respiratory system 
rather than patient effort. In general, there are two main controlled ventilation 
modes, defined upon the variable that the ventilator controls. In volume 
control, the ventilator controls the inspiratory tidal volume (VT), and in 
pressure control, the ventilator controls the inspiratory pressure (Pinsp). The 
relationship between the volume and/or pressure delivered depends on the 
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mechanical characteristics of the respiratory system (i.e. resistance and 
compliance) (14,15). The following ventilator settings are set by physicians 
during controlled ventilation modes: ventilation controlled variable, VT or 
Pinsp; inspired fraction of oxygen (FIO2); respiratory frequency (fR), which is 
the number of mechanically delivered breaths provided to the patient per 
minute; the inspiratory time (Ti), which is the time required to achieve VT 
according to the set inspiratory flow during volume-controlled ventilation, or 
is the time Pinsp is maintained during pressure controlled ventilation; 
inspiratory flow (V̇i), is set in volume-controlled ventilation, and is the 
inspiratory flow delivered to the patient, its value depends on VT and Ti; ramp 
or slope, is set on pressure-controlled ventilation, and is the time it takes to 
the ventilator to pressurize the patient breathing circuit to reach Pinsp; 
inspiratory flow pattern, defines the shape of the flow profile provided to the 
patient, which can be either accelerating, decelerating, or constant, 
depending on the flow setting for volume-controlled ventilation or ramp time 
setting for pressure-controlled ventilation; and level of positive end expiratory 
pressure (PEEP). 
In volume-controlled ventilation mode, physicians determine the minute 
ventilation (V̇E) i.e. the product between VT and fR, a known value of V̇E is 
therefore guaranteed in this mode. In contrast, during pressure controlled 
ventilation, a predefined V̇E is not known, and V̇E can change acutely due to 
a sudden change in lung compliance. A fixed V̇E can be seen as an 
advantage of volume-controlled mode, however, pressure-controlled 
ventilation is usually associated with both a lower Pinsp and a decelerating 
flow pattern on inspiration. Both of these are thought to be beneficial and have 
led to combined pressure and volume modes such as pressure regulated 
volume controlled (PRVC) which combine the benefits of pressure control 
with a guaranteed V̇E (16). 
1.2.2. ASSISTED VENTILATION MODES 
During assisted (or assisted/supported) ventilation modes the ventilator 
delivery of breaths is influenced by patients’ effort. The inspiratory phase of 
the respiratory cycle is typically patient-triggered, but can also be 
mechanically triggered when the ventilator switches into apnea mode. The 
most common assisted ventilation modes used in the intensive care unit (ICU) 
are assist-control ventilation (ACV), and pressure-support ventilation (PSV) 
(7-10,17,18). The main difference between these ventilation modes is the 
controlled variable, ACV controls VT and PSV controls Pinsp. In PSV, the 
level of Pinsp is called pressure support (PS). The relationship between VT 
and PS depends on the mechanical characteristics of the respiratory system 
(i.e. resistance and compliance) and patients’ muscle generated pressure 
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(Pmus) (9,14,19,20). During ACV or PSV, patients determine their fR, and in 
PSV patients determine their VT and fR. 
ACV is a volume-controlled, time cycled, patient-triggered, ventilation mode 
(10,15), meaning that the ventilator supplies a determined VT within a fixed 
time, when patients generate spontaneous breathing effort. The settings for 
ACV are: inspiratory tidal volume (VT) that the ventilator delivers for each 
breath; inspired fraction of oxygen (FIO2); inspiratory time (Ti), which is the 
time required to achieve VT according to the set inspiratory flow; inspiratory 
flow (V̇i), which usually is constant, and depends on the inspiratory flow 
pattern; inspiratory flow pattern, which defines the shape of the flow profile 
provided to the patient, which can be either constant, accelerating, or 
decelerating; trigger sensitivity, which is the patient generated inspiratory flow 
(or pressure) required to trigger the delivery of inspiratory flow; back-up 
respiratory frequency or apnea setting, is the minimum respiratory frequency 
of the patient, below this value, the ventilator starts delivering mechanically 
triggered breaths; and level of positive end expiratory pressure (PEEP). 
PSV is a pressure-controlled, flow cycled, patient triggered, ventilation mode 
(9,15,21), meaning that the ventilator supplies a determined PS during a time 
interval that is actively determined by the patient with via an inspiratory flow-
based criterion, when patients generate a spontaneous breathing effort. The 
settings for PSV are: level of inspiratory pressure or pressure support (PS) 
that the ventilator delivers for each breath during the inspiration; inspired 
fraction of oxygen (FIO2); ramp time or slope, which is the time the ventilator 
takes to reach the PS level; cycling to expiration criterion, which defines the 
decrease in inspiratory flow needed to actively terminate the inspiratory 
phase of the respiratory cycle; trigger sensitivity, which is the patient 
generated inspiratory flow (or pressure) required to trigger the delivery of 
inspiratory flow; back-up respiratory frequency or apnea setting, is the 
minimum respiratory frequency of the patient, below this value, the ventilator 
starts delivering mechanically triggered breaths; and level of positive end 
expiratory pressure (PEEP). 
1.3. CHALLENGES OF MECHANICAL VENTILATION 
The process of finding and selecting ventilator settings to optimize the work 
of breathing promote removal of CO2 and delivery of O2 without inducing lung 
damage, is difficult. Patients may require very different ventilator settings, 
according to their underlying physiological abnormalities and may respond 
quite differently to changes in ventilator support. The challenges of 
mechanical ventilation when using to the two major ventilation modes are 
summarized in the following sub-sections. 
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1.3.1. CHALLENGES OF CONTROLLED VENTILATION 
Physicians confront several conflicting therapeutic goals when selecting 
ventilator settings for patients in controlled ventilation modes. Patients may 
require large V̇E, high PEEP levels and high FIO2 to maintain normal acid-
base and oxygenation status. Large V̇E is, however, often obtained using 
high values of Pinsp, VT and fR, all of which can promote ventilator induced 
lung injury (VILI) (22). Indeed, low V̇E and the subsequent permissive 
hypercapnia is usually accepted in patients with severe respiratory 
abnormalities to avoid VILI (23,24). The most common VILIs are 
barotrauma/volutrauma caused by lung over-distention due to high Pinsp or 
VT, and atelectrauma caused by repeated opening and closing of collapsed 
alveolar units (atelectasis) (22,25). Avoiding barotrauma/volutrauma can be 
achieved by limiting Pinsp or/and VT settings on the ventilator. In contrast, to 
avoid atelectrauma, it may be necessary to reopen collapsed alveolar units 
with a recruitment maneuver (25). When successful, recruitment is usually 
followed with an increase of PEEP to counteract the compressive forces 
acting on the recently reopened (or recruited) alveolar units, and by reducing 
FIO2 to prevent the collapse of low ventilation-perfusion ratio (V̇/Q̇) alveolar 
units due to gas-absorption atelectasis (22,26,27). Thus, selecting the 
appropriate V̇E to promote removal of CO2 and delivery of O2, keeping 
adequate blood acid-base and oxygenation status, requires that physicians 
balance the risk of developing hypercapnia against the risk of developing 
VILI. In a similar way, selecting the appropriate level of PEEP to keep the 
lung open, requires that physicians balance the risk of increasing the stress 
and strain of already open lung regions, against the risk of alveolar collapse 
when decreasing PEEP (22). Selecting the appropriate FIO2 to achieve 
adequate oxygenation, requires that physicians balance the risk of 
hypoxemia when decreasing FIO2, against the risks of developing absorption 
atelectasis (28) or oxygen induced lung edema and cellular death (29), on 
increasing FIO2. 
1.3.2. CHALLENGES OF ASSISTED VENTILATION 
Similar conflicting therapeutic goals exist in assisted ventilation modes i.e. 
selecting VT or PS levels, to promote removal of CO2 and delivery of O2, 
keeping adequate blood acid-base and oxygenation status without increasing 
the risk of developing VILI; and selecting PEEP and FIO2 to ensure adequate 
oxygenation without increasing the risk of developing gas-absorption 
atelectasis, and oxygen induced lung edema and cellular death. In addition, 
during assisted ventilation, physicians often search for an optimal setting of 
volume or pressure by titrating the level of ventilator support (VT or PS), and 
evaluating patients’ response. The individual patient clinical response is 
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typically evaluated with measurement of arterial blood gases (ABG), pulse 
oximetry, capnography, changes in fR and VT, or assessing for increased 
work of breathing by observation or palpation of accessory respiratory 
muscles (e.g. sternocleidomastoid) (9,10). 
After modifying the level of ventilator support, physicians also often take into 
account the effects of excessive or too little support (9,17,21,30). Excessive 
support may increase the number of ineffective triggering efforts and induce 
respiratory muscle atrophy with the patient effectively being ventilated as in 
controlled ventilation mode. Too little support may cause respiratory distress, 
reduce alveolar ventilation (V̇A) and compromise blood acid-base status, 
increase patients’ work of breathing, and induce respiratory muscle fatigue 
(31). On reduction of the level of ventilator support, if patients show 
inadequate response (e.g. respiratory distress, significant increase of work of 
breathing, anxiety, reduction SaO2 and PaO2, or increase of PaCO2 and 
FECO2), physicians typically increase the level of support in order to improve 
ventilation, and  reduce the work of breathing. 
This section has highlighted the challenges facing clinicians when deciding 
upon appropriate ventilator therapy. Several clinical and technological 
solutions have been proposed for aiding clinicians in selecting appropriate 
settings. The following section reviews the state of the art of such solutions. 
1.4. CURRENT CLINICAL AND TECHNOLOGICAL SOLUTIONS 
FOR IMPROVING MECHANICAL VENTILATION 
Current solutions for selecting adequate ventilator settings can be divided in 
two categories:  clinical and technological. Clinical solutions include clinical 
recommendations, like the ARDSnetwork guidelines (32), which have been 
developed as the result of clinical studies designed to develop strategies  for 
lung-protective and safe ventilation (23,24). Technological solutions include 
decision support systems (DSSs), which are computer systems either 
controlling or providing advice on appropriate ventilator settings. These 
systems are either rule-based systems, model-based systems or hybrid 
systems (which combine rule and model-based systems). DSSs can aid in 
setting the ventilator in two different ways. Rule-based systems mimic 
physicians’ clinical decisions by applying artificial-intelligence algorithms. 
Model-based and hybrid systems simulate patients’ response via 
physiological models, and then generate advice on ventilator settings, 
according to simulated patient responses. The following text presents a 
summary of clinical and technological solutions applied to help in selecting 
ventilator settings in the two major ventilator modes. 
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1.4.1. CURRENT SOLUTIONS FOR IMPROVING THE SELECTION OF 
VENTILATOR SETTINGS IN CONTROLLED VENTILATION 
1.4.1.1 Use of clinical solutions for improving controlled ventilation 
settings 
Several clinical recommendations have been developed and evaluated for 
providing lung-protective and safe ventilation in patients with acute 
respiratory distress syndrome (ARDS) (23,24). Application of these 
recommendations have, primarily through the provision of low VT, been 
shown to reduce both mortality and weaning time (32). Current clinical 
guidelines recommend the ventilator be set to a VT of 6 ml/kg of predicted 
body weight (PBW), plateau pressure <30 cm H2O, and FIO2 required to 
achieve 88 %<SaO2<95 %. These guidelines are considered as the “gold 
standard” for ventilating safely ALI/ARDS patients in controlled ventilation 
modes (32).  
1.4.1.2 Use of technological solutions for improving controlled 
ventilation settings 
In controlled ventilation modes, DSSs have been developed which combine 
mathematical models of several physiological systems, with these used to 
describe and simulate patients’ response to changes in ventilator settings 
(6,33-36). One such system is the INVENT system (1,6). This is a model-
based DSS that includes models of: blood acid-base status (37,38); body 
buffering (O2 and CO2 transport and storage) (39); and pulmonary gas-
exchange (40), plus rudimentary models of lung mechanics and circulation. 
INVENT has been evaluated retrospectively and prospectively to describe 
patients in controlled ventilation, with a wide range of abnormalities of 
pulmonary gas-exchange and blood acid-base status (2-5). INVENT’s 
retrospectively generated advice on controlled mode settings has been 
shown to be in agreement with ARDSNetwork guidelines for providing safe 
ventilation (2-5). 
1.4.2. CURRENT SOLUTIONS FOR IMPROVING THE SELECTION OF 
VENTILATOR SETTINGS IN ASSISTED VENTILATION 
1.4.2.1 Use of clinical solutions for improving assisted ventilation 
settings  
As for controlled ventilation, recommendations for ventilating patients in 
assisted ventilation must provide protective ventilation, and reduce the risk of 
developing VILI. In addition, selecting the appropriate level of ventilator 
support requires consideration of patient synchrony with the ventilator, and 
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risk of development of respiratory muscles fatigue or atrophy. The current 
clinical recommendation is to set the level of PS to the individual patient, in 
order to achieve a VT of 6 ml/kg of PBW. Reduction of PS has been 
associated with increase of synchrony between patient and ventilator. 
Reducing PS from 20 to 13 cm H2O resulted in a significant reduction of 
number of ineffective triggering events, and a VT of 6 ml /kg of PBW (41,42). 
Interestingly, setting the level of PS in order to achieve a low VT (6 ml/kg of 
PBW), provided better gas-exchange (measured as FRC) than using a level 
of PS in order to achieve high VT (8 ml/kg of PBW) (18). 
1.4.2.2 Use of technological solutions for improving assisted 
ventilation settings 
DSS have been incorporated into two commercially available ventilation 
modes, with these ventilator modes being capable of automatically modifying 
the level of ventilator support (43). These systems are SmartCare/PS and 
Adaptative Support Ventilation (ASV). As illustrated in figure 1-1 both of these 
systems measure patients response to changes in ventilator settings and 
automatically use this response as feedback to adapt the level of ventilator 
support.  
SmartCare P/S is rule-based DSS, which integrates an artificial intelligence 
algorithm that mimics physicians’ actions in changing the level of pressure 
support (PS) (16,44). The ventilator operating under SmartCare P/S, provides 
PS so as to maintain the patient’s breathing pattern within a comfort zone of 
ventilation, which is delimited by 12/min < fR <30/min and FECO2< 0.077 (55 
mm Hg) (45). If patients are stable within the comfort zone, the ventilator 
automatically starts a progressive reduction of PS, and evaluates whether or 
not the patient is ready for extubation (46). To evaluate patients’ response, 
this ventilator mode requires continuous monitoring of fR, VT and FECO2. 
ASV is hybrid DSS, which integrates a physiological model of work of 
breathing and a rule-based algorithm to provide safe limits of VT and fR, and 
to reduce the risk of developing intrinsic PEEP (16,44,47). The ventilator 
operating under ASV, provides sufficient PS to maintain the patient’s 
ventilation with the optimal VT and fR combination required to reduce the rate 
of work of breathing according to a physiological model (48). The ventilator 
modifies the level of PS required to meet the targeted VT and fR combination 
in response to patient effort and changes of the time constant of the 
respiratory system, the latter being estimated form the expiratory flow (49). A 
new implementation of this ventilator mode is IntelliventASV, which is 
designed to maintain a level of FECO2 determined by the physician, adjust 
PEEP-FIO2 according to the ARDSnetwork tables to maintain acceptable 
levels of SpO2, in addition to the optimal VT and fR combination (50-53). 
CHAPTER 1. CLINICAL AND TECHNICAL BACKGROUND 
23 
 
Figure 1-1. Representation of DSS integrated into ventilator modes. The ventilator is 
composed of two components. The effector is the hardware that allows the delivery of 
inspiratory gas and waste of expiratory gas. The controller is composed of software 
and microprocessors that control the effector. The controller of ventilators including 
the ventilation modes SmartCare P/S and ASV, receives input signals from the patient. 
These signals can be FECO2, fR or/and SpO2, and are used among ventilator settings 
to determine the level of PS provided to the patient. The control circuit of conventional 
ventilator is indicated inside the dotted area. 
 
Other ventilator modes have been developed for delivering a breath-by-
breath customized level of ventilator support, according to an amplified signal 
of continuously measured patient-effort. This signal is also employed to 
trigger delivery of inspiratory flow, and to determine the level of ventilator 
support provided for each breath. Proportional-assisted ventilation (PAV) is a 
ventilator mode that uses the instantaneous inspiratory flow to increase the 
airway pressure in proportion to patient effort (16,44,54). PAV has been 
shown to reduce dyssynchrony between patient and ventilator (55). Neurally 
adjusted ventilation (NAVA) is a ventilator mode that uses the electrical 
activity of the diaphragm (EAdi) to trigger, increase, and modulate, the airway 
pressure (16,44). NAVA has been shown to increase patient synchrony with 
the ventilator (56). 
The above mentioned DSSs and ventilator modes determine the level of PS 
based upon either rules, work of breathing, mechanical characteristics of the 
respiratory system or surrogate signals of patients’ effort. These systems and 
ventilation modes do not provide a complete description of patients’ 
physiology, including, for example, the relationship between ventilation and 
acid-base status. 
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This section has addressed the clinical challenges of mechanical ventilation 
and clinical and technological solutions. Clinical studies have shown that 
mechanical ventilation needs to be administered with protective settings, in 
order to reduce the risk of inducing VILI. Clinical solutions such as guidelines 
and recommendations have been established to protect patients from 
deleterious effects of mechanical ventilation and aid physicians to select 
adequate ventilator settings. In addition, technological solutions have been 
developed to aid physicians. Model-based DSS can describe and simulate 
patients’ response to changes in controlled ventilation, and hence, can 
provide advice in accordance to the protective guidelines for mechanical 
ventilation. Alternatively, rule-based and hybrid DSSs, already included in 
ventilator modes, can modify the level of PS according to patients’ response 
within, limits programed within the systems’ algorithms or set by the 
physician. The next section describes the limitations of the current clinical and 
technological solutions used to set mechanical ventilation. 
1.5. LIMITATIONS OF THE CURRENT CLINICAL AND 
TECHNOLOGICAL SOLUTIONS FOR IMPROVING 
MECHANICAL VENTILATION SETTINGS 
Despite having shown clinical benefit, current clinical and technological 
solutions for improving mechanical ventilation can be seen as having 
limitations. Clinical guidelines are general recommendations for ventilating 
patients, with limited patient specific advice or interpretation of the underlying 
physiological state of the individual patient. Technological solutions include 
those that are model-based, rule-based or hybrid systems, but these 
approaches can currently be seen as having a number of important 
limitations. This section describes the limitations of current solutions, 
highlighting the need for further work. 
1.5.1. LIMITATIONS OF CLINICAL SOLUTIONS 
The use of general recommendations for providing lung-protective ventilation 
to patients in controlled-ventilation with heterogeneous lung abnormalities 
may be misleading. Several studies (57,58) have pointed out that the 
guidelines for providing protective ventilation to patients with ALI/ARDS may 
not be applicable for all ventilated patients. For instance, critically ill patients 
with severe pulmonary abnormalities (e.g. low FRC and low compliance) may 
be at risk of developing VILI when ventilated with 6 ml/kg PBW. Conversely, 
patients without pulmonary abnormalities may be suitable for being ventilated 
with VT higher than 6 ml/kg PBW (58). It may therefore be argued that the 
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selection of ventilator settings needs to be performed accounting for 
individual patients’ physiological conditions (25,57-59). 
The general recommendation for setting adequate level of PS i.e. setting PS 
to achieve a VT of 6 ml/kg of PBW, to spontaneously breathing patients, 
highlights the importance of providing individualized ventilation and 
understanding patients’ physiology. PS is adjusted to produce a low level of 
VT considering: individual patients’ PBW; patient respiratory effort; and 
characteristics of the respiratory system (17,20,30). In addition, low VT 
requires adequate levels of PEEP and FIO2, to maintain stable alveolar units 
(22,26,60), and encourages reduction of PS, which is associated with a 
reduction the number of missing efforts due to over-support (42). 
1.5.2. LIMITATIONS OF TECHNOLOGICAL SOLUTIONS 
The use of physiological models to simulate individual patients can be used 
to provide appropriate ventilator settings tailored to individual patients’ 
physiological conditions. INVENT is a DSS that includes physiological models 
of pulmonary gas-exchange, blood acid-base status, and body buffering. The 
set of physiological models included in INVENT has however been limited to 
describe patients in controlled ventilation, as the set of models does not 
include a mechanism that controls ventilation to regulate arterial pH (pHa), or 
arterial partial pressure of CO2 (PaCO2) i.e. model of respiratory control. 
Hence, INVENT has not been developed to provide advice for describing 
spontaneously breathing patients in support ventilation (6). 
The integration of rule-based and hybrid DSS into ventilator modes, has 
enabled ventilators to have the capability of automatically modifying the level 
of PS in response to changes in patients’ breathing pattern. SmartCare P/S 
adapts the level of PS in order to maintain patients’ breathing pattern (VT, fR, 
and FECO2) in a comfort zone. ASV adapts the level of PS according to 
changes in compliance and resistance, in order to maintain optimal VT and 
fR. Both systems, modify PS to produce a respiratory pattern, which is 
acceptable according to each system’s limits, rather than describing (and 
understanding) individual patients. Describing patients’ response is difficult 
because the effects of modifying for example PS, may affect different 
physiological processes involved in ventilation, e.g. pulmonary gas-
exchange, blood acid-base status and respiratory control (17,20,30). The use 
of physiological models to describe those physiological processes may be a 
useful way to combine their effects, and hence, describe patients’ respiratory 
response. Patients’ response to changes in mechanical ventilation settings 
during controlled ventilation has been described using the set of models 
included in the INVENT system. This system includes physiological models 
which can be tuned to describe individual patients’ physiological 
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abnormalities. The use of such physiological models for describing patients’ 
response during controlled ventilation, might be extended to describe 
spontaneously breathing patients in support ventilation. To do so requires 
integration of a model of respiratory control to existing models included in the 
INVENT system (6). 
1.6. AIMS OF THE PHD THESIS 
This chapter has described the typical modes of mechanical ventilation and 
the challenges and current solutions to those challenges. It can be concluded 
that there does not currently exist a technological solution to the challenge of 
setting support ventilation which adequately describes individual patients’ 
physiology and therefore enables simulation of response to changes in 
ventilator support. Several model components to such technological solution 
exist within the INVENT system, but this lacks integration of a model of 
respiratory control if it is to provide advice in assist modes of ventilation. The 
aim of this PhD thesis is therefore to investigate whether it is possible to 
identify a suitable model of respiratory control and integrate this into existing 
INVENT models. The resulting model, including that for respiratory control, 
should be useful at the bedside, meaning that it must be possible to tune the 
model to the individual patient’s conditions only with clinically available data. 
When tuned, it should be possible to describe patients’ state, predict patients’ 
response to changes in the level of ventilator support, and evaluate whether 
the integrated models enable description of patients in assisted ventilation. It 
is therefore also an aim of this thesis to evaluate the integrated models with 
prospective clinical studies. The strategy for each of these tasks is outlined 
below with the details given in subsequent chapters of the thesis. 
 Review and selection of models  
Chapter 2 describes the selection process of an appropriate respiratory 
control model to be integrated into the set of physiological models of INVENT. 
So far, it has been assumed that the set of models included in INVENT are 
appropriate to describe patients’ response. Whether this assumption is valid 
in the context of other physiological models described in the literature is 
reviewed in section 2.1. To do so, a brief description of the models included 
in INVENT is presented in section 2.1.1. The criteria for reviewing 
physiological models similar to INVENT’s set of models is presented in 
section 2.1.2. The review of physiological models is presented in section 
2.1.3. A summary of the review of physiological models describing the 
relationship between blood acid-base status and ventilation is presented in 
section 2.1.4. The additional model components required to describe how 
ventilation is generated (a mechanism that controls ventilation to regulate 
either arterial hydrogen ion concentration in the arterial blood ([H+a]), pHa or 
CHAPTER 1. CLINICAL AND TECHNICAL BACKGROUND 
27 
PaCO2) and hence, allow description spontaneously breathing patients, are 
described in section 2.1.5.  
Published physiological models of respiratory control are reviewed in section 
2.2. A brief description of respiratory control physiology is presented in 
section 2.2.1. The criteria for reviewing respiratory control models is 
presented in section 2.2.2. The review of the respiratory control models is 
presented in section 2.2.3, and the selection of the respiratory control model 
that best met these criteria is presented in section 2.2.4.   
 Integration of models 
Chapter 3 presents the integration of the selected respiratory control model 
into INVENT’s set of models. As will be shown in this chapter, the selected 
respiratory control model required several modifications, these being 
necessary to allow description of patients on assisted ventilation modes 
(section 3.2). Two additional models, were required to complete the 
description of patients in assisted ventilation modes. These were a model of 
muscle function, described in section 3.3, and a model of effective 
compliance, described in section 3.4. 
 Evaluation of the integrated model 
Chapter 4 describes the verification of the INVENT’s set of models including 
the respiratory control model. The models were verified against literature 
data, to see if they could adequately describe typical effects of abnormal 
blood acid-base status on ventilation (section 4.2.1). In addition, chapter 4 
presents a sensitivity analysis of the model parameters included in the 
respiratory control model illustrating which patient-specific model parameters 
could be identified from clinical data (section 4.2.2). Section 4.3 describes the 
parameter estimation method used for estimating patient-specific model 
parameters and, as such, tuning the respiratory control model to specific 
patients. 
Chapters 5 and 6 describe the clinical evaluation of the INVENT’s set of 
models including the respiratory control model. Model simulated values of 
patient response were compared against data collected from two prospective 
clinical studies, performed as part of this PhD thesis. In these studies, 
patients were subjected to up to 5 different levels of ventilator support. The 
two studies were performed with different assisted ventilation modes i.e. 
assisted controlled-volume support ventilation (ACV) and pressure support 
ventilation (PSV), respectively. 
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CHAPTER 2. REVIEW AND SELECTION 
OF MODELS 
The previous chapter outlined the potential for using physiological models to 
describe patients’ response to changes in the level of ventilator support. In 
this chapter, published physiological models describing the relationship 
between blood acid-base status and ventilation, and physiological models of 
respiratory control are reviewed, and a physiological model of respiratory 
control is selected to be included in to the set of models of INVENT. Section 
2.1 presents the review of physiological models describing the relationship 
between blood acid-base and ventilation. Section 2.2 presents the review of 
respiratory control models, and the selection of the model of respiratory 
control that will be included into INVENT’s set of models. 
2.1. REVIEW OF PHYSIOLOGICAL MODELS DESCRIBING THE 
RELATIONSHIP BETWEEN BLOOD ACID-BASE STATUS 
AND VENTILATION 
Physiological models describing the relationship between blood acid-base 
status and ventilation that are similar to the set of models of INVENT are 
reviewed, in order to validate the assumption that the INVENT’s set of models 
is appropriate to describe patients’ response. 
2.1.1. DESCRIPTION OF INVENT’S SET OF MODELS 
Figure 2-1 illustrates the set of physiological models included in INVENT. The 
set of models includes lung mechanics, pulmonary gas-exchange, blood acid-
base status, and body buffering. INVENT is a DSS, which applies this set of 
physiological models to describe patients current state, and then, generates 
advice for selecting settings of controlled ventilation modes (i.e. FIO2, VT, and 
fR). The advice is generated as follows: First, model parameters describing 
pulmonary gas-exchange and blood acid-base status are tuned to patient-
specific conditions through an experimental procedure, which involves 3-5 
step changes in FIO2 (61,62). Then, the values of model parameters are 
considered as constants. Second, the set of physiological models, and 
patient-specific model parameters are used to perform a series of simulations 
with different ventilator settings. Third, the detrimental effects of simulated 
patient-specific responses (with outcomes e.g. PaO2, PaCO2, pHa) are 
quantified with penalty functions, which reflect clinical preferences to patient’s 
outcome and ventilator settings, in a decision theoretic approach. INVENT’s 
advice is then the simulated patient response that best balances simulated 
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ventilator settings, which is found with a mathematical optimization process 
that minimizes the associated penalty (1,6). The physician in charge of setting 
the ventilator is then in position of accepting or rejecting INVENT’s advice, 
i.e. an open-loop decision support system (figure 2-1). The importance of 
using physiological models relies on the necessity of adequately describing 
patients’ response to changes in mechanical ventilation, in order to 
adequately simulate patients’ outcomes, and hence provide advice. 
Different physiological models describing the relationship between blood 
acid-base status and ventilation have been developed and published. The 
next sub-section describes criteria for reviewing such physiological models in 
comparison to INVENT’s set of models, the aim being to evaluate the 
appropriateness of the models included in the INVENT system.  
 
2.1.2. CRITERIA FOR REVIEWING PHYSIOLOGICAL MODELS SIMILAR 
TO INVENT’S SET OF MODELS 
As highlighted in the previous sub-section, physiological models are essential 
for describing patients’ response to changes in mechanical ventilation. The 
models must describe patients with different physiological abnormalities 
through tunable model parameters. Previously, a set of models has been 
formulated for use in the INVENT system describing the relationship between 
blood acid-base status and ventilation. This section reviews other similar 
published models, using a set of criteria, to see if they have functionality 
similar to the requirements of the current INVENT system. The following 
criteria are used in this process:  
1. Model parameters can be tuned with clinically available data.  
2. Model parameters are identified with a well-established and 
described method. The model parameters may not be tuned with 
non-standard or special measurements that are not available in the 
ICU. 
3. Model parameters have a physiological interpretation, and as such 
may provide deeper understanding of patients’ physiology. 
4. Model complexity includes description of pulmonary gas-exchange. 
5. Model complexity includes description of blood acid-base status. 
6. Model complexity includes description of body buffering. 
7. Models have been adequately evaluated and shown to describe the 
effects of abnormal pulmonary gas-exchange and blood acid-base 
status. 
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Figure 2-1. Structure of the INVENT DSS. The system components are: a set of 
physiological models (represented with the connected and interconnected boxes 
inside the pentagon); a method to identify model parameters (represented with the 
arrow below the patient); and an optimization process according to penalty functions 
(represented with the oval). Patients’ response is described and simulated with a set 
of physiological models (with outcomes e.g. PaO2, PaCO2, pHa). The set of models 
includes lung mechanics, pulmonary gas-exchange, blood acid-base status, and body 
buffering. To describe individual patients’ response, the parameters of the set of 
models are tuned to the individual patient and used to simulate patient response to 
changes in ventilator settings (represented with the box below the pentagon). Through 
a series of simulations, the DSS can optimize ventilator settings according to penalty 
functions, which quantify the clinical preference to patients’ outcomes and side-effects 
of ventilator settings. The “optimal” ventilator settings are those resulting in the 
minimal penalty (represented as DSS advice). The physician is then in position of 
accepting or rejecting the DSS advice, and modify the ventilator settings. 
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2.1.3. REVIEW OF PHYSIOLOGICAL MODELS SIMILAR TO INVENT’S 
SET OF MODELS 
Table 2-1 summarizes this review of 16 published physiological models of 
pulmonary gas-exchange and blood acid-base status. All models were 
reviewed according to the criteria presented in 2.1.2, with the first two 
columns of table 2-1 listing the main author and name of the models, 
respectively, and the rest of the columns representing a single criterion. Table 
cells contain either ‘yes’ or ‘no’, denoting whether each model meets the 
requirement. The third column, also includes the legend ‘sim’, which is used 
to denote complex models that cannot be identified with clinical data. The 
ninth column indicates whether each model includes additional model 
complexity. 
The model of West (63) was developed to simulate the effects of ventilation 
and perfusion (V̇/Q̇) impairment at different conditions of FIO2, V̇E, and blood 
characteristics (base excess or hemoglobin concentration). A method for 
determining patient-specific model parameters was developed latter (64) 
which employed a mixture of (six) inert gases that is infused to the test subject 
with gas concentrations measured  in exhaled gas and arterial and mixed 
venous blood. The retention and excretion of these gasses were calculated 
from measured concentrations for each infused gas, and these values used 
to determine model parameters. This procedure, known as the Multiple Inert 
Gas Elimination Technique (MIGET) is considered the reference technique 
for measuring ventilation-perfusion distribution (V̇/Q̇) in the lungs. Model 
parameters have physiological interpretation, indeed much of that which is 
known about gas exchange impairment in the lungs has been learned from 
application of MIGET (28,65). The use of multiple gasses, not available in a 
standard clinical setting, and complex measurement technology usually limits 
its application outside the experimental setting. The model describes different 
physiological conditions, and allows the simulation of the effects of changes 
in ventilation on arterial and mixed-venous partial pressures of O2 and CO2. 
The model has been evaluated in healthy subjects (64) and patients with 
COPD (66-69), ARDS (70,71), and prone position in ARDS (72,73). 
The model of Dickinson, is included in a simulation program (MacPuf) that 
can be used to describe spontaneously breathing patients on mechanical 
ventilation. This model could not be used due to restrictions on computer 
power when it was developed. Recently, Jouvet (74) applied this model into 
a new simulation program (SimulResp) that describes the effects of changes 
in mechanical ventilation in pediatric patients. There is no description of a 
method for determining patient-specific parameter values. SimulResp’s 
parameters have physiological interpretation e.g. functional residual capacity 
(FRC), compliance (C), and resistance (R). SimulResp includes a description 
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of pulmonary gas-exchange, blood acid-base, body buffering, respiratory 
drive, cerebral blood flow, and lung mechanics. SimulResp has been used for 
simulation of different physiological conditions, however no clinical 
evaluations for describing individual patients have been performed (75). 
The model of Rutledge (76) is included in a simulation program (VentSim) 
that describes the effects of changes in mechanical ventilation on PaO2 and 
PaCO2. Model parameters were input by the user of the program, and there 
is no description of a method for determining patient-specific parameter 
values. VentSim’s parameters have physiological interpretation e.g. shunt 
fraction (fs), fraction of perfused pulmonary compartments (fp1 and fp2), and 
volume of ventilated pulmonary compartments (VA1 and VA2). VentSim 
includes a description of pulmonary gas-exchange, but lacks description of 
blood acid-base status and body buffering. VentSim has been used for 
simulating the effects of changes in mechanical ventilation, however, no 
clinical evaluations for describing individual patients have been performed. 
The model of Winkler (77) is included in a simulation program (SimuVent) that 
describes the effects of changes in mechanical ventilation on lung mechanics, 
and gas exchange, transport and mixing. There is no description of a method 
for determining patient-specific parameter values, so that, the user of the 
program inputs the values of model parameters. SimuVent’s parameters have 
physiological interpretation, e.g. resistance (R), compliance (C), functional 
residual capacity (FRC). SimuVent includes a description of pulmonary gas-
exchange, blood acid-base status and oxygenation, and lung mechanics, but 
lacks from a description of the effects of body buffering. SimuVent has been 
used for simulating the effects of mechanical ventilation, however no clinical 
evaluations for describing individual patients have been performed. 
The model of Vidal-Melo (78) (2C) was developed to describe and quantify 
the effects of ventilation and perfusion (V̇/Q̇) impairment with a 2 lung-
compartment (2C) model. A method for determining patient-specific model 
parameters is described. This method includes an experimental procedure 
where the level of FIO2 is modified in two different occasions until reaching 
steady state. Arterial blood gases (ABG), oxygen consumption (V̇O2) and 
production of (V̇CO2) are measured at each level of FIO2.These 
measurements are then used to determine the values of model parameters. 
The model parameters have physiological interpretation, and parameter 
values can be used for describing pathological conditions e.g. the logarithmic 
mean and standard deviation of the V̇/Q̇ distribution. The 2C model includes 
description of pulmonary gas-exchange, blood acid-base status and 
oxygenation, and buffer capacity buffering (BC). The 2C model has been eva- 
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Table 2-1 Review of physiological models describing the relationship between blood 
acid-base status and ventilation. 
 
 
Model 
parameters 
  Model 
complexity 
Autors Name of the 
system or 
model 
Tunable to 
individual 
patient with 
clinical data 
Well-
established 
and 
described 
tuning 
method 
Physiological 
interpretation 
Pulmonary 
gas-
exchange 
West, 
Wagner 
(63,64) 
MIGET 
sim 
no 
yes yes yes 
Dickinson, 
Jouvet (74) 
MacPuf 
SimulResp 
no no no yes 
Rutledge 
(76) VentSim sim no yes yes 
Winkler (77) 
SimuVent sim no yes yes 
Vidal-Melo 
(78) 2C yes yes yes yes 
Hardman 
(36,79) NPS yes yes yes yes 
Kwok, Wang 
(33,80) 
 
SIVA-
SOPAVent 
yes yes no yes 
Rees (1) 
INVENT yes yes yes yes 
Ben-Tal (81) 
ns sim no yes yes 
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Table 2-2 Review of physiological models describing the relationship between blood 
acid-base status and ventilation (continuation). 
 
Model 
complexity    
Autors Blood acid-
base and 
oxygen-nation 
Body buffering Others Clinical 
evaluation of 
the model 
West,  
Wagner 
(63,64) 
 
yes no --- yes 
Dickinson 
Jouvet (74) 
yes yes 
respiratory 
drive, lung 
mechanics 
no 
Rutledge (76) 
no no lung mechanics no 
Winkler (77) 
yes no 
lung mechanics, 
circulatory 
system 
no 
Vidal-Melo (78) 
yes yes --- yes 
Hardman (36,79) 
yes yes 
lung mechanics, 
circulatory 
system 
no 
Kwok, Wang 
(33,80) 
 
yes no lung mechanics yes 
Rees (1) 
yes yes lung mechanics yes 
Ben-Tal (81) 
yes no 
respiratory 
control 
no 
 
  
THE APPLICATION OF PHYSIOLOGICAL MODELS TO DESCRIBE SPONTANEOUSLY BREATHING PATIENTS’ 
RESPONSE TO CHANGES IN VENTILATOR SUPPORT 
36
 
Table 2-3 Review of physiological models describing the relationship between blood 
acid-base status and ventilation. 
  
Model 
parameters 
  Model 
complexity 
Autors Name of 
the 
system or 
model 
Tunable to 
individual 
patient with 
clinical data 
Well-
established 
and 
described 
tuning 
method 
Physiological 
interpretation 
Pulmonary 
gas-
exchange 
Chakrabotty 
(82) 
Multiscale 
pulmonary 
model 
sim no yes yes 
Kapitan (83) 
ns sim no yes yes 
Chbat 
Albanesse 
(84,85) 
CP sim no no no 
Wilson (86) 
ns yes yes yes yes 
Reynolds 
(87) ns sim no yes yes 
Kretschmer 
(88) Beat-to-
beat 
yes yes yes yes 
Schadler 
(89) EWS yes yes --- yes 
 
luated in healthy subjects and COPD patients at different conditions e.g. high 
altitude. Evaluations have been performed in animal models on mechanical 
ventilation (90). 
The Nottingham Physiological Simulator (NPS) (79,91) is a simulation 
program that describes physiological processes, including pulmonary gas 
exchange, blood acid-base status, circulation, and metabolism. Recently, a 
method for tuning this system to describe ventilated patients has been 
implemented and evaluated in COPD patients (36). NPS has been used to 
optimize mechanical ventilation settings to avoid VILI and simulate 
recruitment maneuvers (92,93). NPS includes description of pulmonary gas-  
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Table 2-4 Review of physiological models describing the relationship between blood 
acid-base status and ventilation (continuation). 
 
Model 
complexity    
Autors Blood acid-base 
and oxygen-
nation 
Body buffering Others Clinical 
evaluation of 
the model 
Chakrabotty 
(82) 
yes no 
capillary 
dilatation, red 
cell 
morphology 
yes 
Kapitan (83) 
yes no --- no 
Chbat 
Albanesse 
(84,85) 
yes no 
lung 
mechanics, 
circulatory 
system, 
respiratory 
control 
no 
Wilson (86) 
yes no 
lung 
mechanics, 
tracheal tree 
CFD, 
pulmonary 
circulation 
yes* 
Reynolds (87) 
yes no 
inflammation 
model 
no 
Kretschmer (88) 
yes no --- yes 
Schadler (89) 
yes no 
lung 
mechanics 
yes 
 
exchange, blood acid-base and oxygenation, and body buffering, in addition 
to lung mechanics and circulatory system. NPS has been used for simulate 
different physiological conditions. Evaluations describing vitual patients with 
ARDS and COPD have been performed (93-96). 
The Sheffield Intelligent Ventilator Advisor (SIVA) (33,97) is a hybrid DSS that 
employs the physiological model ‘Simulation of patients under artificial 
ventilation’ (SOPAVent) to describe the effects of changes in mechanical 
ventilation on blood acid-base status. SOPAVent uses a fuzzy logic algorithm 
with includes models of V̇CO2 and pulmonary shunt, which are necessary for 
THE APPLICATION OF PHYSIOLOGICAL MODELS TO DESCRIBE SPONTANEOUSLY BREATHING PATIENTS’ 
RESPONSE TO CHANGES IN VENTILATOR SUPPORT 
38
 
determining the value of the patient-specific parameter ‘relative dead space’ 
(Kd) (80). The model parameter Kd, depends on fuzzy-logic rules. SIVA-
SOPAVent includes a description of pulmonary gas-exchange, blood acid-
base status and oxygenation, and lung mechanics, but does not include a 
model of body buffering. SOPAVent has been evaluated in patients on 
mechanical ventilation, and was shown to provide acceptable model 
predictions of PaCO2, PaO2, and pHa (80). 
The Intelligent Ventilator (INVENT) (1) is a model-based DSS, which 
generates advice for setting mechanical ventilation. The advice is found by 
optimizing patient-specific simulations considering penalty functions that 
reflect clinical preferences over ventilator settings and the simulated patients’ 
outcome (98). A method for determining patient-specific model parameters is 
described. This method includes an experimental procedure, where FIO2 is 
modified in 3 to 5 step changes until the patient reaches steady state (61,62). 
Continuous measurements of pulse oximetry saturation, FIO2, FECO2, FEO2, 
inspiratory and expiratory flow, and a single arterial blood gas (ABG) 
measurement taken at the beginning of the experiment are required for 
determining the value of model parameters. Most measurements are 
available in the clinical setting but it does require both volumetric 
capnography and indirect calorimetry. INVENT’s parameters have 
physiological interpretation, model parameters describing pulmonary gas-
exchange are: shunt fraction (fs); fraction of ventilation to alveolar 
compartment 2 (fA2); and fraction of perfusion to compartment 2 (f2) (40). 
INVENT includes a description of pulmonary gas-exchange, blood acid-base 
status and oxygenation, body buffering, and lung mechanics. INVENT has 
been evaluated retrospectively and prospectively to describe patients status 
during controlled ventilation, and to generate advice for FIO2, VT and fR 
(2,4,5). 
The model of Ben-Tal (81) was developed to describe the respiratory control, 
as such, the model includes a mono-compartmental description of pulmonary 
gas-exchange and blood acid-base status. There is no description of a 
method for determining patient-specific parameters, because the aim of the 
model of pulmonary gas-exchange is not to describe ventilation-perfusion 
impairment. Ben-Tal’s model includes a description of pulmonary gas-
exchange, blood acid-base status, and respiratory control, but lacks 
description of body buffering. This model has not been evaluated for 
describing patients on mechanical ventilation. 
The model of Chakrabotty (82) is a multi-scale physiological model, which 
has been developed for describing the lungs function from a micro, meso and 
macro scale. There is no description of a method for determining patient-
specific parameters. The model has a large number of model parameters and 
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provides an insight to pathologies that increase high V̇/Q̇ regions of the lung. 
The model includes a description of pulmonary gas-exchange, blood acid-
base status and oxygenation, pulmonary capillary circulation, and red-blood 
cell oxygen saturation, but does not include a model of body buffering. This 
model has been evaluated qualitatively to describe hepatopulmonary 
syndrome. 
The model of Kapitan (83) is included in a patient simulator program, which 
is used for training physicians, and simulating different conditions of 
pulmonary gas-exchange, blood acid-base abnormalities, circulation and 
metabolism. Although Kapitan’s model has the potential for describing 
patients’ response, there is no description of a method for determining 
patient-specific parameter values. This model is capable of simulating 
different physiological conditions, but no clinical evaluations for describing 
individual patients have been performed. 
The cardio pulmonary (CP) model (84,85) is a physiological model capable 
of simulating changes in pulmonary gas-exchange, circulation and respiratory 
control for a variety of physiological conditions. There is no method for 
determining the values of patient-specific model parameters, which are input 
by the user. CP’s pulmonary gas-exchange parameters have physiological 
interpretation e.g. pulmonary shunt (Fsh), blood flow to the pulmonary 
capillary (Fpp). This model includes a description of pulmonary gas-
exchange, blood acid-base, cardiovascular system, lung mechanics, and 
respiratory control, but not body buffering. The CP model has not been 
evaluated for describing patients on mechanical ventilation. 
The model of Wilson (86) provides a detailed description of fluid dynamics in 
the bronchial tree and pulmonary gas-exchange. A method for determining 
patient-specific model parameter describing pulmonary gas exchange is 
described. This model parameter i.e. ‘% lung damage’ can be tuned from 
clinical data, however, it may be not provide the complexity required to 
describe heterogeneous V̇/Q̇ distributions seen in abnormalities of pulmonary 
gas exchange. Wilson’s model includes a description of pulmonary gas-
exchange, blood acid-base, pulmonary circulation and fluid dynamics of the 
bronchial tree, but not body buffering. Despite the level of complexity of this 
model, Wilson concluded that the description of patients on mechanical 
ventilation was not adequate for blood acid-base status and FECO2 (86). 
The model of Reynolds (87) provides a description of how inflammation of the 
lung tissue can alter pulmonary gas-exchange. There is no description of a 
method for determining patient-specific model parameters. Reynold’s model 
parameters for pulmonary gas-exchange parameters have physiological 
interpretation, and are input by the researcher according to conditions of 
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interest. This model includes a description of pulmonary gas-exchange, blood 
acid-base, lung tissue buffer, and immune system, but not body buffering. 
Reynolds’ model has not been evaluated to describe patients on mechanical 
ventilation, rather has been used to evaluate retrospectively and qualitatively 
data from typical patients. 
The beat-to-beat model (88), is a physiological model capable of simulating 
changes in pulmonary gas-exchange, circulation, lung mechanics and the 
effects of positive ventilation on the circulatory system. A method for 
determining the values of patient-specific model parameters is described. 
This method includes an experimental procedure where fR is increased and 
reduced form the clinical value, until patients reach FECO2 steady state. 
Continuous measurements of FECO2 and V̇CO2 during the experimental 
procedure, cardiac output (Q̇) are required to calculate the pulmonary gas-
exchange model parameters. The beat-to-beat’s parameters have 
physiological interpretation, model parameters describing pulmonary gas-
exchange are: shunt fraction (fs); fraction of ventilation to alveolar 
compartment 1 (fA); and fraction of perfusion to compartment 1 (fQ). The 
beat-to-beat model includes a description of pulmonary gas-exchange, blood 
acid-base, pulsatile circulation and lung mechanics, but does not include a 
model of body buffering. The beat-to-beat model has been evaluated in 
patients on mechanical ventilation, and was shown to provide acceptable 
model predictions of FECO2 (35). 
The Evita weaning system (EWS) (89), is hybrid DSS, that integrates a rule-
based and physiological models. There is no description of a method used 
for determining patient-specific model parameters. EWS includes a 
description of pulmonary gas-exchange and blood acid-base status, lung 
mechanics, but not body buffering. EWS has been evaluated in patients on 
mechanical ventilation model, and is was shown to provide adequate levels 
of ventilation support.  
2.1.4. SUMMARY OF THE REVIEW 
This section has reviewed models similar to INVENT’s set of models. There 
are physiological models more complex than INVENT’s set of models, which 
allow the simulation of the effects of inflammation, air flow in the bronchial 
tree, circulatory system and respiratory drive. However, no single model 
incudes extra complexity and at the same time can be identified from clinically 
available data. The majority of the models listed in table 2-1 were developed 
to simulate patient response with complex models, without the intention of 
inverting the models and performing parameter estimation.  
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A few of the models reviewed have functionality and complexity similar to 
INVENT, these being: 2C, NPS, SIVA-SOPAVent; Wilson’s model, beat-to-
beat, and EWS. SIVA-SOPAVent and EWS are hybrid DSS. For both 
systems, however, the interpretation of model parameters is not clear, and 
neither include a description of body buffering. The beat-to-beat and Wilson’s 
models are similar to that of INVENT, with clear interpretation of model 
parameters. These models, however, do not include a representation of body 
buffering. The models 2C, and NPS are also similar to that of INVENT with a 
clear interpretation of parameters. These models describe all required model 
components (pulmonary gas-exchange, blood acid-base status and body 
buffering), however, models differ in the assumptions considered for 
describing each model component. For instance, INVENT’s representation of 
bicarbonate distribution through a model of whole body buffering compares 
well to simulation of in-vivo blood-buffer curves (39,99,100). This model is 
necessary to describe the respiratory response of patients with abnormal 
blood acid-base status. The 2C model has been evaluated in animal models 
on mechanical ventilation, and COPD patients in conditions of hypoxia 
(90,101), NPS has been evaluated with virtual patients describing typical 
behavior of COPD and ARDS (36,93), the beat-to-beat model has been 
evaluated to simulate FECO2 in ventilated patients (35), and the model of 
Wilson was evaluated in six patients on mechanical ventilation (86). 
In conclusion, the set of models included in INVENT appears to be 
reasonable when considering the 7 criteria established at the start of this 
section. Model parameters can be tuned with clinically available data, at least 
with volumetric capnography and indirect calorimetry; model parameters 
have clinical interpretation; the set of models appears to have sufficient 
complexity, apart from the absence of a model of respiratory control; and 
models have been evaluated in laboratory and clinical conditions. The need 
of a respiratory control model is considered in the next sub-section. 
2.1.5. MODEL REQUIREMENTS FOR DESCRIBING SPONTANEOUSLY 
BREATHING PATIENTS 
Spontaneously breathing patients’ response to changes in ventilator support 
depends upon different physiological processes. For instance, consider a 
patient being ventilated in PSV that is subjected to a reduction in PS. After 
reducing PS, there will be a dynamic response followed by a new steady state 
condition (30). The dynamic response will be an immediate reduction in VT, 
and total breathing time. The stready state response will be the increased 
ventilation that compensates for changes in blood acid-base status. These 
responses can be explained as a sequence of processes. After reducing PS, 
both inspired VT and the alveolar volume are reduced, since the respiratory 
system compliance is constant. In turn, changes in the alveolar volume 
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modify concentration of alveolar gases, the alveolar concentration of O2 
(FAO2) decreases, and the alveolar concentration of CO2 (FACO2) increases. 
Accordingly, capillary, arterial and mixed venous pressures of O2 decrease, 
and capillary, arterial and mixed venous pressures of CO2 increase. Changes 
in blood O2 and CO2 are delayed due to blood circulation, washing in and 
washing out of CO2 and bicarbonate distribution within body fluid 
compartments (blood, interstitial fluid, tissue water). Decreased PaO2 
reduces blood oxygen saturation, and increased PaCO2, alters blood acid-
base status, increasing [H+a] (reducing pHa and increasing PaCO2). In turn, 
the respiratory chemoreflexes increase ventilation in response to increasing 
[H+a], PaCO2 and PaO2, typically by increasing the muscle generated 
pressure (Pmus) to increase VT. Increasing respiratory muscles activity may 
increase V̇O2, V̇CO2, and VT. The steady state ventilation results from the 
equilibrium between all of these processes.  
The set of models included in INVENT describes the processes affecting 
changes in ventilation and blood acid-base status, taking into account the 
effects of bicarbonate distribution, the Bohr and Haldane effects, and 
changes in O2 intake (V̇O2) and production of CO2 (V̇CO2). In order to 
describe spontaneously breathing patients with INVENT’s set of models 
requires the addition of a process describing the mechanism of chemoreflex 
response to [H+a] (or PaCO2) that controls ventilation to regulate [H+a] and 
PaO2. The next section presents and reviews several mechanisms describing 
chemoreflex control of ventilation i.e. models of respiratory control. The 
criteria for reviewing such models is based upon their potential applicability 
to describe individual patients’ response to changes in the level of ventilator 
support at the bedside. 
2.2. REVIEW AND SELECTION OF RESPIRATORY CONTROL 
MODELS 
Several respiratory control models describing the mechanism that controls 
ventilation to regulate either arterial hydrogen ion concentration in the arterial 
blood ([H+a]) or PaCO2, and PaO2, have been previously developed 
(102,103). This section presents a review of these models in the context of 
applying them at the bedside to describe patients’ response to changes in 
ventilator support. 
2.2.1. DESCRIPTION OF THE MECHANISM OF RESPIRATORY 
CONTROL 
Figure 2-2 illustrates the chemoreflex mechanism that controls ventilation to 
regulate [H+a], and PaO2, (103). This figure illustrates the feedback regulation 
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linking ventilation and acid-base status of blood and CSF (104). Ventilation is 
generated by the addition of three respiratory drives i.e. wakefulness, central 
chemoreflex and peripheral chemoreflex. Wakefulness drive does not 
depend on chemical inputs, and is considered the behavioral component of 
breathing. It is assumed to be zero during sleeping or unconscious breathing 
(105). Central and peripheral chemoreflex drives are generated at the central 
and peripheral chemoreceptors, respectively. Central chemoreceptors are 
located in the ventrolateral surface of the medulla oblongata (106,107). This 
type of chemoreceptors sense the hydrogen ion concentration in the 
cerebrospinal fluid (CSF) ([H+csf]), which depends on PaCO2 and the buffer 
capacity of the CSF (108,109). Central chemoreceptors generate the central 
chemoreflex respiratory drive as a function of [H+csf]. Peripheral 
chemoreceptors are located in the carotid bodies (106,107). These 
chemoreceptors sense [H+a], which depends on PaCO2, and arterial blood 
acid-base status. The peripheral chemoreceptors generate the peripheral 
chemoreflex respiratory drive as a function of [H+a], PaCO2, which is 
modulated by the level of PaO2 (103). 
 
 
Figure 2-2. Block diagram describing the chemoreflex control of ventilation to regulate 
pHa or PaCO2. Ventilation is produced as the addition of three respiratory drives i.e. 
wakefulness, peripheral chemoreflex, and central chemoreflex. The peripheral and 
central chemoreflex drives are generated by [H+a] and [H+csf], respectively. In 
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addition, the peripheral chemoreflex drive is sensitive to PaO2. [H+a] and [H+csf] are 
dependent upon PaCO2 and the acid-base status within arterial blood and CSF, 
respectively. PaO2 and PaCO2 depend upon the pulmonary gas-exchange conditions 
and ventilation. 
The three respiratory drives described above result in ventilation or 
respiratory drive, which, depending upon FIO2 and pulmonary gas-exchange, 
will result in changes in PaO2 and PaCO2. In turn, values of PaO2 and PaCO2, 
will result in arterial blood oxygen saturation and [H+a] which will depend upon 
patients blood acid-base status, including base excess (BE) and the 
characteristics of the oxygen dissociation curve. CO2 molecules diffuse freely 
from arterial blood to CSF and the value of [H+csf] will therefore depend upon 
PaCO2 and the buffer capacity of CSF (SIDcsf). These changes in acid-base 
status complete the feedforward loop with changes in [H+a], [H+csf], and 
PaO2, signaling central and peripheral chemoreceptors. 
Spontaneously breathing patients in assisted-ventilation modes, may present 
abnormal blood acid-base status, and increased V̇O2 and V̇CO2. Abnormal 
blood acid-base status, characterized by changes in BE, modifies the 
relationship between PaCO2 and [H+a], altering the ventilation generated by 
the chemoreflex drives (104,110). To illustrate the effects of abnormal blood 
base excess (BE) in the respiratory response, figure 2-3 illustrates changes 
in ventilation on increasing PaCO2 due to increasing inspired fraction of CO2 
(FICO2), measured at three different blood acid-base conditions: normal 
(BE=0 mmol/l); metabolic acidosis (BE=-5 mmol/l); and metabolic alkalosis 
(BE=5 mmol/l). For normal conditions of blood acid-base (i.e. BE=0 mmol/l), 
ventilation increases linearly as PaCO2 increases (solid line ‘b’ figure 2-3). 
For metabolic acidosis (i.e. negative values of BE), the respiratory response 
to increasing PaCO2, is shifted to the left side from the normal blood acid-
base response, so that, ventilation increases with lower PaCO2 in comparison 
to normal blood acid-base (solid line ‘a’ in figure 2-3). Conversely, for 
metabolic alkalosis (i.e. positive values of BE), the respiratory response to 
increasing PaCO2, is shifted to the right, so that, ventilation increases with 
higher PaCO2 in comparison to normal blood acid-base (dashed line ‘c’ in 
figure 2-3). The solid lines were taken from (107) and the dashed line ‘c’ was 
taken from (11,12).  
Increasing FICO2 is an experimental procedure, which is not commonly 
performed in patients on mechanical ventilation. However, models ability to 
reproduce the effects of increased FICO2 may imply that such models are 
likely to describe adequately changes in V̇CO2. Section 4.2.1 verifies the 
ability of the model of respiratory control integrated into INVENT’s set of 
models to simulate abnormal blood acid-base states at two levels of V̇CO2. 
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In conclusion, [H+a], [H+csf], and PaO2, determine ventilation generated by 
the chemoreflex drives. In addition, blood acid-base status, V̇O2, and V̇CO2 
modulate ventilation generated by the chemoreflex drives, as illustrated in 
figure 2-3. A suitable respiratory control model for being integrated into 
INVENT’s set of models, therefore, requires that both, peripheral and central 
drives, can describe the modulation effect of abnormal blood or CSF acid-
base status, under different conditions of V̇O2, and V̇CO2.  
 
Figure 2-3. Respiratory response to increased FICO2, during normal blood acid-base 
status, metabolic acidosis and metabolic alkalosis. The solid line ‘a’ illustrates the 
respiratory response to increasing FICO2 in subjects with metabolic acidosis (BE=-5 
mmol/l). The solid line ‘b’ illustrates the respiratory response to FICO2 in subjects with 
normal blood acid-base status (BE=0 mmol/l). The solid line ‘c’ illustrate the 
respiratory response to increasing FICO2 in subjects with metabolic alkalosis (BE=5 
mmol/l). The dotted line represents the metabolic hyperbola, and the dot and dashed 
lines represent extensions of the respiratory response to PaCO2. 
Different respiratory control models have been developed to describe the 
chemoreflex mechanism controlling ventilation to regulate [H+a], PaO2, and 
[H+csf] or PaCO2 (102,103). The next sub-section describes criteria for 
reviewing such respiratory control models in regards to their capabaility to 
describe the modulation of ventilation according to blood and CSF acid-base 
disturbances, and their potential to be tuned with clinically available data. The 
aim of the review being to select a respiratory control model to describe 
patients’ response to changes in the level of ventilator support. 
2.2.2. CRITERIA FOR REVIEWING RESPIRATORY CONTROL MODELS 
As mentioned in the previous sub-section, the selection of appropriate 
respiratory control models is essential for describing patients’ respiratory 
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response to abnormal blood and CSF acid-base status and changes in V̇O2, 
and V̇CO2. The models are, therefore, reviewed with the following criteria: 
1. Model parameters can be tuned with clinically available data and 
standard measurements available in the ICU (these being defined 
as measurement of ABG, volumetric capnography and/or indirect 
calorimetry). 
2. Model parameters have physiological interpretation, and as such 
provide deeper understanding of patients’ physiology. 
3. Model complexity includes modulation of peripheral respiratory drive 
due to blood acid-base disturbances. 
4. Model complexity includes modulation of central respiratory drive 
due to CSF acid-base disturbances. 
5. Models have been adequately evaluated and shown to describe the 
respiratory response of healthy subjects or/and subjects with 
induced or pathological acid-base abnormalities. 
The following sub-section reviews published respiratory control models, using 
these criteria.  
2.2.3. REVIEW OF RESPIRATORY CONTROL MODELS 
Table 2-2 summarizes this review of 14 published respiratory control models. 
All models were reviewed according to the criteria presented in 2.2.2, with the 
first column of table 2-2 listing the main authors of the models, and the rest 
of the columns representing a single criterion. Table cells of the second, third 
and last columns contain either ‘yes’ or ‘no’, denoting whether each model 
meets the requirement. The fourth and fifth columns list each model’s input 
variables and parameters, respectively. The sixth column indicates whether 
each model includes additional model complexity. 
The model of Lloyd (111) provides a description of the respiratory response 
to CO2 in healthy subjects. Lloyd’s model parameters can be tuned from 
clinical data and have physiological interpretation. To estimate ventilation the 
model requires PaCO2 and PaO2, but there is no description of modulation of 
the respiratory drive. 
The model of Grodins (112), provides a description of the respiratory 
response to CO2, including a mechanism to modulate ventilation via the CSF 
pH (pHcsf), and cerebral blood flow (CBF). Grodins’ model parameters can 
be tuned from clinical data and have physiological interpretation. To estimate 
ventilation, the model requires PaCO2, pHa, and pHcsf. The modulation of 
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ventilation is performed by varying CBF and changing the value of the 
parameter describing the relationship between pHa and pHcsf. 
The model of Khoo (113) provides a description of the respiratory response 
to CO2. Khoo’s model parameters can be tuned from clinical data and have 
physiological interpretation. To estimate ventilation, the model requires 
PaCO2, and PaO2. The modulation of ventilation is performed by changing 
controller gains and time delay due to blood circulation. 
The model of Longobardo (114) provides a description of periodic breathing 
at different metabolic rate conditions, the model includes a mechanism to 
modulate ventilation via CBF and body circulation. Not all model parameters 
can be tuned with clinical data, neither have physiological interpretation. To 
estimate ventilation, the model requires PaCO2 and PaO2. The modulation of 
ventilation can be performed by changing the values of time delay constants 
that modify body circulation and CBF. 
The model of Yamamoto (115) provides a description of steady state 
ventilation during resting conditions and exercise. Also, this model tries to 
explain the mechanism of exercise hyperpnoea. Yamamoto’s model 
parameters can be tuned from clinical data and have physiological 
interpretation. To estimate ventilation, the model requires PaCO2. The 
modulation of ventilation is performed by varying the gradient between brain 
and arterial PCO2. 
The model of Ursino (116,117) provides a description of response to 
hypercapnia and hypoxia, also includes a mechanism to modulate ventilation 
via CBF and central ventilatory depression (CVD). Ursino’s model parameters 
can be tuned from clinical data and have physiological interpretation. To 
estimate ventilation, the model requires PaCO2 and PaO2. The modulation of 
ventilation is performed by changing values of chemoreceptor gains and time 
delay due to blood circulation. 
The model of Topor (118) provides a description of respiratory response to 
CO2, and is focused on describing respiratory control instability e.g. 
Cheyenne-Stokes breathing (CSB). Topor’s model parameters can be tuned 
from clinical data and have physiological interpretation. To estimate 
ventilation, the model requires PaCO2, and PaO2. The modulation of 
ventilation is performed by changing values of chemosensitivity, and time 
delay due to blood circulation. 
The model of Zhou (119) provides a description of respiratory response to 
CO2, and includes a mechanism to modulate ventilation via CBF and CVD. 
Zhou’s model parameters can be tuned with clinical data and have physio- 
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Table 2-2. Review of respiratory control models. 
Autors Model parameters:  Model complexity 
 Can be tuned to 
individual patient 
with clinical data 
Physiological 
interpretation 
Blood variables 
driving the 
respiratory response 
Lloyd (111) yes yes PaCO2, PaO2 
Grodins (112) yes yes PaCO2, pHa 
Khoo (113) yes yes PaCO2, PaO2 
Longobardo (114) yes no PaCO2, PaO2 
Yamamoto (115) yes yes PaCO2 
Ursino (116,117) yes* yes PaCO2, PaO2 
Topor (118) yes yes PaCO2, PaO2 
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Table 2-2. Review of respiratory control models (continuation). 
Autors Model complexity  Evaluation of the 
model in subjects 
with and without 
blood acid-base 
abnormalities. 
 Modulation of the 
respiratory drive 
 
Others 
Lloyd (111) no --- no 
Grodins (112) pHcsf and via time 
delay constants 
CSF acid-base, 
body circulation, 
CBF 
no 
Khoo (113) via  circulation 
delays, and 
controller gains 
Cheyne-Stokes 
breathing 
no 
Longobardo (114) via time delay 
constants 
Body circulation, 
CBF, CO2 and O2 
stores in the body 
no 
Yamamoto (115) via PbrainCO2, 
gradient arterial-
brain CO2 
CBF, exercise 
hyperpnea 
no 
Ursino (116,117) via chemoreceptor 
gains and circulation 
delay 
CVD, CBF no 
Topor (118) via chemosensitivity 
and time delay 
between lungs and 
chemoreceptors 
Cheyne-Stokes 
breathing, body 
circulation 
no 
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Table 2-2. Review of respiratory control models. 
Autors Model parameters:  Model complexity 
 Can be tuned to 
individual patient 
with clinical data 
Physiological 
interpretation 
Blood variables 
driving the respiratory 
response 
Zhou (119) yes yes PaCO2, PaO2 
Duffin (103) yes yes pHa, PaCO2, PaO2 
Anslie (102) yes yes PaCO2, PaO2 
Ben-Tal (81,120) yes* yes PaCO2, PaO2 
Poon (121) yes yes PaCO2 
Albanese, Chbat 
(84,85) 
yes no PaCO2, PaO2 
Fowler (122) yes yes PaCO2,  pHa 
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Table 2-2. Review of respiratory control models (continuation). 
Autors Model complexity  Evaluation of the 
model in subjects 
with and without 
blood acid-base 
abnormalities. 
 Modulation of the 
respiratory drive 
 
Others 
Zhou (119) via chemosensitivity 
and time delay 
between lungs and 
chemoreceptors 
CVD, CBF no 
Duffin (103) via acid-base of CSF 
and blood 
CSF acid-base yes 
Anslie (102) via acid-base of CSF 
and blood 
CBF, PcsfCO2 yes 
Ben-Tal (81,120) via time delay 
between lungs and 
chemoreceptors 
Neural rhythm 
generator, body 
circulation, CBF 
no 
Poon (121) via chemoreceptor 
gains and time delay 
Work of breathing no 
Albanese, Chbat 
(84,85) 
via chemoreceptor 
gains and time 
delays 
Body circulation, 
lung mechanics 
no 
Fowler (122) via chemoreceptor 
gains and time 
delays 
CBF, control of 
CSF buffering 
no 
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logical interpretation. To estimate ventilation, the model requires PaCO2 and 
PaO2. The modulation of ventilation is performed by changing values of 
chemosensitivity and time delay between lungs and chemoreceptors due to 
blood circulation. 
The model of Duffin (103) provides a description of respiratory response to 
CO2, and includes a model of acid-base status of the CSF. Duffin’s model 
parameters can be tuned with clinical data and have physiological 
interpretation. To estimate ventilation, the model requires pHa, PaCO2 and 
PaO2. The modulation of ventilation is performed by defining the acid-base 
status of the CSF. This model has been evaluated qualitatively against data 
from literature, and quantitatively against experimental conditions including 
increase in FICO2, high altitude acclimation and hypoxia (110,123). 
The model of Anslie (102) is an extension of Duffin’s model. This model 
includes a mechanism to modulate ventilation via CBF, and a model for 
estimating the CSF partial pressure of CO2 (PcsfCO2). Anslie’s model 
parameters can be tuned with clinical data and have physiological 
interpretation. To estimate ventilation, the model requires PaCO2, and PaO2. 
The modulation of ventilation is performed by defining the acid-base status of 
the CSF, which depends on CBF and PcsfCO2. This model has been 
evaluated with an experimental protocol. 
The model of Ben-Tal (81,120) provides a description of respiratory response 
to CO2, this model includes a neural rhythm generator, and ventilation is 
modulated via the time delay between lungs and chemoreceptors. Ben-Tal’s 
model parameters can be tuned with clinical data and have physiological 
interpretation. To estimate ventilation, the model requires PaCO2 and PaO2. 
The modulation of ventilation is performed by changing the values of time 
delay constants due to blood circulation. 
The model of Poon (121,124) provides a description of respiratory response 
to CO2, exercise hyperpnoea, and includes a model of work of breathing. 
Poon’s model parameters can be tuned with clinical data and have 
physiological interpretation. To estimate ventilation, the model requires 
PaCO2, and the relationship between dead space and tidal volume (VD/VT). 
The modulation of ventilation is performed by changing values of 
chemoreceptor gains, time delay constantans due to blood circulation, and 
VD/VT. 
The model of Albanese-Chbat (84,85) provides a description of respiratory 
response to CO2, body circulation and lung mechanics. This is a theoretical 
model developed to simulate patients on mechanical ventilation. Albanese-
Chbat’s model parameters can be tuned with clinical data, but not all the 
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parameters have clinical interpretation. To estimate ventilation, the model 
requires PaCO2 and PaO2. The modulation of ventilation is performed by 
changing values of chemoreceptor gains, and time constants due to blood 
circulation. 
The model of Fowler (122) provides a description of respiratory response to 
CO2, body circulation, CBF, and CSF buffering. Fowler’s model parameters 
can be tuned with clinical data and have physiological interpretation. To 
estimate ventilation, the model requires PaCO2, and pHa. The modulation of 
ventilation is performed by changing values of chemoreceptor gains and time 
constants due to blood circulation.  
2.2.4. MODEL SELECTION 
All the models of respiratory control listed in table 2-2 have parameters that 
can be tuned with clinical data, and all of them but two, use parameters that 
have physiological interpretation. In general, these model parameters are: 
time delay constants due to blood circulation, chemoreceptor sensitivity to 
either PaCO2, or [H+a], and central and peripheral chemoreceptor gains. All 
the models but one, have the capacity of modulating the respiratory response, 
so that, several abnormal respiratory responses can be simulated.  
The model of Duffin (103), has been previously evaluated against literature 
data and experimental data, and is the only model that includes an explicit 
model of acid-base status for the CSF. The advantage of using a CSF acid-
base model is that, the central respiratory chemoreflex drive can be 
modulated by abnormal CSF acid-base status due to e.g. metabolic acidosis, 
rather than a selecting a certain value of chemoreceptor gain. The same 
advantage applies for arterial blood, in this case, the peripheral chemoreflex 
respiratory drive can be modulated due to blood acid-base disturbances. 
Besides Duffin’s model, the models of Grodins (112) and Fowler (122) also 
require pHa to estimate the peripheral chemoreflex respiratory drive, and 
highlight the importance of estimating pHcsf for modulating the respiratory 
response to CO2. However, only Duffin’s model includes mass-action 
equations for determining the CSF acid-base status.  
According to the review of respiratory control models, the model of 
chemoreflex control of breathing of Duffin includes a model of CSF acid-base 
status that can be used to modulate the respiratory response. For this reason, 
Duffin’s model was selected to be integrated into INVENT’s physiological 
models. The resulting model may describe spontaneously breathing patients 
in assisted ventilation. The next chapter describes the integration of the 
model of chemoreflex control of breathing into INVENT. 
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CHAPTER 3. INTEGRATION OF THE 
SELECTED MODEL OF RESPIRATORY 
CONTROL INTO INVENT’S SET OF 
MODELS 
In the previous chapter, the model of respiratory control that will be integrated 
into INVENT’s set of models was selected. To do so, a review of models of 
respiratory control was performed. In addition, the underlying assumption that 
INVENT’s set of models adequately describes patient’s response was 
validated, by reviewing physiological models similar those included in 
INVENT’s set of models. The respiratory control model selected was the 
chemoreflex breathing control model of Duffin. This was selected due to its 
capability to describe respiratory response, and being potentially tuned for 
individual patients with clinical data. In order to integrate  Duffin’s model into 
the set of models included in INVENT, Duffin’s model requires two 
modifications, these being: to describe  the relationship between patients’ 
blood and CSF acid-base status; and to allow disfacilitation of the respiratory 
drive due to abnormal blood or CSF acid-base status. In addition to 
integration of Duffin’s model, two further modifications of INVENT’s models 
were required for these models to describe spontaneous breathing. These 
are model representation of the situation where patients respond 
inadequately to changes in ventilator support, due to for example respiratory 
muscles failure, and the representation of respiratory mechanics in the 
situation of active breathing. This chapter describes the integration of Duffin’s 
model into the INVENT’s set of models, including the above mentioned 
modifications. Section 3.1 describes INVENT’s physiological models and how 
model parameters are tuned to individual patients. Section 3.2 describes the 
model of chemoreflex breathing control, and the modifications performed to 
the model. Section 3.3 describes the quantification of muscle function, and 
section 3.4 describes the quantification of effective compliance. Model 
assumptions and limitations are listed in section 3.5. 
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3.1. DESCRIPTION INVENT’S SET OF PHYSIOLOGICAL 
MODELS 
INVENT is a model-based DSS that provides patient-specific advice on 
ventilator settings in controlled ventilation modes. To do so, models 
parameters are tuned to individual patients’ conditions. The models can then 
be used to perform a series of simulations describing the likely patient 
response to changes in ventilation, and advice is generated based upon the 
most optimal simulation results. The simulations are performed with the set 
of physiological models illustrated in figure 2-1. The use of physiological 
models to describe or simulate patients’ response allows combining the 
effects of relevant physiological systems involved in ventilation (blood acid-
base status, body buffering, and pulmonary gas-exchange). The set of 
physiological models has been evaluated retrospectively (2-4) and 
prospectively (5) to describe patients-response to changes in controlled-
ventilation. The following subsections describe the models included in 
INVENT, i.e. those describing blood acid-base status, body buffering, and 
pulmonary gas-exchange. 
 
 
Figure 3-1. Model of blood acid-base status (38). (With kind permission from Springer 
Science+Business Media: Eur J Appl Physiol, Mathematical modeling of the acid–
base chemistry and oxygenation of blood – A mass-balance, mass-action approach 
including plasma and red blood cells, 108, 2010, page 485, Rees SE, Klæstrup E, 
Handy J, Andreassen S, Kristensen SR, figure 1B.) 
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3.1.1. BLOOD ACID-BASE STATUS MODEL 
The model of blood acid-base status, illustrated in Figure 3.1, includes six 
blood components: O2; CO2; hemoglobin (Hb(RH)3NH3+); plasma non-
bicarbonate buffer (NBB); buffer base (BB) or strong ion difference (SID); and 
concentration of 2,3 diphosphoglycerate (DPG) (37). The relationship 
between these components is given by 26 equations (37,38), including mass-
balance and mass-action equations, and physico-chemical properties of 
blood, as illustrated in figure 3-1. This model of blood acid-base chemistry 
describes acid-base and oxygenation of red blood cells, and a formulation of 
the oxygen dissociation curve describing the Bohr and Haldane effects (125-
127). The 26 equations can be solved with data from a single arterial blood 
gas measurement (pHa, PaO2, PaCO2, Hb, SaO2), to determine the blood 
acid-base model parameters base excess (BE or buffer base-normal buffer 
base) and DPG (37). 
 
3.1.2. BODY BUFFERING MODEL (WHOLE BODY O2-CO2 TRANSPORT 
AND STORAGE) 
The model of body buffering describes O2 and CO2 transport from the lungs 
to the tissues and vice-versa, considering CO2 storage in interstitial fluid and 
tissue water (figure 3-2). The model was designed to describe the effects of 
abnormal V̇O2 and V̇CO2, which alter the equilibrium (homeostasis) between 
ventilation, and the acid-base status of arterial blood, mixed venous blood, 
interstitial fluid and tissue water. To do so, the model includes 45 equations 
(39) describing acid-base chemistry and mass conservation within the 
interstitial fluid and tissue water, taking into account V̇O2 and V̇CO2, cardiac 
output (Q̇). These equations are combined with the model of blood acid-base 
status to describe arterial and mixed venous blood (39). At steady state, the 
body buffering model determines the content of CO2 stored in the interstitial 
fluid and tissue water, and hence the distribution of bicarbonate [HCO3-] 
between blood, interstitial fluid and tissue compartments. This model is 
necessary to describe and simulate the in-vivo equilibration curves for the 
relationship between [HCO3-a] and PaCO2 (39,99,100). 
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Figure 3-2. Model of body buffering (whole body O2 and CO2 transport and storage). 
Reproduced from (39) with kind permission of Begell House Inc. 
 
3.1.3. PULMONARY GAS-EXCHANGE MODEL 
The model of pulmonary gas-exchange describes the effects of serial dead 
space (Vds), shunt fraction (fs), and mismatch of the lung’s ventilation-
perfusion (V̇/Q̇) distribution on blood acid-base status (figure 3-3). The model 
consists of four compartments, two ventilated and perfused compartments, a 
shunted compartment, and a serial dead space compartment. Two sets of 10 
equations each, are used for describing delivery of O2 (V̇O2)and removal of 
CO2 (V̇CO2), respectively (40), as illustrated in figure 3-3. The pulmonary gas-
exchange model equations require simultaneous solution with the models of 
blood acid-base, and body buffering. The three model parameters are shunt 
fraction (fs), fraction of alveolar ventilation ventilating the second alveolar-
compartment (fA2), and fraction of non-shunted blood perfusing the second 
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alveolar-compartment (f2). The model parameters are estimated with an 
experimental procedure in which FIO2 is modified in 3-5 step changes. The 
corresponding measurements of pulse oximetry (SpO2), FIO2, end tidal O2 
(FeO2), end tidal CO2 (FECO2), V̇O2, V̇CO2 taken at each FIO2 step change, 
and a single arterial blood gas (ABG) measurement taken at the beginning of 
the experimental procedure, are required for parameter estimation (61,128). 
The model determines the relationship between end tidal gases and arterial 
blood pressures for given inspired gases (FIO2, FICO2), V̇CO2, V̇O2 and Vds. 
The pulmonary gas-exchange model has been applied in a number of clinical 
studies (2-5) and has been evaluated against the reference technique for 
determining gas-exchange (i.e. MIGET) in both homogeneous and 
heterogeneous lung models (129,130). 
 
 
Figure 3-3. Model of pulmonary gas-exchange (40). Reprinted from Medical 
Engineering and Physics, 33, Karbing DS, Kjaergaard S, Espersen K, Rees SE. 
Minimal model quantification of pulmonary gas exchange in intensive care patients, 
240-248, Copyright (2011), with permission of Elsevier. 
 
Figure 3-4 illustrates a complete picture of the models included in INVENT 
(figure 3-4 A-C). The components of the respiratory control model (figure 3-4 
D-E), and the descriptions of muscle function (figure 3-4 F), and effective 
compliance (figure 3-4 G), are also included. These components represent 
the added modelling complexity of this PhD thesis, and their details are 
explained in the following sections. 
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Figure 3-4. Structure of the set of physiological models describing patients’ response 
to changes in the level of ventilator support. The set of model includes: pulmonary 
gas-exchange (A); blood acid-base status (B); body buffering (whole body O2 and CO2 
transport and storage) (C); cerebrospinal fluid (CSF) acid-base status (D); 
chemoreflex respiratory drive (E); muscle function (F); ventilation (G); and effective 
compliance (H). 
 
3.2. CHEMOREFLEX BREATHING CONTROL MODEL  
The chemoreflex breathing control model of Duffin (103) determines the 
ventilation as the addition of three respiratory drives (Figure 3-4E), these 
being peripheral and central respiratory chemoreflex drives, and a behavioral 
drive (wakefulness drive). The peripheral and central chemoreflex drives are 
dependent upon [H+] sensed at the carotid bodies and medulla oblongata, 
respectively. The wakefulness drive is considered a constant input, 
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depending upon the patients’ state of consciousness. The model of Duffin 
was modified to be integrated into INVENT’s set of models in the following 
ways: to represent the  inhibition of the chemoreflex respiratory drives due to 
metabolic blood acid-base compensation, as often occurs in chronic 
obstructive pulmonary disease (COPD) (101); to modify CSF acid-base 
status according to blood acid-base status; and to calibrate the values of 
constants in Duffin’s models such that the normal values of the peripheral and 
central thresholds to [H+] were calculated to match the normal values of blood 
acid-base status simulated using INVENT’s set of models . The following sub-
sections describe the components of Duffin’s model, and the corresponding 
modifications. The description of the calculation of the normal values of the 
peripheral and central thresholds is in the next chapter. 
3.2.1. PERIPHERAL CHEMOREFLEX DRIVE  
Equation 1 describes the peripheral chemoreflex drive as a function of the 
arterial hydrogen ion concentration ([H+a]), where Sp is the peripheral 
sensitivity to [H+a], TP is the peripheral threshold, and Dp is the peripheral 
drive. Sp is modulated by PaO2 as defined in Equation 2, where A=2.373 l 
kPa/(min nM/l) and P0=4 kPa. Duffin’s model was modified by adding a 
condition, which allows disfacilitation (or down-regulation) of ventilation, so 
that, Dp can reduce ventilation up to -1 l/min. As such, Dp can reduce 
ventilation when [H+a] is lower than TP. This situation can be due to e.g. 
abnormal blood acid-base status, hyperventilation or reduced V̇CO2 (131-
133). Describing disfacilitation of ventilation through Dp is therefore 
necessary to describe patients in assisted ventilation.  
 
𝐷𝑝 = 𝑆𝑝 ([𝐻𝑎
+] − 𝑇𝑃)    (1) 
𝑖𝑓 𝐷𝑝 < −1 𝑡ℎ𝑒𝑛 𝐷𝑝 = −1  
 
𝑆𝑝 =
𝐴
𝑃𝑎𝑂2−𝑃0
     (2) 
 
In order to determine Dp, the following variables are required [H+a] and PaO2, 
which are determined with the model of blood acid-base status from 
INVENT’s set of models. 
3.2.2. CENTRAL CHEMOREFLEX DRIVE  
Equation 3 describes the central chemoreflex drive as a function of the CSF 
hydrogen ion concentration ([H+csf]), where Sc is the central sensitivity to 
[H+csf], TC is the central threshold, and Dc is the central drive. Duffin’s model 
was modified by adding a condition, which allows disfacilitation (or down-
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regulation) of ventilation, so that, Dc can reduce ventilation up to -1 l/min. As 
such, Dc can reduce ventilation when [H+csf] is lower than TC. This situation 
can be due to e.g. abnormal CSF acid-base status, change in the state of 
consciousness, increase in cerebral blood flow, hyperventilation, or reduced 
V̇CO2 (131-135). Describing disfacilitation of ventilation through Dc is 
therefore necessary to describe patients in assisted ventilation.  
 
𝐷𝑐 = 𝑆𝑐 ([𝐻𝑐𝑠𝑓
+ ] − 𝑇𝐶)    (3) 
𝑖𝑓 𝐷𝑐 < −1 𝑡ℎ𝑒𝑛 𝐷𝑐 = −1  
 
In order to determine Dc, the variable required is [H+csf], which is determined 
with the CSF acid-base model described in the next sub-section. 
3.2.3. CSF ACID-BASE MODEL  
The model of CSF acid-base status is illustrated in Figure 3-4D. This model 
describes CSF with four components: PCO2, strong ion difference (SIDcsf), 
and concentration of phosphate (Pi) and albumin (Alb). The equations of the 
CSF acid-base model (equations 4-9) were taken from Duffin’s model (103). 
The calculation of the CSF partial pressure of CO2 (PcsfCO2) was taken from 
(102) (equation 10), which is an extension of Duffin’s model. Equation 10 
allows the estimation of PcsfCO2 from PaCO2, and constant values of brain 
metabolism V̇bCO2, cerebral blood flow (Q̇b) and the dissociation constant of 
CO2 (KCO2). The values of the constants are listed in table 3-1. The model of 
CSF acid-base status was modified with the addition of equation 11, which 
allows estimating CSF bicarbonate concentration ([HCO3-csf]) from individual 
patients’ estimated  mixed-venous  blood  bicarbonate concentration 
([HCO3,0-]) (136). Estimating [HCO3-csf] is necessary to calculate SIDcsf, 
which determines the relationship between PscfCO2 and [H+csf], and hence, 
Dc. Alterations in SIDcsf due to abnormal blood BE due to metabolic 
compensation of either acidosis or alkalosis, result in changes in ventilation 
(11,12,108,109).  
 
[𝐻+][𝑂𝐻−] = 𝐾𝑤
′     (4) 
[𝑃𝑖−] = [𝑃𝑖𝑡𝑜𝑡] {2 −
[𝐻+]
𝐾2+[𝐻
+]
}    (5) 
[𝐴𝑙𝑏−] = [𝐴𝑙𝑏𝑓𝑖𝑥
− ] −
[𝐻+][𝐴𝑙𝑏𝐻,𝑡𝑜𝑡]
𝐾𝐻+[𝐻
+]
   (6) 
[𝐻+][𝐻𝐶𝑂3
−] = 𝐾𝑐𝑃𝐶𝑂2    (7) 
[𝐻+][𝐶𝑂3
2−] = 𝐾3[𝐻𝐶𝑂3
−]    (8) 
[𝑆𝐼𝐷] + [𝐻+] = [𝑂𝐻−] + [𝑃𝑖−] + ⋯  
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            [𝐴𝑙𝑏−] + [𝐻𝐶𝑂3
−] + 2[𝐶𝑂3
2−]   (9) 
𝑃𝐶𝑂2 = 𝑃𝑎𝐶𝑂2 +
?̇?𝑏𝐶𝑂2
𝐾𝐶𝑂2 ?̇?𝑏
    (10) 
[𝐻𝐶𝑂3,𝑐𝑠𝑓0
− ] = [𝐻𝐶𝑂3,0
− ] + ∆[𝐻𝐶𝑂3
−]   (11) 
 
In order to determine [H+csf] and SIDcsf, the variables required are PaCO2 
and [HCO3,0-], which are determined with the model of blood acid-base status 
from INVENT’s set of models. The importance of estimating [H+csf] is to 
calculate Dc, conversely, the importance of estimating SIDcsf is to simulate 
the effects of changing PaCO2 on Dc. SIDcsf is considered constant because 
ion-exchange between blood and CSF is restricted due to the blood-brain 
barrier. As CO2 molecules can pass across this barrier, [H+csf] can estimated 
from PaCO2 (102,107). 
 
Table 3-1. Constants of the CSF acid-base model. 
 
Symbol Name Value 
Kw Ion product for water 2.39 x10-14 
Kc Combined CO2 equilibrium and solubility  2.45 x10-11 
K3 Carbonate dissociation 1.16 x10-10 
K2 Phosphoric acid dissociation constant 2.19 x 10-7 
KH Histidine dissociation constant 1.77 x10-7 
KCO2 CO2 Dissociation constant (ml/(ml kPa)) 0.0375 
[Alb-Fix] Albumin fixed negative charge concentration (mM/l) 3.95 
[Alb-H,tot] Albumin concentration of histidine residues (mM/l) 3.01 
[Pitot] Phospahte concentration (mM/l) 0.61 
V̇bCO2  Brain production of CO2 (ml (min/100gr)) 3 
Qḃ  Brain blood flow (ml (min/100gr)) 55 
Δ[HCO-3] CSF bicarbonate calibration factor ( mmol/l) 0.12 
 
 
 
In addition, an equation combining the three respiratory drive components is 
required to calculate the expected alveolar ventilation (V̇Aexp). Equation 12 
represents V̇Aexp as the sum of the peripheral (Dp), central (Dc), and 
wakefulness drives (Dw). The values of Dw depend upon the state of 
consciousness of the patient, with Dw=0 l/min for sleeping or 
unconsciousness (105), and Dw=2 l/min for awaken patients. The latter Dw 
value was assumed to describe patients are calmly breathing, implying that 
Dw is not the major drive during spontaneous ventilation. 
 
?̇?𝐴𝑒𝑥𝑝 = 𝐷𝑝 + 𝐷𝑐 + 𝐷𝑤    (12) 
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So far, INVENT’s set of models and the model of chemoreflex breathing 
control were described. The model of respiratory control can be used to 
calculate V̇Aexp from two chemoreflex respiratory drives (Dp and Dc), and 
Dw. Considering Dw as a constant depending upon the patients’ state of 
consciousness, V̇Aexp can be calculated requiring four input variables from 
INVENT’s set of models i.e. [H+a], PaO2, PaCO2 and [HCO3,0-]. The following 
sections describe the remaining model components, which are necessary to 
describe spontaneously breathing patients in assisted ventilation. 
3.3. MODEL FOR QUANTIFYING MUSCLE FUNCTION 
The chemoreflex breathing control model described above enables 
simulation of the expected alvelor ventilation (V̇Aexp) due to chemoreceptor 
response. However there may be situations where following reduction of 
ventilator support patients cannot respond adequately to meet the 
chemoreflex driven ventilation, due to, perhaps, reduced muscle strength and 
endurance. In this situation, it is typical that V̇A falls, and hence, blood acid-
base status changes, resulting in lower values of pHa and higher FECO2. In 
order to describe this situation, a model of muscle function was required to 
describe patients’ response to changes in the level of ventilator support. The 
quantification of muscle function model describes the difference between V̇A 
determined by the respiratory control model (V̇Aexp) and the current 
measured V̇A generated by the patient (V̇Apat) (Figure 3-4F). Reduction of 
V̇A after reduction of ventilator support, has been described as fatigue or lack 
of strength of the respiratory muscles to generate Pmus (17,21,31). On 
reduction of ventilator support, patients’ inability to satisfy V̇Aexp was, 
therefore, interpreted as fatigue, lack of strength or respiratory muscle failure. 
Considering that patients are likely to maintain a preferred level of pHa (and 
FECO2) (41,42), and assuming that the respiratory control model generates 
V̇Aexp that is required to maintain patients’ preferred pHa. Then, the 
difference between V̇Aexp and V̇Apat can be quantified as a ratio. Equation 
13 describes the ratio between V̇Apat and V̇Aexp. This ratio was postulated 
as an indicator of the degree of patient response or muscle function (fm). A 
value of fM= 1 indicates that a patient responds according to their respiratory 
chemoreflex drive without any limits imposed by muscle function. After a step 
reduction in the level of ventilator support, values of fM<1 indicate reduced 
V̇Apat, in comparison to the respiratory chemoreflex drive, perhaps due to 
inadequate patient response. Conversely, after increase in ventilator support, 
values of fM>1 indicate increased V̇Apat in comparison to chemoreceptor 
drive, perhaps due to patients being ventilated with level of ventilator support 
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which was too low, such that respiratory muscle could be more effectively 
used at higher levels.  
 
𝑓𝑀 =
?̇?𝐴𝑝𝑎𝑡
?̇?𝐴𝑒𝑥𝑝
     (13) 
 
V̇Apat can be estimated from substituting Vds from equation 15 in equation 
14, describing minute ventilation (V̇E). 
 
?̇?𝐸 = 𝑉𝑇 ∗ 𝑓𝑅 = ?̇?𝐴𝑝𝑎𝑡 + (𝑉𝑑𝑠 ∗ 𝑓𝑅)   (14) 
𝑉𝑑𝑠 =
?̇?𝐶𝑂2
𝑓𝑅 (𝑉𝑇 (𝐹𝐸𝐶𝑂2−𝐹𝐼𝐶𝑂2))
    (15) 
 
 
The use of fM to describe patients’ response to changes in the level of 
ventilator support will be presented in chapters 5 and 6, accounting for 
changes in VT and PS, respectively. The following section describes the 
quantification of patient effort. 
3.4. MODEL FOR QUANTIFYING CHANGES IN EFFECTIVE 
COMPLIANCE DURING ASSISTED VENTILATION 
In assisted ventilation, V̇E depends upon patients’ effort and the level of 
ventilator support. Quantifying the contribution of patients’ effort to V̇E is 
therefore necessary to describe patients’ response to changes in the level of 
ventilator support. During PSV, VT results from patient effort, the level PS 
and the respiratory system mechanical characteristics (30,137,138). Thus, 
the ratio between VT and PS, i.e. effective compliance (Ceff) illustrated in 
figure 3-4 H, might be used to quantify changes in patient effort as PS is 
modified. The values of Ceff can be interpreted as follows: Ceff <0.05 l/cm 
H2O, may indicate over-support, as VT might be mostly explained by the level 
of ventilator support (PS) and respiratory system mechanics (58); and Ceff 
>0.05 l/cm H2O, may indicate that patient contributes to VT through 
substantial patient effort, as VT cannot be explained by accounting the level 
of ventilator support (PS) and respiratory system mechanics alone, and 
therefore these values probably reflect some patient effort. Equation 16 
describes Ceff as the ratio between VT and PS in spontaneously breathing 
patients on mechanical ventilation. 
 
𝐶𝑒𝑓𝑓 =
𝑉𝑇
𝑃𝑆
     (16) 
 
Ceff may be able to describe patient effort and can be measured readily at 
the bedside. Despite this, it may be a gross simplification the calculation of 
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patient effort (Pmus) and respiratory system mechanics. In chapter 6 the use 
of Ceff will presented for describing patients effort during mofication in PS 
levels. 
3.5. MODEL ASSUMPTIONS AND LIMITATIONS 
The model of respiratory control includes a large number of assumptions, 
which require consideration. The model describes steady state ventilation, for 
conditions of oxygenation and acid-base status. The model determines 
V̇Aexp form three respiratory drives, Dc, Dp and Dw. Dc depends upon 
[H+csf], which in turn is dependent upon SIDcsf and cerebral blood flow. Acute 
changes in these variables may alter Dc. SIDcsf is estimated from mixed 
venous blood bicarbonate, then is considered constant. Cerebral blood flow 
can change due to alterations in [HCO3-a] or PaCO2, and this variation is not 
included in the model. Dp depends upon [H+a], and PaO2. [H+a] which 
depends upon blood acid-base status, and PaO2 depends upon FIO2 and 
blood oxygenation. Thus, acute changes blood acid-base and oxygenation 
status may alter Dp. Dw is dependent upon patients’ state of consciousness, 
and behavior. Conditions of stress or pain may alter Dw, however, changes 
in Dw are not included in the model. In addition, the respiratory control model 
can be unstable i.e. steady state cannot be reached, under certain conditions. 
For example, conditions of low V̇CO2, increased cerebral blood flow or 
abnormal CSF acid-base status, can lead to instability of respiratory control. 
For these conditions a model of steady state conditions, such as that 
presented here, might be inadequate.  
The model for quantification of muscle function assumes that the ventilation 
at baseline conditions is adequate, and is considered as reference. In 
conditions where respiratory muscles are responding adequately, then, 
V̇Apat is equal to V̇Aexp. There are, however, conditions that may alter V̇Apat 
such as fatigue, respiratory muscles failure, reduced strength or endurance, 
anxiety or pain. This description cannot identify the cause of altered V̇Apat. 
These respiratory control model assumptions will be returned in the 
discussion (section 7.3.1) in the context of the necessity of simplifying the 
model, in order to develop a clinical application sufficient to describe and 
simulate patients’ response to changes in ventilator support. 
The model of pulmonary gas-exchange assumes 4 ventilated compartments, 
and hence does not have the descriptive power of the 50 compartmental 
model used in the reference technique (64). The blood acid-base chemistry 
model does not include a description of electrolyte balance, which may be 
necessary for the description of fluid replacement therapy (139). Both blood 
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acid-base and pulmonary gas-exchange models assume constant cardiac 
output (Q̇), which is seldom measured. In some circumstances it might be 
reasonable to estimated values if Q̇ from the body surface area (4).  
In the context of this work, applying models of ventilation, pulmonary gas-
exchange, and blood acid-base and oxygenation, to describe patient 
response requires tuning all model parameters. To do so, measurements of 
Q̇, V̇O2, V̇CO2, arterial blood gas analysis and an experimental procedure 
where FIO2 is modified in 3-5 step changes are necessary. These 
measurements will be returned in the discussion (section 7.3.2) as practical 
limitations when performing the clinical study. 
The model for quantification of changes in Ceff, assumes that the relationship 
between VT and PS may describe changes in patient effort. This assumption 
implies a gross description of patient effort and respiratory system 
mechanics. The interpretation of Ceff is further limited since there were no 
measurements of esophageal pressure, so Pmus or work of breathing are not 
available. The measurement of Ceff will be returned in the discussion (section 
7.3.2) as a practical limitation when performing the clinical study. 
3.6. CONCLUSION 
This chapter has described the integration of physiological models to describe 
patient’s response to changes in the level of ventilator support. For this 
purpose, two previously published models were integrated. The model of 
chemoreflex breathing control was integrated into the set of models included 
in INVENT, which previously described pulmonary gas-exchange, blood acid-
base status and body buffering. The model of respiratory control has two 
model components (figure 3-4 D-E) i.e. CSF acid-base and respiratory 
control. Both model components were modified in order to describe 
spontaneously breathing patients in assisted ventilation. The CSF acid-base 
model required an equation to determine SIDcsf from the current blood acid-
base status. The respiratory control equations required the addition of two 
conditions that allow the disfacilitation (down-regulation) of ventilation, which 
can result due to conditions of abnormal blood and CSF acid-base status. 
In addition, two models were required to complete the description of 
spontaneously breathing patients’ response: quantification of muscle 
function; and quantification of effective compliance. These two models allow 
to consider the situation of reduction of V̇Aexp due e.g. to respiratory muscles 
failure, and the increase of patient effort as PS is modified, respectively.  
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Before applying this set of models to simulate patients’ response to changes 
in support ventilation, there are three additional requirements: estimation of 
the normal values of the respiratory control model parameters (TP and TC); 
identification of the patient-specific model parameters that describe patient 
response; and description of a method to calculate the values of such 
parameters. The following chapter describes these three requirements. The 
application of this set of models to describe patient response is described in 
chapters 5 and 6. 
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CHAPTER 4. SENSITIVITY ANALYSIS 
AND IDENTIFICATION OF MODEL 
PARAMETERS 
The integration of the respiratory control model into INVENT’s set of models 
was described in the previous chapter. Two additional models were also 
integrated, with these describing changes in: V̇A due to muscle function; and 
effective compliance (Ceff) due to patient effort and mechanics of the 
respiratory system. Describing patients’ respiratory response through 
physiological models requires that models’ parameters can be tuned to 
individual patients’ data. This is done by determining which parameters 
describe patient-specific response, and determine a method for estimating 
values of these patient-specific parameters (140). 
An overview describing the model parameters of the existing INVENT 
models, and their estimation has been presented in section 3.1. This chapter 
deals with the parameters of the respiratory control model. The models 
describing and quantifying muscle function (fM) and effective compliance 
(Ceff) do not require tuning since are measurements of patient performance, 
and their values are calculated as explained in sections 3.3-3.4. The 
parameters of the respiratory control model have been listed in section 3.2.  
However, neither the effect of these parameters on model simulations nor the 
estimation of values of these parameters to individual patient’s data has been 
described. 
This chapter describes the effect of modifying the respiratory control model 
parameters on simulated patients’ responses under different conditions. In 
doing so, the necessary patient-specific parameters are identified, and a 
method for their estimation is proposed. For that purpose, in section 4.1 the 
normal values of the respiratory control model parameters TP and TC are 
estimated. To determine the appropriate patient-specific parameters, section 
4.2 presents two series of model simulations, each corresponding to a group 
of factors that modify simulated patients’ response (V̇Aexp). V̇Aexp can be 
modified by either directly measured factors (describing blood acid-base 
status and metabolism) or indirectly measured factors (respiratory control). 
The first series of model simulation of V̇Aexp were performed varying two 
different directly measured factors (BE and V̇CO2). The second series of 
model simulation of V̇Aexp were performed at different conditions of BE and 
V̇CO2 varying each respiratory control model parameter, i.e. a sensitivity 
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analysis. Following this sensitivity analysis it was possible to identify which 
patient-specific model parameters were important and identifiable, and a 
single was selected as that to be tuned from clinical data. Section 4.3 
describes the method for estimating patient-specific model parameters to 
individual patients using clinically available data.  
For the complete set of models describing respiratory drive (i.e INVENT’s set 
of models including models of respiratory control, quantification of fM, and 
quantification of Ceff) to be useful, they need to be evaluated in the clinical 
setting. Section 4.4 describes two clinical protocols that were designed to 
evaluate the ability of the set of models to describe patient’s response to 
changes in ventilator support, and hence, to evaluate the integration of the 
model of respiratory control into the set of INVENT models. 
 
4.1. DETERMINATION OF NORMAL VALUES OF TP AND TC  
To perform simulations using the set of models describing respiratory drive, 
it is first necessary to determine the normal values of TP and TC that describe 
normal typical conditions of blood acid-base status and ventilation at steady 
state. Previously, values of TP and TC have been reported (102,103). 
However these values were determined to fit the model of respiratory 
breathing control to the normal subjects being studied. In addition, these 
subjects were spontaneously breathing without mechanical ventilation, and 
through a device designed to increase FICO2 at several levels of FIO2. Thus, 
physiological conditions of these subjects may differ from normal typical 
values of blood acid-base. In contrast, Sp and Sc are the slopes of the linear 
increase in ventilation due to increasing arterial or CSF [H+]. These slopes 
are similar among subjects (13,107), and hence values of Sc and Sp were 
assumed to be constant (90). The normal values of variables included in 
INVENT’s models of blood acid-base, pulmonary gas-exchange and body 
buffering are reported in table 4-1 (39). In addition, the normal values of 
SIDcsf and Dw were determined as SIDcsf=31 mmol/l (103) and Dw=0 l/min. 
The normal values of TP and TC were estimated as follows. Normal values 
of PaCO2 and SIDcsf, were used to solve the CSF acid-base model to 
determine a normal value of [H+csf]. Peripheral and central chemoreflex 
respiratory drives (equations 17 and 18) were calculated from [H+a] and 
[H+csf] respectively, with normal values of Sp, Sc, and [H+a] calculated from 
normal pHa. To do so the normal values of Sp and Sc were taken from (103). 
The value of normal alveolar ventilation (4.2 l/min) was equated to the sum 
of Dp and Dc (equation19). As equation 19 is undetermined, in order to 
determine TP and TC a condition describing the normal operating point of the 
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system (118) was included (equation 20). The solution of equations 19 and 
20 resulted in the normal values of TP (TP=37.75 nmol/l) and TC (TC=45.24 
nmol/l). 
Table 4-1. Typical normal conditions of blood acid-base status, pulmonary gas-
exchange, ventilation and respiratory control. 
 
Symbol Name Value 
Blood acid-base, body buffering and ventilation 
FIO2 Inspired fraction of O2 0.208 
FICO2 Inspired fraction of CO2 0.003 
V̇A Alveolar ventilation (l/min) 4.2 
V̇CO2  CO2 production (ml/min) 0.222 
V̇O2  O2 consumption (ml/min) 0.253 
Q̇  Cardiac output (l/min) 5 
BEa Arterial base excess (mmol/L) 0 
pHa Arterial pH 7.4 
PaO2 Arterial partial pressure of O2 (kPa) 12.15 
PaCO2 Arterial partial pressure of CO2 (kPa) 5.35 
[HCO3,0-] Mixed-venous bicarbonate concentration (mmol/l) 26.3 
Hb Hemoglobin concentration (mmol/l) 9.3 
DPG 2,3 diphosphoglycerate (mmol/l) 5 
Pulmonary gas exchange model parameters 
s Pulmonary shunt (%) 5 
f2 Fraction of non-shunted perfusion to compartment 2 0.9 
fA2 Fraction of alveolar ventilation to compartment 2 0.9 
Vds Serial dead space (l) 0.15 
Chemoreflex respiratory drive model parameters 
Sc Central sensitivity ( l/min/(nmol/l)) 1.78 
Sp Peripheral sensitivity ( l/min/(nmol/l)) 0.29 
TC Central threshold (nmol/l) 45.24 
TP Peripheral threshold (nmol/l) 37.75 
SIDcsf CSF strong ion difference (mmol/l) 31 
Dw Wakefulness drive (l/min) 0 
 
 
𝐷𝑝𝑛𝑜𝑟𝑚𝑎𝑙 = 0.29 ∗ (39.78 − 𝑇𝑃)  (17) 
𝐷𝑐𝑛𝑜𝑟𝑚𝑎𝑙 = 1.78 ∗ (47.27 − 𝑇𝐶)  (18) 
?̇?𝐴𝑒𝑥𝑝𝑛𝑜𝑟𝑚𝑎𝑙 = 𝐷𝑝𝑛𝑜𝑟𝑚𝑎𝑙 + 𝐷𝑐𝑛𝑜𝑟𝑚𝑎𝑙 = 4.2  (19) 
0.29 ∗ (39.78 − 𝑇𝑃) + 1.78 ∗ (47.27 − 𝑇𝐶) = 4.2  
(39.78 − 𝑇𝑃) = (47.27 − 𝑇𝐶)   (20) 
 
 
Aside of calculating [H+csf], solving the CSF acid-base model at normal 
conditions provided a calculated value for normal CSF bicarbonate 
concentration ([HCO3-csf]=26.4 mmol/l). The importance of this value is to 
establish a reference value of HCO3-csf which could then be modified for 
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abnormal conditions of blood acid-base. This modification, Δ[HCO3-], is 
calculated using equation 11 (figure 3-4)  as the difference between normal 
values of bicarbonate concentration in CSF and mixed venous blood 
([HCO3,0-]). 
As mixed venous  blood  samples  are seldom  measured, the value of 
[HCO3,0-] can be determined as follows. Assuming that there is equilibrium of 
BE between arterial and mixed venous blood, and steady state conditions, 
the total content of O2 and CO2 for mixed venous is calculated by subtracting 
V̇O2 from arterial blood, and adding V̇CO2 to arterial blood, respectively. 
Then, with values of total content of O2 and CO2 in mixed venous blood, and 
values of hemoglobin concentration, DPG and BE, the blood model 
(illustrated in figure 3-1) is solved to calculate [HCO3,0-]. 
Following determination of the normal values of TC and TP, it is possible to 
simulate the effects of modifying the respiratory control model parameters 
(Sp, Sc, TP and TC) on V̇Aexp. The effect of modifying each model parameter 
on V̇Aexp is described in the following section, in order to identify the 
parameters of importance and select those which can be uniquely identifiable 
from clinical data. For that purpose, the set of models describing respiratory 
drive was used to perform simulations of V̇Aexp describing the effects of 
abnormal blood acid-base status, and increased V̇CO2. 
4.2. SENSITIVITY ANALYSIS AND IDENTIFICATION  
This section describes a sensitivity analysis of the respiratory control model 
parameters. To do so, factors that modify V̇Aexp are identified. Two groups 
of factors can modify V̇Aexp, i.e. those that are directly and indirectly 
measured, respectively. Directly measured factors are blood acid-base status 
and metabolism (V̇O2, and V̇CO2). Indirectly measured factors are e.g. 
respiratory control parameters or pulmonary gas-exchange parameters. The 
purpose of performing the sensitivity analysis is to determine the effects of 
variations in respiratory control parameters i.e. Sp, Sc, TP, and TC, on the 
simulated values of V̇Aexp, considering different conditions of directly 
measured factors (BE and V̇CO2). For simplicity, all sensitivity analysis 
simulations were performed assuming normal pulmonary gas-exchange 
parameters. 
The sensitivity analysis of respiratory control model parameters is important 
for two reasons. First, if changes in parameter values produce similar 
changes in the simulated values of V̇Aexp then it might not be possible to 
uniquely identify these parameters, and choices may be required as to which 
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parameter values to fix and which to estimate. Second, if values of V̇Aexp 
vary very little with changes in parameter values, then it might not be 
important to estimate patient-specific values. To investigate the effects of 
variation in parameter values the respiratory control model was used to 
simulate V̇Aexp when varying parameter values under a wide range of 
physiological conditions including different blood acid-base status, and V̇CO2. 
Simulated values of V̇Aexp are plotted as the relationship between VT and 
fR, the product of which gives a constant minute ventilation V̇E (equation 14). 
By assuming a constant serial dead space (Vds =150 ml) in these 
simulations, plots of changes in V̇E and V̇Aexp are interchangeable. The 
relationship between VT and fR seen in plots illustrated in this section 
describe hypothetical response profiles of a patient ventilated in ACV, which 
responded adequately to changes in VT. 
 
4.2.1. VARIATION IN BE AND V̇CO2 (DIRECTLY MEASURED FACTORS) 
V̇E was simulated at three blood acid-base conditions i.e. normal (BE=0 
mmol/l), metabolic acidosis (BE=-4.2 mmol/l), and metabolic alkalosis 
(BE=5.3 mmol/l), and at two V̇CO2 levels (0.22 and 0.66 ml/min) consistent 
with normal and elevated V̇CO2. Simulating these conditions was necessary 
as patients in support ventilation modes may present either blood acid-base 
abnormalities, increased V̇CO2 or both.  
Figure 4-1 illustrates simulated V̇E at three blood acid-base conditions 
(normal, metabolic acidosis and alkalosis) and two levels of V̇CO2 for normal 
values of TP, TC, Sp and Sc as given in table 4-1. Simulated values of V̇E for 
each V̇CO2 level are illustrated in separate plots (figure 4-1 A and B). Figure 
4-1 A illustrates the effects of metabolic acidosis and alkalosis at normal 
V̇CO2. Simulated V̇E is increased during metabolic acidosis and reduced 
during metabolic alkalosis. Figure 4-1 B illustrates the effects of metabolic 
acidosis and alkalosis at increased V̇CO2, showing that these factors act in 
combination, thus all V̇E curves are shifted towards increased ventilation. The 
set of models describing respiratory drive simulated increased V̇E in the 
following conditions: metabolic acidosis; and increase of V̇CO2. Conversely, 
simulated V̇E was reduced on metabolic alkalosis. These model simulations 
are in agreement with several experimental protocols, where metabolic 
alkalosis or acidosis was induced in subjects with dietary supplements. 
Subjects’ V̇E was increased during metabolic acidosis, and was decreased 
during metabolic acidosis (11,12,103,104).  
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Figure 4-1. Simulations of V̇E at three different blood acid-base status at two levels of 
V̇CO2. V̇E is represented as the relationship between VT and fR, considering a 
constant Vds of 150 ml. Abnormal blood acid-base shifts V̇Aexp in respect to normal 
BE (solid lines). Metabolic acidosis (dashed lines) increases ventilation, and metabolic 
alkalosis (dotted lines) reduce ventilation. Increasing V̇CO2 increases V̇E (B), 
depending upon blood acid-base status. 
 
4.2.2. VARIATION IN RESPIRATORY CONTROL MODEL PARAMETERS 
(INDIRECTLY MEASURED FACTORS) 
The effects of varying respiratory control model parameters on V̇E can be 
simulated for different physiological conditions. Three different conditions 
described in the previous section were selected, those being: normal BE and 
normal V̇CO2; normal BE and increased V̇CO2; and metabolic acidosis and 
increased V̇CO2. The latter two represent abnormal conditions that increase 
V̇E. Model parameters, TP, TC, Sp, and Sc, were varied one at a time, 
maintaining the others at normal values. Thresholds (TP and TC) represent 
the arterial blood and CSF [H+] concentration value, above which the 
respiratory drive increases linearly. These parameters were varied by 
subtracting and adding 5 nmol/l to the corresponding normal values 
(TP=37.75 nmol/l and TC=45.24 nmol/l). Peripheral and central 
chemoreceptor sensitivities (Sp and Sc) are multiplicative parameters that 
determine the increase in ventilation due to arterial or CSF [H+] value above 
the respective threshold. Sensitivities were varied by multiplying the normal 
values (Sp= 0.29 l/min/(nmol/l) and Sc=1.78 l/min/(nmol/l)) by zero and 2. 
Figure 4-2 illustrates simulated V̇E at different three physiological conditions, 
and different values of respiratory control model parameters. The plots in 
figure 4-2 are arranged in 3 columns and 4 rows. The plots on each column 
correspond to V̇E simulated under different physiological conditions: normal 
blood acid-base conditions and normal V̇CO2; normal blood acid-base 
conditions and increased V̇CO2; and metabolic acidosis and increased V̇CO2. 
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The plots on each row of figure 4-2 correspond to V̇E simulated under 
different physiological conditions with variations in a single respiratory control 
model parameter: Sc, TC, Sp and TP. The plots of simulated V̇E in the first 
row of figure 4-2, show that setting Sc to zero, reduces V̇E significantly. 
Increasing Sc, however, only slightly augments V̇E. The plots of simulated 
V̇E in the second row of figure 4-2, show that reducing TC, augments the V̇E, 
while increasing TC reduces the V̇E. The shifts on simulated V̇E generated 
by modifying TC are almost symmetrical. The plots of simulated V̇E in the 
third and fourth rows of figure 4-2 show that modifying either Sp or TP 
generate marginal changes in model simulated V̇E in conditions of normal 
oxygenation. Variations in Sp and TP produced slight shifts on simulated V̇E, 
hence, under conditions of normal oxygenation, Sp and TP do not change V̇E 
substantially and might not be the most important parameters for tuning 
patient response. In contrast, variations in Sc and TC produced similar, and 
significant shifts in simulated V̇E at the three conditions of blood acid-base 
status and V̇CO2. As the effects of Sc and TC are similar, estimating unique 
values of both from measurements of acid-base status and ventilation is not 
possible. It was therefore decided to fix the value of Sc at normal conditions 
and estimate TC for the specific patient. TC then represents the patient 
specific chemical drive. Selecting a central chemoreceptor parameter to 
describe the patient specific response is consistent with (110), where the 
respiratory control model showed that the central chemoreflex drive has a 
major role in the control of breathing, in the conditions of normal oxygenation. 
4.3. TUNING THE RESPIRATORY DRIVE MODEL 
In the previous section, TC was selected as the patient-specific model 
parameter describing respiratory control. The method to tune this model 
parameter to individual patients is presented in this section. 
TC can be determined by solving equation 12 with clinically available data, 
such as: pHa, PaO2, PaCO2, VT, fR, V̇CO2, FICO2 and FECO2. For this 
purpose, all input and output variables from the respiratory control model are 
identified from the set of models illustrated in figure 3-4 E. The input variables 
are [H+a], PaO2, and [H+csf], and the output variable is V̇Aexp. The values of 
[H+a] and PaO2 can be obtained from an arterial blood gas (ABG) analysis. 
[H+csf] can be calculated by solving equations 4-11, with PaCO2 obtained 
from an ABG analysis, and [HCO3,0-] estimated as described in section 4.1. 
The value of V̇Aexp can be calculated from the current patients’ ventilation, 
using equation 14 and Vds calculated from equation 15. This implies that for 
tuning TC, patients are generating V̇Aexp, and hence have an adequate 
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muscle function (fM=1). The value of TC can then be calculated by re-writing 
equation 12. 
 
Figure 4-2. Simulations of V̇E with modifications in respiratory control model 
parameters, at three different conditions of blood acid-base and V̇CO2. Each column 
corresponds to simulations of V̇E at: normal blood acid-base, and normal V̇CO2; 
normal blood acid-base and V̇CO2=0.66 ml/min; and metabolic acidosis and 
V̇CO2=0.66 ml/min. Each row corresponds to simulations of V̇E on modifying a single 
respiratory control model parameter, i.e. Sc, TC, Sp and TC, respectively. The effects 
of modifying model parameters Sc and TC modify the respiratory response (plots A-
C and D-F, respectively). In conditions of normal oxygenation, the effects of modifying 
model parameters Sp and TP do not modify the respiratory response (plots G-I and J-
L). 
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𝑇𝐶 =
𝐷𝑝+𝐷𝑤−𝑉𝐸−(𝑉𝑑𝑠∗𝑓𝑅)
𝑆𝑐
+ [𝐻+𝑐𝑠𝑓]  (21) 
  
𝑇𝐶 =
2.373∗([𝐻+𝑎]−39.77)
𝑃𝑎𝑂2−4
+2−𝑉𝐸−(𝑉𝑑𝑠∗𝑓𝑅)
1.78
+ [𝐻+𝑐𝑠𝑓]  
 
Equation 21 can be solved assuming that Dw is known. For conscious 
spontaneously breathing patients in assisted ventilation Dw was set to 2 l/min, 
as mentioned in section 3.2.  
To this point, the set of models describing respiratory response has been 
shown to describe typical respiratory responses due to abnormal blood acid-
base status (metabolic acidosis or alkalosis), the patient-specific model 
parameter have been selected (i.e. TC), and a method for tuning such 
parameter to patient-specific conditions has been described. The set of 
models describing the respiratory response, therefore, needs to be evaluated 
with clinical data. The next section describes two clinical protocols designed 
to evaluate the set of models describing the respiratory drive. 
4.4. CLINICAL PROTOCOLS  
Chapter 3 described the set of models including respiratory control, and 
section 4.3 described a method to tune this model to patient-specific 
conditions. For this set of models to be useful in the clinical practice, the 
models need to be evaluated for their ability to describe patients’ response to 
changes in the level of ventilator support. This section describes the clinical 
protocols performed to evaluate the set of models describing respiratory 
drive. 
4.4.1. JUSTIFICATION OF THE CLINICAL PROTOCOLS  
For the set of models presented here to be useful in clinical practice it is 
necessary that they can adequately describe the response of patients to 
changes in the level of ventilator support. Patient response to these changes 
can be measured using several variables. Response in ventilation can be 
measured from changes in VT or fR, and changes in blood acid-base status 
can be measured using continuous measurement of FECO2, or by periodic 
arterial blood gas (ABG) analyses measuring pHa, or PaCO2. The models 
can be used to simulate changes in these variables on varying the level of 
ventilator support. The principle of both protocols was therefore to compare 
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measured and model simulated values following changes in ventilation to see 
if the models could adequately describe patient response. 
Two clinical protocols were performed with ventilator settings changes in two 
different ventilation modes, ACV and PSV. In both protocols the level of 
ventilator support (VT or PS) was changed on no more than 5 different 
occasions, each lasting 15 minutes to allow patients to reach steady state. 
Changes in VT or PS generate immediate changes in V̇E. In turn, changes in 
V̇E alter alveolar fraction of gases, and consequently arterial blood gases 
(PaO2 and PaCO2). Changes in PaO2 and PaCO2, alter arterial blood and 
CSF [H+], modifying V̇Aexp. At the end of each 15 minute period, steady state 
ventilation was expected and, values of fR, FECO2, and pHa were measured, 
requiring data from the bedside patient monitor, and an ABG measurement. 
During the entire protocol, patients’ indirect calorimetry, and pressure and 
flow measurements were used to measure VT, PS, FECO2, V̇O2, and V̇CO2. 
The two clinical protocols were needed to evaluate the set of models 
describing respiratory drive, this being necessary to describe patients’ 
response to changes in VT or PS. Describing changes in VT requires less 
model complexity than describing changes in PS. Accordingly, in the first 
protocol, the set of models describing respiratory control was evaluated to 
describe patients’ response to step changes in VT. For this reason, patients 
were ventilated in ACV, with the consequence that patients’ response is 
limited to change fR to modulate ventilation. Patients’ changes in fR were 
expected to resemble figures 4-1 and 4-2. Further protocol details are 
provided in section 4.4.2. 
In the second protocol, the set of models describing respiratory drive was 
evaluated to describe patients’ response to step changes in PS. For this 
reason patients were ventilated in PSV, and hence, patients were able to 
modulate ventilation by changing both fR and VT. During this protocol, Ceff 
was determined at each level of PS. Further protocol details are provided in 
section 4.4.2. 
The set of models was used to simulate patients’ response, to do so, models 
were tuned to individual patients’ conditions at the beginning of the protocol 
(baseline conditions). Models simulated values of FECO2, pHa, and fR, were 
calculated for each level of ventilator support, and compared against 
measured values. The statistical methods employed to quantify the difference 
between model simulated values and measured values of FECO2, pHa and 
fR are described in section 4.4.3.  
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4.4.2. TECHNICAL DETAILS OF THE CLINICAL PROTOCOLS  
This subsection describes the technical details of the clinical protocols as 
follows: general requirements for patient inclusion; procedure of clinical 
protocol performed in ACV; procedure of clinical protocol performed in PSV; 
and measurements taken during the protocol.  
4.4.2.1 General requirements for patient inclusion  
Data form the two clinical protocols were collected with ethical approval from 
the Ethics committee of Mid-Jutland, Denmark. The inclusion criteria for 
enrolling patients were: informed written and oral consent given by all patients 
or relatives, and in case of the latter, also the patient’s general practitioner as 
required by Danish law; patients >18 years old; intubated and ventilated in 
support ventilation mode; dynamic lung compliance >30 ml/ cm H2O at the 
time of inclusion; PEEP<10 cm H2O; without hemodynamic instability (systolic 
blood pressure <90 mmHg with vasopressor); PaCO2<8.5 kPa, and not being 
previously diagnosed with COPD; and presence of arterial catheter. 
4.4.2.2 Clinical protocol performed with patients ventilated in ACV  
After inclusion, ventilator mode was switched to V-C A-C (Evita XL, Dräger 
Medical, Lübeck, Germany). V-C A-C is a volume-controlled, time cycled, 
patient triggered ventilation mode i.e. ACV. The ventilator settings were 
selected as follows: flow trigger was set between 1-2 l/min, inspiratory flow at 
30-35 l/min, inspiratory pause time at 0.1 sec, AutoFlow and automatic tube 
compensation (ATC) were disabled and the apnea setting (minimum fR) was 
set at 5/min. Baseline VT was adjusted to maintain PaCO2 within 0.3kPa from 
original conditions. 15 minutes after the clinical protocol had started, ABG 
was measured (ABL Flex 800, Radiometer, Brønshøj, Denmark), and 
pulmonary gas-exchange was determined with a procedure involving 3-5 
FIO2 step changes (ALPE integrated, MermaidCare AP/S, Nr.Sundby, 
Denmark). Then, patients were subjected to a maximum of five VT-step 
changes of 50 ml each, beginning with reduction of VT from baseline.  
After each 50 ml reduction, 15 minutes were waited to allow ventilation and 
CO2 reach steady state followed by measurement of ABG. VT was further 
reduced only if pHa>7.3 and fR< 30/min or if the maximum 5-steps was not 
met. In case of completing the 5-step VT modifications solely with VT 
reduction, the protocol concluded with a measurement of ABG taken 15 
minutes after resetting the ventilator the settings before the protocol started. 
Otherwise, VT was increased to the baseline level, and subsequently by 50 
ml step increases. After each 50 ml increase, 15 minutes were waited to allow 
CO2 to reach steady state, followed by measurement of ABG. VT was further 
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increased only if VT<8 ml/kg, and PIP< 30 cm H2O, or the maximum of 5-step 
changes in VT was not met. After completing the five VT-step changes, or if 
not possible to further increase VT, the protocol concluded with a 
measurement of ABG taken 15 minutes after resetting the ventilator the 
settings before the protocol started. 
4.4.2.3 Clinical protocol performed with patients ventilated in PSV  
After inclusion, ventilator mode was shifted to P-C A-C (Evita XL, Dräger 
Medical, Lübeck, Germany). P-C A-C is a pressure-controlled, flow cycled 
patient triggered ventilation mode i.e. PSV. The ventilator settings were 
selected as follows: flow trigger was set to 5 l/min, slope (ramp time) was 
adjusted to achieve an inspiratory flow<60 l/min, apnea setting (minimum fR) 
was set to 5/min, and automatic tube compensation (ATC) was turned off. 
Baseline PS was adjusted to maintain PaCO2 within 0.3kPa from original 
conditions. 15 minutes after the clinical protocol had started, ABG was 
measured (ABL Flex 800, Radiometer, Brønshøj, Denmark), and pulmonary 
gas-exchange was determined with a procedure involving 3-5 FIO2 step 
changes (ALPE integrated, MermaidCare AP/S, Nr.Sundby, Denmark). Then, 
patients were subjected to a maximum of five PS-step changes of 2 cm H2O 
each, beginning with reduction of PS from baseline.  
After each PS reduction, 15 minutes were waited to allow ventilation and CO2 
reach steady state followed by measurement of ABG. PS was further reduced 
only if pHa>7.3 and fR<30/min, or if less than five PS-steps were performed 
and if PS>0 cmH2O. In case of completing the five PS-step modifications 
solely with PS reduction, the protocol concluded with a measurement of ABG 
taken 15 minutes after resetting the ventilator the settings before the protocol 
started. Otherwise, PS was increased to the baseline level, and subsequently 
by 2 cmH2O step increases. After each PS increase, 15 minutes were waited 
to allow steady state, followed by measurement of ABG. PS was further 
increased only if VT<8 ml/kg, and if PIP<30 cmH2O, or if less than five PS-
step changes were performed. After completing the five PS-step changes, or 
if it was not possible to further increase PS, the protocol concluded with a 
measurement of ABG taken 15 minutes after resetting the ventilator the 
settings before the protocol started. 
4.4.2.4 Measurements taken during the protocol  
To describe patients’ response to changes in the level of ventilator support 
measurements of FECO2, pHa and fR were required. Accordingly, pHa was 
obtained from an ABG measurement taken at the end of each step change 
of VT or PS (ABL Flex 800, Radiometer, Brønshøj, Denmark). Both fR and 
FECO2 were obtained from patients’ bedside monitor (CARESCAPE, GE 
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Healthcare, Helsinki, Finland). In order to calculate fR and FECO2, and model 
input variables (V̇O2, V̇CO2, FIO2, Vds, VT and PS), waveforms from 
measurements of airway pressure, flow, and concentration of O2 and CO2 
were required. Each patient’s waveforms were stored in a text file with the 
software S/5 Collect (GE-Healthcare, Helsinki, Finland). The data contained 
in the text files were used to determine breath by breath PS, FEO2 and 
FECO2; the flow waveform was integrated to determine VT, and used to 
calculate fR. A time window of one minute was used to calculate average 
values for fR, VT, FECO2, V̇O2, V̇CO2, and for the second protocol effective 
compliance (Ceff).  
Synchronizing data from the bedside monitor and ABG measurements taken 
during the protocol was performed with a case report form (CRF). The 
physician performing the clinical protocol was instructed to write-down in the 
CRF the time displayed in the bedside monitor at the time blood sampling. 
The time registrations on the CRF were used to synchronize ABG 
measurements and waveforms collected from the bedside monitor during the 
data analysis. 
4.4.3. STATISTICAL ANALYSIS 
This subsection describes the methods employed to compare model 
simulated and measured FECO2, pHa and fR. The comparison between 
measured and simulated variables was performed with two methods: χ2 test 
and Bland-Altman analysis. Summary statistics are reported as mean±SD if 
normally distributed, otherwise as median[range]. The association between 
patient variables was quantified with Pearson correlation coefficients (r-
values). 
4.4.3.1 𝛘𝟐 test  
The difference between measured and model simulated values of fR, pHa 
and FECO2 was quantified with a weighted residual sum of squares (WRSS) 
at each level of ventilator support. Equation 22 describes WRSS for 5 
modifications in the level of ventilator support. 
 
WRSS = ∑ (
(𝑓𝑅𝑚 − 𝑓𝑅𝑠)
2
𝜎𝑓𝑅2
+
(𝐹𝐸𝐶𝑂2𝑚 − 𝐹𝐸𝐶𝑂2𝑠)
2
𝜎𝐹𝐸𝐶𝑂2
2
𝑛=5
+
(𝑝𝐻𝑎𝑚 − 𝑝𝐻𝑎𝑠)
2
𝜎𝑝𝐻𝑎2
)
𝑛
                                                                   (22) 
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where sub-indices m and s indicate measured or simulated values, and n 
indicates the number of modification in levels of ventilator support. The 
weights are the expected standard deviation of each variable (σfR, σFECO2, 
and σpHa). The expected standard deviation of fR was assumed σfR=1/min. 
The expected standard deviation of FECO2 was assumed σFECO2=0.25%, 
which corresponds to the standard deviation of FECO2 reported in healthy 
subjects (0.2kPa) (141), adjusted to humidity, temperature and measurement 
error from the device employed during the clinical protocol (±0.02kPa) (142). 
The expected standard deviation of pHa was assumed σpHa=0.015, which 
corresponds to the effect produced by one standard deviation of FECO2 in 
the calculation of pHa. 
When the squared difference between measurements and model simulated 
values is equal to the squared expected standard deviation, the model fit is 
good. Thus, the expected value of the weighted residual sum of squares 
E(WRSS) for five VT levels is 15 as described in equation 23. 
 
𝐸(𝑊𝑅𝑆𝑆) = ∑ (
(𝑓𝑅𝑚 − 𝑓𝑅𝑠)
2
𝜎𝑓𝑅2
+
(𝐹𝐸𝐶𝑂2𝑚 − 𝐹𝐸𝐶𝑂2𝑠)
2
𝜎𝐹𝐸𝐶𝑂2
2
𝑛=5
+
(𝑝𝐻𝑎𝑚 − 𝑝𝐻𝑎𝑠)
2
𝜎𝑝𝐻𝑎2
)
𝑛
= 5 ∗ 3 = 15                                          (23) 
 
A degree of freedom is lost for every estimated value of fM, because FECO2 
is used as part of model fit, and hence, its value is not part of model 
simulation. As an example, for a single value of fM (q=1), the E(WRSS) is 14 
as described in equation 24. 
 
𝐸(𝑊𝑅𝑆𝑆) = ∑ (
(𝑓𝑅𝑚 − 𝑓𝑅𝑠)
2
𝜎𝑓𝑅2
+
(𝐹𝐸𝐶𝑂2𝑚 − 𝐹𝐸𝐶𝑂2𝑠)
2
𝜎𝐹𝐸𝐶𝑂2
2
𝑛=5
+
(𝑝𝐻𝑎𝑚 − 𝑝𝐻𝑎𝑠)
2
𝜎𝑝𝐻𝑎2
)
𝑛
− 𝑞 = (5 ∗ 3) − 𝑞 = 14                      (24) 
 
The goodness of model fit to data was performed with a χ2 test that compares 
E(WRSS) with WRSS. To be conservative, a cut off value of p≥0.2 was 
defined for interpreting a good model fit to measured data. 
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4.4.3.2 Bland-Altman analysis  
The difference between measured and simulated values of fR, pHa and 
FECO2 was quantified with Bland-Altman analysis for repeated 
measurements (143). Bias and limits of agreement between measured and 
model simulated variables were calculated for each variable. 
4.5. CONCLUSION 
This chapter has explored the behavior of the parameters of the respiratory 
control model, concluding that the model is complex enough to describe 
changes in ventilation with a single patient-specific parameter, i.e. TC. The 
method to estimate TC only requires clinically available data has been 
described. In principle, after tuning all model parameters (BE, DPG, fs, fA2, 
f2, SIDcsf, and TC) and using input variables (V̇O2, V̇CO2, Vds, VT or PS, fM, 
and Ceff), the set of models describing respiratory drive should be able to 
describe patient response to changes in ventilator support. 
To be useful in clinical settings, the set of models needs to be evaluated for 
its ability to describe patients’ response to changes in ventilator support as 
quantified by changes in FECO2, pHa and fR. Two clinical protocols that 
produced changes in these variables have been designed to evaluate the set 
of models. In the first protocol, patients were ventilated in ACV, so that, VT 
was constant for each breath. In this way, patients’ response was limited to 
changes in fR to modulate ventilation. In the second protocol, patients were 
ventilated in PSV, so that, PS was constant for each breath. In this way, 
patients were able to modify both fR and VT to modulate ventilation. Chapters 
5 and 6 describe the results of each of the clinical protocols. 
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CHAPTER 5. EVALUATION OF THE 
SET OF MODELS IN ACV 
The previous chapter described two clinical protocols for evaluating the set of 
models describing respiratory drive in patients being ventilated in ACV and 
PSV respectively. In addition, the tuning process of the respiratory control 
model parameter (TC) was also described. The objective of performing 
clinical protocols is to evaluate the set of models capability to describe 
patients’ response to changes in ventilator support, to see whether they can 
predict patients’ response to changes in ventilator support at the bedside.  
This chapter presents the results from the evaluation of the set of models with 
the protocol of patients ventilated in ACV. Evaluation of the models in ACV 
provided a natural starting point, as VT delivered is not dependent on patient 
effort, meaning that patient response was confined to changes in fR. To 
assess whether the models formulated in this thesis are of an appropriate 
complexity to describe change in support, model simulated responses were 
calculated at three levels of model complexity, with these simulations 
compared to measurements from patients ventilated in ACV. Section 5.1 
describes the justification of the use of ACV in this protocol. Section 5.2 
presents patients’ characteristics and model parameters. Section 5.3 shows 
model simulations at the three levels of model complexity. Section 5.4 
presents the comparison of measured and model simulated variables (i.e. fR, 
pHa, and FECO2). At the end of the chapter main findings of the clinical 
protocol are described. 
5.1. JUSTIFICATION OF THE VENTILATION MODE  
The set of models was evaluated in patients ventilated in V-C A-C ventilation 
mode, which is a specific ventilator brand name for ACV. This ventilation 
mode was selected for two practical reasons: a) VT is fixed, so patients’ 
response to VT step changes was expected to resemble Figures 4-1 and 4-
2; and b) the model complexity is reduced, because patient effort does not 
affect VT, and hence, the patient response is isolated to changes in fR 
(10,20,30,144). In this way, the protocol design allowed to determine the level 
of model-input complexity required to describe the respiratory control without 
the complications of patient effort, essentially isolating the chemical control 
component. The set of models describing respiratory drive were used to 
perform simulations of fR, pHa and FECO2 considering different levels of 
model-input complexity. 
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Table 5-1. Demographics, diagnosis and model parameters. 
 
Patient 
 
1 2 3 4 5 6 
Gender 
 
M F F F F M 
Age (years) 56 56 84 84 77 64 
Diagnosis AP PO MI ARDS PO PS 
IBW (kg) 72 54 66 63 68 78 
RASS 0 0 -4 -1 -- -1 
Days on MV 11 31 4 14 4 8 
fs (%) 0.0 16.0 3.0 15.0 13.0 13.0 
High V̇/Q̇ 3.98 26.0 9.27 5.19 4.77 4.47 
Low V̇/Q̇ 0.68 1.18 0.67 0.20 0.95 0.28 
BE      
(mmol/l) 
2.7 -1.0 2.0 3.8 4.0 1.5 
Hb     
(mmol/l) 
6.5 6.7 7.3 5.8 6.0 6.3 
DPG 
(mmol/l) 
5.0 4.5 5.0 6.0 2.7 2.9 
SIDcsf 
(mmol/l) 
33.2 30.1 33.1 35.9 35.7 34.1 
TC      
(nmol/l) 
41.4 44.4 38.5 50.8 40.2 47.8 
Vds (l) 0.181 0.165 0.078 0.215 0.152 0.220 
Lung mechanics during PSV 
PS (cmH2O) 9.0 9.0 12.0 10.0 10.0 6.0 
VT (l) 0.63 0.51 0.39 0.42 0.45 0.74 
Compliance 
(l/cmH2O) 
0.07 0.06 0.03 0.04 0.04 0.12 
Lung mechanics during ACV 
VT (l) 0.50 0.51 0.39 0.45 0.45 0.65 
Flow  
(l/min) 
30 30 30 30 35 35 
Compliance 
(l/cmH2O) 
0.04 0.03 0.03 0.03 0.03 0.38 
Resistance 
(cmH2O     
/(l/min)) 
0.04 0.06 0.01 0.12 0.05 0.02 
AP. Aspiration pneumonia; ARDS. Acute respiratory distress syndrome; EC. 
Endocarditis; MI. Myocardial infraction; PO. Postoperative complications; PS. 
Pneumonia and sepsis; RA. Retroperitoneal abscess; SA. Sarcoidosis. 
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Table 5-1. Demographics, diagnosis and model parameters (continuation). 
 
Patient 
 
7 8 9 10 11 12 
Gender 
 
F M F F M M 
Age (years) 65 78 79 74 39 74 
Diagnosis PS MI EC PO RA SA 
IBW (kg) 65 75 68 66 65 70 
RASS -2 -2 0 0 0 -3 
Days on MV 3 3 -- 19 15 1 
fs (%) 6.0 7.0 11.0 5.0 1.0 7.0 
High V̇/Q̇ 25.2 8.64 21.2 4.45 1.43 1.89 
Low V̇/Q̇ 1.58 0.86 0.96 0.50 0.17 0.25 
BE      
(mmol/l) 
-0.6 3.4 -4.2 1.6 7.3 2.1 
Hb     
(mmol/l) 
5.7 5.6 5.4 5.4 4.8 6.6 
DPG 
(mmol/l) 
2.4 1.0 3.1 2.3 5.0 4.3 
SIDcsf 
(mmol/l) 
34.2 33.8 26.1 33.2 39.0 35.2 
TC      
(nmol/l) 
49.9 35.4 48.3 40.1 41.3 52.3 
Vds (l) 0.100 0.192 0.217 0.135 0.152 0.222 
Lung mechanics during PSV 
PS (cmH2O) 12.0 9.0 12.0 12.0 6.0 12.0 
VT (l) 0.41 0.52 0.50 0.32 0.45 0.57 
Compliance 
(l/cmH2O) 
0.03 0.06 0.04 0.03 0.07 0.5 
Lung mechanics during ACV 
VT (l) 0.45 0.52 0.50 0.36 0.45 0.57 
Flow  
(l/min) 
30 30 30 30 30 30 
Compliance 
(l/cmH2O) 
0.03 0.03 0.03 0.02 0.05 0.04 
Resistance 
(cmH2O     
/(l/min)) 
0.09 0.10 0.03 0.01 0.05 0.13 
AP. Aspiration pneumonia; ARDS. Acute respiratory distress syndrome; EC. 
Endocarditis; MI. Myocardial infraction; PO. Postoperative complications; PS. 
Pneumonia and sepsis; RA. Retroperitoneal abscess; SA. Sarcoidosis. 
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5.2. PATIENTS’ CHARACTERISTICS AND MODEL 
PARAMETERS 
Fifteen patients were enrolled in the clinical protocol, with three patients were 
not further considered for data analysis. Two of them did not complete the 
clinical protocol due to reduction in fR after the ventilator mode was changed 
to V-C A-C. The third patient was not included because data from the bedside 
monitor were lost due to computer failure. For the rest of the enrolled patients, 
basic demographics, diagnosis, and model parameters tuned at baseline are 
listed in Table 5-1. Patients presented different intensive care unit (ICU) 
admission diagnosis: three patients were mechanically ventilated due to post-
operative complications (2, 5, 10); two patients presented myocardial 
infarction (3, 8); one patient presented retroperitoneal abscess (11); and the 
remaining patients were diagnosed with pneumonia, two recovering from 
sepsis (6, 7) and a single each with sarcoidosis (12), endocarditis (9), 
aspiration pneumonia (1), and recovering from acute respiratory distress 
syndrome (ARDS) (4).  
Patients were age 74[39-84] years, had been 8[1-31] days on mechanical 
ventilation (at the time of the study), had Richmond Agitation-Sedation Scale 
(RASS) score -1[-4-0], and five were male. Model parameters were tuned at 
baseline conditions, these being: for pulmonary gas-exchange fs=7[0-16]%, 
fA2=0.45[0.09-0.98], and f2=0.85[0.53-0.98] (high V̇/Q̇ =5[1.4-26.0] and low 
V̇/Q̇ =0.7[0.2-1.6]); for blood acid-base BE=1.9±2.9 mmol/l, DPG=3.7±1.5 
mmol/l, and Hb=6.0±0.7 mmol/l; for chemoreflex respiratory drive 
SIDcsf=33.6±3.18 mmol/l, and TC=44.2±5.48 nmol/l; and for ventilation 
Vds=0.17±0.05 l. Blood acid-base abnormalities at baseline explain the 
variation of SIDcsf (see table 5-1). For instance, patient 9 presented the 
lowest BE and SIDcsf, and patient 11 presented the highest BE and SIDcsf 
at baseline conditions. 
5.3. MODEL SIMULATIONS WITH DIFFERENT LEVELS OF 
MODEL COMPLEXITY 
The patients included in the protocol were subjected up to five different levels 
of VT. During that period of time, the input variables (V̇O2, V̇CO2, and Vds) of 
the set of models were continuously measured. To determine the required 
level of model complexity to adequately describe patients’ response, the set 
of models was used to simulate fR, pHa and FECO2, considering three levels 
of model-input complexity. For level 1, V̇CO2 and Vds were considered 
constant, with their respective value equal baseline conditions. Muscle 
function (fM) was assumed adequate, and considered constant and equal to 
1 at each VT level. For level 2, V̇CO2 and Vds were measured at each VT 
CHAPTER 5. EVALUATION OF THE SET OF MODELS IN ACV 
89 
step, and fM was assumed adequate, and considered constant and equal to 
1 at each VT level. For level 3, V̇CO2 and Vds were measured at each VT 
step, and fM was estimated at each VT level. Three simulated values of fR, 
pHa and FECO2, corresponding to each level were performed. 
Figures 5-1 and 5-2 (patients 1, 2 respectively) illustrate two contrasting 
examples of patient-response to changes in VT. Patient 1 (figure 5-1) is a 
representative case. Patient 2 (figure 5-2) is an extreme case that required 
the lowest values of fM (fM≈0.7) among the patient group. Blank symbols 
represent measured values, and grey symbols represent model simulated 
values. Error bars represent one SD of continuously measured variables over 
the last minute of ventilation at each VT level. Each figure is divided into 4 
rows (A-D). The first 3 rows (A-C) illustrate measurements and model 
simulated values for the three levels of model complexity, with row A 
illustrating simulations performed assuming constant V̇CO2, Vds and fM=1 
(level 1), row B accounting for changes in V̇CO2, and Vds, and assuming 
adequate muscle function (fM=1), and row C accounting for changes in VD, 
V̇CO2 and fM. Row D illustrates values of V̇CO2, Vds and fM at each VT level. 
The appendix A, includes plots in rows C and D of figures 5-1 and 5-2 for all 
twelve patients. 
Patients 1 and 2 responded with increasing fR on reduction in VT.  Nine of 
the twelve patients responded similarly, with the remaining three (3, 7, 12) 
showing little change in fR on changing VT (see appendix A). Patient 1 
presented little change in pHa or FECO2 with decreasing VT in contrast, 
patient 2 presented large changes in pHa and FECO2 at the lowest VT. 
Patient 1 showed systematic decrease in VD and increase in V̇CO2 on 
reduction of VT (figure 5-1 D1-D2). A similar pattern was seen in six patients 
(1, 5, 6, 8, 9, 10), the remaining patients showed no systematic changes. 
Model simulations corresponding to level 1 of model-input complexity for 
patients 1 and 2 (figures 5-1 and 5-2, row A) resulted in simulated values of 
FECO2, fR, and pHa (grey symbols) different from measurements (blank 
symbols).  
Figures 5-1 and 5-2 show that there is an improvement in model fitting as the 
model inputs increase. The next section describes statistics reporting the 
goodness of fit of the three levels model-input assumption, and presents 
Bland-Altman analysis for the differences between measured and model 
simulated values of fR, pHa and FECO2. 
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Figure 5-1. Measured and model simulated values of fR, pHa, and FECO2 for a typical 
patient response to changes in VT. Blank symbols represent measured values, and 
grey symbols represent model simulated values. Rows A-C illustrate model 
simulations of fR (column 1), pHa (column 2), and FECO2 (column 3), using different 
level of model complexity. Row D illustrates the input variables required for each level 
of model complexity. Row A corresponds to complexity including constant Vds, V̇CO2 
and fM (dotted lines in D1-3). Row B corresponds to complexity including variable 
Vds, and V̇CO2 (symbols in D1-2), and fM=1 (dotted line in D3). Row C corresponds 
to complexity including variable Vds, V̇CO2 and fM (symbols in D1-3). The solid line 
in plots A1, B1 and C1, represents V̇E calculated at baseline conditions (upwards 
triangle), considering constant values of Vds and V̇CO2 are represented with dotted 
lines in the plots D1-2. Each symbol corresponds to a different VT level: first (circles), 
second (squares), third (diamonds), fourth (hexagrams) and fifth (downward triangles) 
VT modification, and baseline (upward triangles). 
CHAPTER 5. EVALUATION OF THE SET OF MODELS IN ACV 
91 
 
Figure 5-2. Measured and model simulated values of fR, pHa, and FECO2 for patient 
response to changes in VT, where fM was significantly low. Blank symbols represent 
measured values, and grey symbols represent model simulated values. Rows A-C 
illustrate model simulations of fR (column 1), pHa (column 2), and FECO2 (column 3), 
using different level of model complexity. Row D illustrates the input variables required 
for each level of model complexity. Row A corresponds to complexity including 
constant Vds, V̇CO2 and fM (dotted lines in D1-3). Row B corresponds to complexity 
including variable Vds, and V̇CO2 (symbols in D1-2), and fM=1 (dotted line in D3). 
Row C corresponds to complexity including variable Vds, V̇CO2 and fM (symbols in 
D1-3). The solid line in plots A1, B1 and C1, represents V̇E calculated at baseline 
conditions (upwards triangle), considering constant values of Vds and V̇CO2 are 
represented with dotted lines in the plots D1-2. Each symbol corresponds to a different 
VT level: first (circles), second (squares), third (diamonds), fourth (hexagrams) and 
fifth (downward triangles) VT modification, and baseline (upward triangles). 
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5.4. COMPARISON BETWEEN MEASURED AND MODEL 
SIMULATED DATA 
The analysis of the appropriate level of model complexity to describe patients’ 
response is shown in table 5.2. This table reports the goodness of fit for the 
three levels of model-input complexity at each level of VT (rows) and for each  
Table 5-2. Values of WRSS between measured data and model simulations for the 
three analyses; and F-test for comparison between the analyses. 
 
 
Patient 1 2 3 4 5 6 
 Level of model complexity: 1 
High VT 1.5 10.6 16.0  8.0 0.5 8.5 
 6.1 9.4 6.7 1.5 1.0 15.2 
 14.5 0.8 35.5 1.0 0.9 4.3 
 8.8 367.7 * 58.6 1.0 8.4 
Low VT 18.1 127.6 * * 8.3 137.9 
  
∑(WRSS) χ2 
test p 
49.1 
0.0  
516.1 
0.0  
58.2 
 0.0 
69.1  
0.0 
11.7  
0.70 
174.4  
0.0 
 
 Level of model complexity: 2 
High VT 0.3 0.8 0.5 6.2 0.6 0.2 
 0.2 2.9 2.5 0.9 1.3 2.5 
 0.9 2.8 45.2 1.2 0.9 0.8 
 0.5 144.8 * 9.5 0.1 6.7 
Low VT 5.2 175.4 * * 5.7 34.1 
  
∑(WRSS) χ2 
test p 
7.0  
0.95 
326.8  
0.0 
48.2  
0.0 
17.7  
0.12 
8.6 
0.90 
44.2  
0.0 
 
 Level of model complexity: 3 
High VT 0.3 0.8 0.5 2.2† 0.6 0.2 
 0.2 2.9 2.5 0.9 1.3 0.3† 
 0.9 2.8 0.4† 1.2 0.9 0.8 
 0.5 4.2† * 1.4† 0.1 6.7 
Low VT  0.1† 1.4† * * 0.4† 0.6† 
  
∑(WRSS) χ2 
test p 
1.97 
0.99 
12.1 
0.52 
3.4 
0.91 
5.7 
0.84 
3.4 
0.99 
8.5 
0.81 
* Missing VT step changes due to patient outside protocol defined ranges. 
† WRSS value calculated including estimation of fM. 
‡ Comparison of goodness of fit between analyses 1 and 2. 
§ Comparison of goodness of fit between analyses 2 and 3. 
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patient (columns). For level 1, χ2 p-values showed poor model fit to data in all 
patients except patient 5. For level 2, χ2 p-values showed poor model fit to 
data except in four patients (1, 5, 8, 10), where χ2 p-value≥0.2. In six of the 
patients (2, 3, 4, 6, 7, 12), poor model fit to data was due to patients having 
inadequate V̇A to maintain pHa and FECO2 at the lowest VT settings. An F-
ratio  test  showed  the model  fit of  analysis 2  was significantly  better than 
 
 
Table 5-2. Values of WRSS between measured data and model simulations for the 
three analyses; and F-test for comparison between the analyses (continuation). 
 
 F-Test 
Patient 7 8 9 10 11 12  
 Level of model complexity: 1  
High VT 8.1 24.0 47.7 27.6 70.4 31.3  
 4.0 1.3 71.8 38.6 64.6 28.3  
 21.3 15.0 2.0 6.6 64.9 12.6  
 * 8.0 8.6 30.9 4.0 *  
Low VT * * * * * *  
   
∑(WRSS) 
χ2 test p 
33.5 
0.0 
48.3  
0.0 
130.1 
 0.0 
103.7  
0.0 
203.9  
0.0 
72.2 
0.0 
 
 p<0.001‡ 
 Level of model complexity: 2  
High VT 0.6 5.3 5.5 2.0 55.0 1.0  
 0.0 1.4 21.7 1.4 7.8 0.9  
 16.9 4.8 1.6 0.3  9.9 17.4  
 * 4.3 2.8 0.2 6.5 *  
Low VT * * * * * *  
   
∑(WRSS) 
χ2 test p 
17.5  
0.04 
15.7  
0.20 
31.7 
0.0 
3.9 
0.99 
79.2 
0.0 
19.4 
0.02 
 
 p<0.001§ 
 Level of model complexity: 3  
High VT 0.6 0.3† 5.5 2.0 2.8† 1.0  
 0.0 1.4 0.3† 1.4 1.1† 0.9  
 0.6† 1.8† 1.6 0.3 2.8† 0.0†  
 * 4.3 2.8 0.2 1.0† *  
Low VT * * * * * *  
   
∑(WRSS) 
χ2 test p 
7.8 
0.65 
10.3 
0.5 
3.9 
0.99 
7.65 
0.47 
1.97 
0.98 
7.8 
0.65 
 
* Missing VT step changes due to patient outside protocol defined ranges. 
† WRSS value calculated including estimation of fM. 
‡ Comparison of goodness of fit between analyses 1 and 2. 
§ Comparison of goodness of fit between analyses 2 and 3. 
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analysis 1 (p<0.001). For level 3, χ2 p-values showed good model fit to data 
(p>0.2) in all patients. An F-ratio test showed the model fit of analysis 3 was 
significantly better than analysis 2 (p<0.001). According to table 5-2, the 
model complexity requiring variable V̇CO2, and Vds, and muscle function 
(fM), provides the best fit to data. 
In addition to the  χ2 test, a Bland-Altman analysis was performed to compare 
measured and model simulated fR, pHa and FECO2 for the most complex of 
the three models evaluated, i.e. that presented in this thesis, as illustrated in 
Figure 5-3. The bias ± limits of agreement for each variable were: fR 0.0±1.4 
1/min (figure 5-3 A); pHa 0.003±0.020 (figure 5-3 B); and FECO2 0.000±0.003 
(figure 5-3 C). Low bias and narrow limits of agreement indicate adequate 
model description of patients’ response. The bias and limits of agreement for 
pHa are comparable to values estimated in a study designed to calculate 
blood variables, after exposure of blood samples to specific concentrations of 
O2 and CO2 (38). 
 
 
Figure 5-3. Bland-Altman plots of difference between measured and simulated patient 
response to changes in VT. Each symbol illustrates a single patient i.e. right-pointing 
triangle (patient 1), vertical cross (patient 2), upwards triangle (patient 3), hexagram 
(patient 4), square (patient 5), diamond (patient 6), circle (patient 7), downwards 
triangle (patient 8), diagonal cross (patient 9), left-pointing triangle (patient 10), dot 
(patient 11) and pentagram (patient 12). The solid lines illustrate the bias between 
measured and simulated values, and the dashed lines illustrate the limits of 
agreement. Each plot illustrates differences between measured and simulated fR (A), 
pHa (B) and FeCO2 (C). 
5.5. CONCLUSION 
This chapter presented the evaluation of the set of models describing 
respiratory drive performed with a clinical protocol in which patients were 
ventilated in ACV. The major finding of this study was that the set of models 
taking into account changes in V̇CO2, Vds, and representation of muscle 
function (fM) i.e. the most complex of the three models evaluated, provided a 
good description of measured values of FECO2, fR, and pHa in all patients. 
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The set of models was shown to adequately describe 12 patients’ response 
in terms of blood acid-base status (pHa), pulmonary gas-exchange (FECO2) 
and respiratory control (fR) to changes in VT. In addition, the set of models 
was shown to be tunable for individual patients, and seems to describe the 
clinical observation that patients have a preferred level pHa and FECO2 
during modification of ventilator support (41,42), unless respiratory distress 
or over-distention result from modifying the level of ventilator support (18,21).  
The set of models describing respiratory drive seems to predict patient 
response to changes in VT adequately, however, patients in assisted 
ventilation are typically ventilated in other ventilator modes than ACV. The 
vast majority of the patients ventilated in assisted ventilation are in PSV (9). 
This ventilation mode provides a constant PS during inspiration instead of 
delivery of a fixed VT, thus, patients are capable of modulating both VT and 
fR. Accordingly, PSV increases the level of model complexity, and requires 
the quantification of changes in patient effort if the correct relationship 
between the level of pressure support and the tidal volume is to be 
represented. The next chapter describes the evaluation of the set of models 
describing the respiratory drive model in PSV. 
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CHAPTER 6. EVALUATION OF THE 
SET OF MODELS IN PSV 
In chapter 4 two clinical protocols were described for evaluating the set of 
models describing respiratory drive in patients being ventilated in ACV and 
PSV respectively. The objective of performing these protocols is to evaluate 
the set of models capability to describe patients’ response to changes in 
ventilator support, and thus, its ability to describe patients’ response to 
changes in ventilator support at the bedside. The previous chapter described 
the evaluation of the set of models in ACV. In addition to evaluating the set 
of models, the correct level of model complexity required to describe patients’ 
response to changes in ventilator support was evaluated. This chapter 
presents the results from the evaluation of the set of models with a protocol 
in which patients were ventilated in PSV. This protocol was designed to 
evaluate the respiratory response taking into account changes in patient 
effort. Section 6.1 describes the justification of the ventilation mode. Section 
6.2 presents patients’ characteristics and model parameters. Section 6.3 
presents the comparison between measured and model simulated fR, pHa, 
and FECO2, with model simulations including changes in effective 
compliance (Ceff). At the end of the chapter main findings of the clinical 
protocol are described. 
6.1. JUSTIFICATION OF THE VENTILATION MODE 
The set of models was evaluated in patients ventilated in P-C A-C ventilation 
mode, which is a specific ventilator brand name for PSV. This ventilation 
mode was selected for two practical reasons: a) PS is fixed, so patients’ 
respiratory response to PS step changes has two components VT and fR; 
and b) the delivery of inspiratory flow is flow-cycled, so that, VT depends upon 
patient effort (9,17). It is also a commonly used mode, meaning that 
evaluation of the models in this mode is important for their clinical 
applicability. 
6.2. PATIENTS’ CHARACTERISTICS AND MODEL 
PARAMETERS 
Fifteen patients were enrolled in the clinical protocol, with three patients not 
considered for data analysis. One patient developed apnea before performing 
modifications in PS, a second patient died after consent was approved and 
before the protocol started, and a third patient presented an erratic breathing  
THE APPLICATION OF PHYSIOLOGICAL MODELS TO DESCRIBE SPONTANEOUSLY BREATHING PATIENTS’ 
RESPONSE TO CHANGES IN VENTILATOR SUPPORT 
98
 
Table 6-1. Demographics, diagnosis, and model parameters. 
 
Patient 1 2 3 4 5 6 
Gender M M M M M M 
Age (years) 76 69 66 78 70 76 
Diagnosis POS ALI AP Renal CA SAP PS 
IBW (kg) 84 60 64 80 82 70 
RASS -3 0 0 -2 -3 -3 
Days on MV 12 1 16 2 17 6 
fs (%) 7 0 20 7 6 8 
High V̇/Q̇ 3.0 3.8 92.9 2.5 6.6 43.6 
Low V̇/Q̇ 0.4 0.2 1.1 0.4 1.0 1.08 
BE (mmol/l) -0.8 7.2 -2.2 3 -2.9 -0.1 
Hb (mmol/l) 5.2 5.9 7.6 5.4 5.7 6.4 
DPG 
(mmol/l) 
3.2 1.2 4.4 3.2 3.6 2.7 
SIDcsf 
(mmol/l) 
29.9 37.3 27.3 34.3 29.1 32.0 
TC (nmol/l) 44.7 41.7 37.7 45.2 53.8 49.7 
Vds (ml) 244 269 387 356 139 365 
Lung mechanics 
PS (cmH2O) 8 12 16 14 13 12 
VT (ml) 620 440 630 790 360 950 
Ceff 
(l/cmH2O) 
0.08 0.04 0.04 0.06 0.03 0.08 
PEEP 
(cmH2O) 
9 7 9 7 7 6 
POS. Postoperative sepsis, ALI. Acute lung injury; AP. Aspiration pneumonia; SAP. 
severe acute pancreatitis; PS Pneumonia and sepsis; HA. Heart attack 
 
 
pattern, making it impossible to integrate flow waveform to calculate VT. For 
the rest of the enrolled patients, basic demographics, diagnosis, and model 
parameters tuned at baseline are listed in table 6-1. Patients presented 
different intensive care unit (ICU) admission diagnosis: two patients 
presented heat attack (8, 9), two patients presented aspiration pneumonia (3, 
11), two patients presented acute lung injury (2, 10); thee patients presented 
pneumonia and sepsis (6, 7, 12); and a single each presented post-operative 
complications (1); renal cancer (4); and severe acute pancreatitis (5). 
Patients were age 72.5[55-80] years, had been 9[1-30] days on mechanical 
ventilation (at the time of the study), had RASS score -2[-4-0], and four were 
female. Model parameters were determined at baseline conditions, these 
being: for pulmonary gas-exchange fs= 8[0-20]%, fA2= 0.44[0.12-0.78], and 
f2= 0.9[0.59-0.99] (high V̇/Q̇ = 11.4[2.5-83] and low V̇/Q̇ = 0.7[0.2-1.7]); for 
blood acid-base  BE=3.3±4.9 mmol/l,  DPG= 4.25±2.13  mmol/l,  and Hb=5.93 
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Table 6-1. Demographics, diagnosis, and model parameters (continuation). 
 
Patient 7 8 9 10 11 12 
Gender F F F M M F 
Age (years) 55 80 79 72 67 73 
Diagnosis PS HA HA ALI AP PS 
IBW (kg) 65 68 60 60 80 58 
RASS -1 -4 -3 0 -1 0 
Days on MV 4 5 9 20 -- 30 
fs (%) 18 16 16 0 10 13 
High V̇/Q̇ 70.5 4.5 2.9 16.3 16.1 41.8 
Low V̇/Q̇ 1.7 0.4 0.4 0.3 0.9 1.5 
BE (mmol/l) 0.1 4.3 8.4 12.4 8.6 1.6 
Hb (mmol/l) 5.2 7.5 5.7 6.7 4.6 5.3 
DPG 
(mmol/l) 
3.4 4.9 4.7 10.2 4.8 4.2 
SIDcsf 
(mmol/l) 
31.5 36.5 40.3 43.9 39.5 30.8 
TC (nmol/l) 40.3 34.9 37.0 44.4 35.1 36.0 
Vds (ml) 189 217 114 185 217 180 
Lung mechanics 
PS (cmH2O) 9 7 10 14 10 14 
VT (ml) 640 450 390 240 380 400 
Ceff 
(l/cmH2O) 
0.07 0.06 0.04 0.02 0.04 0.03 
PEEP 
(cmH2O) 
9 7 6 5 8 6 
POS. Postoperative sepsis, ALI. Acute lung injury; AP. Aspiration pneumonia; SAP. 
severe acute pancreatitis; PS Pneumonia and sepsis; HA. Heart attack 
 
 
±0.94 mmol/l; for chemoreflex respiratory drive SIDcsf=34±5 mmol/l, and 
TC=42.1±5.9 nmol/l; and for ventilation Vds=0.26±0.13 l. Blood acid-base 
abnormalities at baseline explain variation of SIDcsf (see table 6-1). For 
instance patient 5 presented the lowest BE and low SIDcsf, and patient 10 
presented the highest BE and SIDcsf. 
Patients’ responses on modifying the level of PS are illustrated in figures 6-1 
and 6-2. Figures 6-1 illustrates measured and calculated data describing 
respiratory stress for all patients at all PS levels. Figures 6-1 A-B illustrate the 
ventilatory response i.e. fR and VT at each PS level. The r-values for the 
correlation between PS and ventilatory response were r=0.45 (p<0.001) for 
fR, and r=-0.12 (p=0.35) for VT. Both r-values indicate large variations across 
the patient group. In some patient’s, e.g. patient 6 (diamonds), fR increased  
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Figure 6-1. Data describing spontaneously breathing patients ventilated at different 
PS levels. Each symbol illustrates a single patient i.e. right-pointing triangle (patient 
1), vertical cross (patient 2), upwards triangle (patient 3), hexagram (patient 4), square 
(patient 5), diamond (patient 6), circle (patient 7), downwards triangle (patient 8), 
diagonal cross (patient 9), left-pointing triangle (patient 10), dot (patient 11) and 
pentagram (patient 12). Patients’ responses to different PS levels are illustrated in 
terms of fR (A), Vt (B), fR/Vt (C), PIP (D), V̇CO2 (E), and V̇O2 (F). 
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and VT decreased on reducing PS, while in others e.g. patient 5 (squares), 
fR and VT remained relatively constant. Figures 6-1 C-D illustrate surrogate 
measures for respiratory stress, i.e. the fR/VT ratio, and positive inspiratory 
pressure (PIP) for all PS levels. The r-value for the correlation between PS 
and fR/VT was r=0.43 (p<0.001), indicating a wide range of fR/VT variation 
across the patient group. In some cases, this ratio increased at lower values 
of PS, e.g. patient 10 (left-pointing triangle) indicating increased respiratory 
stress. The r-value for the correlation between PS and PIP was r=0.97 
(p<0.001), indicating linear increase of PIP with PS. Figures 6-1 E-F illustrate 
metabolism (V̇CO2 and V̇O2) for all patients at all PS levels. The r-values for 
the correlation between PS and metabolism were r=0.01 (p=0.96) for V̇CO2 
and r=0.13 (p=0.30) for V̇O2, indicating a large variation of metabolism with 
PS. The respiratory exchange ratio (RER) for the patient population at all PS 
levels was 1.03±0.22. 
Figure 6-2 illustrates the acid-base status for all patients at the calculated 
alveolar ventilation from measured data (V̇Apat) associated with all PS levels. 
A wide range of FeCO2, PaCO2, and pHa levels were seen across the group. 
A tendency for higher FeCO2 and PaCO2 levels was observed at lower VApat 
across the patient group. The r-value for the correlation between VApat and 
FeCO2 was r=-0.72 (p<0.001) and between V̇Apat and PaCO2 was r=-0.78 
(p<0.001).  
 
 
Figure 6-2. Measured variables describing blood acid-base status plotted against 
estimated alveolar ventilation (V̇Apat) during changes in PS. Each symbol illustrates 
a single patient i.e. right-pointing triangle (patient 1), vertical cross (patient 2), upwards 
triangle (patient 3), hexagram (patient 4), square (patient 5), diamond (patient 6), circle 
(patient 7), downwards triangle (patient 8), diagonal cross (patient 9), left-pointing 
triangle (patient 10), dot (patient 11) and pentagram (patient 12). 
Two contrasting patients are presented as examples describing the 
relationship between ventilation and blood acid-base status. Patient 5 
(squares in figures 6-1 and 6-2) presented the lowest pHa, highest V̇CO2, and 
lowest BE (table 6-1), in contrast, patient 3 (upwards triangles in figures 6-1 
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and 6-2) presented the lowest FECO2, high values of pHa, and the largest 
high V̇/Q̇ ratio (table 6-1). The set of models describing the respiratory drive 
was used to describe these rather complex patients’ responses. The next 
section presents the evaluation of the respiratory drive simulated variables 
against measured data. 
 
6.3. COMPARISON BETWEEN MEASURED AND SIMULATED 
VARIABLES  
The patients included in the protocol were subjected up to five different levels 
of PS. During that period of time, the input variables (V̇O2, V̇CO2, Vds, and 
VT) of the set of models were continuously measured, as these data were 
necessary to determine patients’ response. All model parameters estimated 
at baseline conditions are given in table 6-1. In addition, figure 6-3 provides 
values of those model parameters estimated at different PS levels, i.e. Vds, 
Ceff, and fM, which are necessary to simulate patients’ response to changes 
in PS with the set of models describing the respiratory drive. Vds showed no 
obvious patterns on modifying PS (figure 6-3 A). Patients 3 (upwards 
triangles), 4 (hexagram), and 6 (diamonds) presented high values of Vds.  
Ceff changed in almost all patients as PS was modified (figure 6-4 B). Patients 
1, 3 and 5 (left-pointing triangle, upwards triangle and square) showed a 
relatively constant Ceff on reduction of PS, in contrast, the rest of the patients 
increased Ceff, presumably by increasing patient effort. The shape of figure 
6-4 B is in agreement with the clinical observation that increasing PS reduces 
patient effort (41,42,138,145), and conversely, reducing PS increases patient 
effort. Two additional characteristics of the PS-Ceff plot are interesting: the 
points appear to lie on a single curve that can describe the relationship 
between PS and patient effort; and at high levels of PS, Ceff is comparable 
with compliance measured in sedated patients (58). 
Muscle function (fM) was equal to 1 in almost all patients on modifying PS 
(figure 6-3 C). Patients 2 (vertical crosses), 4 (hexagrams), and 12 
(pentagram) presented reduction in V̇Apat (fM<1) on reducing PS. 
Conversely, patients 5 (squares), and 10 (left-pointing triangles) presented 
an increase in VApat (fM>1) on PS>10 cm H2O. 
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Figure 6-3. Model inputs estimated at each PS level. Serial dead space (Vds) (A), 
effective compliance (Ceff) (B), and muscle function (fM) (C). Each symbol illustrates 
a single patient i.e. right-pointing triangle (patient 1), vertical cross (patient 2), upwards 
triangle (patient 3), hexagram (patient 4), square (patient 5), diamond (patient 6), circle 
(patient 7), downwards triangle (patient 8), diagonal cross (patient 9), left-pointing 
triangle (patient 10), dot (patient 11) and pentagram (patient 12). 
 
A χ2 test was performed to determine the goodness of fit of the model 
simulations to measured data. Statistics reporting the goodness of fit at each 
level of PS (rows) and for each patient (columns) are given in table 6-2. The 
χ2 p-values showed good model fit to data (p>0.2) in all patients but patients 
6 and 11. Bland-Altman plots were used to compare the values of measured 
and simulated values for the group as a whole and for these two patients in 
detail. Figure 6-4 illustrates these Bland-Altman analyses for the three 
measured and simulated variables (fR, pHa and FECO2). Bias and limits of 
agreement for each variable were:   fR 0.7±2.2 1/min  (figure 6-4 A);      pHa 
-0.0007±0.019 (figure 6-4 B); and FECO2 0.001±0.003 (figure 6-4 C). The 
bias and limits of agreement for pHa and FECO2 are comparable to those 
estimated in the previous chapter. Patient 11, illustrated with dots, presented 
the worst simulation of fR. Patient 11 presented high fR (45.7±4.5 1/min), thus 
the differences represent a relatively small percentage of the measured fR in 
this patient. 
Patient 6, illustrated with diamonds in figures 6-4 B-C, presented with the 
highest values of Vds amongst the patient group, and on reduction of PS 
(from 12 to 10 cm H2O) presented a decrease in pH (from 7.36 to 7.33) and 
at the same time a decrease in FECO2 (from 4.8 to 4.2) at a constant V̇CO2. 
As decreasing FECO2, implies reduction of PaCO2 and hence increase in 
pHa, the model did not describe this behavior. 
The appendix B, includes plots of measured and simulated fR, pHa and 
FECO2, for each of the twelve patients, similar to those presented in chapter 
5 describing patients in ACV. 
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Table 6-2. Values of WRSS between measured data and model simulations for the 
different levels of PS. 
 
Patient 1 2 3 4 5 6 
  
High PS * 0.02† * 0.45 0.01† 11.05 
 0.76 0.03† * 0.65 0.03† 0.11 
 0.10 0.01† 6.81 0.00† 0.02† 1.11 
 0.43 0.00† 1.53 0.00† 0.74 0.71 
Low PS 0.01 0.00† 2.73 0.01† 0.14 8.85 
  
∑(WRSS) χ2 
test p 
1.30 
0.99 
0.06 
0.99 
11.07 
0.27 
1.12 
0.99 
0.95 
0.99 
21.82 
0.11 
* Missing VT step changes due to patient outside protocol defined ranges. 
† WRSS value calculated including estimation of fM. 
 
 
 
 
Figure 6-4. Bland-Altman plots of difference between measured and simulated patient 
response to changes in PS. Each symbol illustrates a single patient i.e. right-pointing 
triangle (patient 1), vertical cross (patient 2), upwards triangle (patient 3), hexagram 
(patient 4), square (patient 5), diamond (patient 6), circle (patient 7), downwards 
triangle (patient 8), diagonal cross (patient 9), left-pointing triangle (patient 10), dot 
(patient 11) and pentagram (patient 12). The solid lines illustrate the bias between 
measured and simulated values, and the dashed lines illustrate the limits of 
agreement. Each plot illustrates differences between measured and simulated fR (A), 
pHa (B) and FeCO2 (C). 
 
6.4. CONCLUSION 
This chapter presented the evaluation of the set of models describing 
respiratory drive performed with a clinical protocol in which patients were 
ventilated in PSV. The set of models describing the respiratory drive 
adequately described patients’ response in terms of blood acid-base status 
(pHa) pulmonary gas-exchange (FECO2), and respiratory control (fR) to 
changes in PS. This being  despite  patients  presented a  range of  different 
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Table 6-2. Values of WRSS between measured data and model simulations for the 
different levels of PS (continuation). 
 
Patient 7 8 9 10 11 12 
  
High PS 0.56 * 0.04 0.00† 43.96 0.20 
 0.89 * 4.64 0.08 55.05 0.36 
 0.48 0.05 0.16 0.01† 36.57 1.56 
 0.07 0.97 0.21 0.01† 2.61 0.21† 
Low PS 0.02 0.03 0.53 0.18 15.27 0.62 
  
∑(WRSS) χ2 
test p 
2.02 
0.99 
1.05 
0.99 
5.58 
0.99 
0.28 
0.99 
153.5 
0 
2.96 
0.99 
* Missing VT step changes due to patient outside protocol defined ranges. 
† WRSS value calculated including estimation of fM. 
 
 
physiological and clinical conditions, including BE, RASS score, and days on 
mechanical ventilation. 
The set of models was shown to be consistent with the results from the 
previous study performed in ACV. This may illustrate that the set of models 
are appropriate to describe patients’ response in both ventilation modes. The 
major difference between the two studies was the addition of a model 
describing changes in Ceff. Ceff should be interpreted as the relationship 
between the level of PS and the VT generated by the sum of the two driving 
pressures i.e. the negative pressure generated by patient effort (Pmus) and 
the positive pressure delivered by the ventilator (PS). 
The development of a set of physiological models that can be tuned with 
clinically available data to describe patients’ response to changes in the level 
of ventilator support, has been presented. This set of models is limited and 
includes several assumptions that have to be considered. Nevertheless, the 
set of models adequately described the effects of changing the level of 
ventilator support in patients’ fR, pHa and FECO2, in two ventilation modes 
ACV and PSV. The next chapter, presents a critique of the set of models, 
additional findings and future work. 
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Chapters 5 and 6 presented the results of two clinical protocols that were 
performed to evaluate the set of models ability to describe patients’ response 
to changes in VT and PS respectively. The set of models were used to 
simulate patients’ response in terms of fR, pHa, and FECO2, and then 
compared against measured data. In both protocols, the set of models 
adequately described patients’ response, with similar bias and limits of 
agreement. This chapter presents a discussion of the set of physiological 
models developed in this PhD thesis and their evaluation. Section 7.1 
presents a summary of the problem addressed and the major findings of this 
thesis. The secondary findings of this thesis are presented in section 7.2. 
Models’ assumptions and limitations of the evaluations are presented in 
section 7.3. The future work using the models integrated in this thesis is 
addressed in section 7.4. The final conclusions are presented in section 7.5. 
7.1. MAJOR FINDINGS 
Selecting adequate ventilator settings to manage patients on assisted 
ventilation modes is difficult. Patients may respond in different ways to 
changes in settings of mechanical ventilation, depending upon their 
underlying physiological state. Understanding patients’ physiology is 
therefore necessary to adequately select ventilation settings. Providing 
adequate ventilation may reduce the deleterious effects of mechanical 
ventilation, reduce mortality, increase patient safety, promote patients 
synchrony with the ventilator, and perhaps reduce the length of stay on 
mechanical ventilation. For these reasons, clinical and technological 
solutions have been developed to assist physicians to set adequately 
ventilation settings. The clinical solutions include general guidelines like the 
ARDSNetwork guidelines for mechanical ventilation. The use of these 
guidelines has shown to reduce the risk of mortality and development VILIs 
(32,53), but do not provide further description about patients’ physiology. 
Nevertheless, these guidelines are a first attempt to individualize ventilator 
settings. 
Technological solutions can either automatize reduction in ventilator support 
and even select levels of FIO2 and PEEP according to established clinical 
guidelines (44,46,51,52) or describe specific patients’ response through 
model simulations and provide advice upon setting mechanical ventilation 
considering the detrimental effects of mechanical ventilation. The latter type 
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of technological solution includes systems like SOPA (80,97), NPS (36,92), 
“beat to beat” (35,88), CP (84,85), and INVENT (1,6), systems which are 
under development, and aim to describe individual patients’ physiology, 
enabling simulation of individual patients’ response to changes in mechanical 
ventilation settings.  
The approach of these model-based systems is to integrate models 
describing different physiological processes involved in ventilation i.e. 
pulmonary gas-exchange, blood acid-base status, circulation, body buffering, 
respiratory control, and lung mechanics. In this way, the effects of each of 
these processes can be combined to describe and simulate patients’ 
response to changes in ventilator settings. In chapter 2 it was shown that, the 
set of physiological models included in INVENT, meets 7 requirements that 
allow description and simulation of patients’ pulmonary gas-exchange, 
ventilation and blood acid-base status at the bedside (section 2.1.3). Despite 
the variety of models similar to the set of models included in INVENT, there 
appear to be no technological solution which have both increased model 
complexity and where the more compex models can be tuned to the individual 
patient at the bedside. 
Prior to this thesis, INVENT was limited to describing patients in controlled 
ventilation modes. This represented a major limitation since the majority of 
patients receiving mechanical ventilation are ventilated in assisted ventilation 
modes (7,8). As integrating a model of respiratory control into INVENT was 
thought to enable the description of spontaneously breathing patients, the 
aim of this PhD thesis was therefore to integrate a model of respiratory control 
into INVENT’s set of physiological modes, and evaluate the integrated model 
capability to describe patients’ response to changes in the level of ventilator 
support i.e. VT or PS.  
For this reason, a review of models of respiratory control was performed to 
identify a suitable model of respiratory control. The model of chemoreflex 
breathing control of Duffin, which includes a detailed model of the CSF acid-
base status (103) that could be used to modulate patients’ respiratory 
response was selected. This model of respiratory control required two 
adaptations before being integrated into INVENT, including a condition 
allowing down-regulation of the two chemoreflex drives (Dp and Dc) (131-
133), and calibration of the CSF acid-base status in relation to mixed venous 
blood (136). These adaptations were necessary to enable description of 
patients on mechanical ventilation, which may present abnormal blood-acid 
base conditions. 
The set of models describing respiratory drive, required two additional models 
to describe and quantify: the situation where patients cannot satisfy V̇Aexp 
CHAPTER 7. DISCUSSION 
109 
due to respiratory muscles failure; and the increase in patient effort on 
reduction of PS to compensate the lack of support. The set of models were 
evaluated with two clinical protocols, performed in ACV or PSV, respectively. 
These ventilation modes provide either VT or PS to the patient, and as such 
the patients’ response to changes is support is different. When VT is fixed, 
patients are able to modulate only fR as response to changes in VT (10). 
Conversely, when PS is fixed, patients are able to modify both VT and fR. 
Patients ability to modify VT when ventilated in PSV is due to patient effort 
(19,20). 
The major finding of this PhD thesis was that when integrating physiological 
models of pulmonary gas-exchange, blood acid-base, body buffering, 
respiratory control, CSF acid-base, muscle function and effective compliance, 
it is possible to adequately describe and simulate patients’ response to 
changes in VT and PS. Model simulated and measured values of fR, pHa, 
and FECO2, showed little bias, and limits of agreement were within that which 
one might consider clinically relevant. These results were similar for both of 
the two protocols. 
Integrating models to describe the relationship between ventilation, 
pulmonary gas-exchange, blood acid-base status, body buffering, and 
respiratory control, and simulate patients’ response to changes in levels of 
ventilator support has not been done before. However, different models have 
been developed to: a) describe the effects of changing FIO2 or/and FICO2 in 
healthy subjects (102,103); b) understand a specific physiological process in 
relation to changes in ventilation, such as cerebral blood flow (102,134), 
functional residual capacity (18), periodic breathing (118,120,122), 
respiratory control during exercise (104,121), or the effects of acclimation to 
altitude on respiratory control (123,146); c) describe only pulmonary gas-
exchange or/and lung mechanics during mechanical ventilation (34,147); or  
d) describe and simulate patients on mechanical ventilation with a 
combination of physiological model components (including pulmonary gas-
exchange, blood acid-base status, and lung mechanics) and either black-box 
control system models, fuzzy logic algoritms or optimization algorithms 
(36,77,80,84,85,88,92,97). Describing patients’ response to changes in 
mechanical ventilation is a complex process because depends upon the 
combined effects of several physiological processes, in particular during 
assisted ventilation where patients are spontaneously breathing. The results 
from the studies conducted for evaluating the set of models described here, 
have shown that by integrating physiological models it is possible to describe 
patients’ response to changes in the level of ventilator support in terms of 
pulmonary gas-exchange, blood acid-base status, and respiratory control. 
The importance of adequately describing patient’s response, may enable 
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simulation and prediction of patients’ response to changes in VT or PS, 
required for providing advice on mechanical ventilaton settings. 
Describing and quantifying the way patients respond to changes in the level 
of ventilator support (VT or PS) with physiological models of this complexity 
is novel. There are, however, descriptive studies where patients have been 
ventilated at different PS levels. These studies have reported the effects of 
changing PS among patients with several pathologies (18,21,30,42,138,148), 
and have comparied PS with other ventilation modes, e.g. intermittent 
mandatory ventilation (IMV) (149), synchronized intermittent mandatory 
ventilation (SIMV) (144), proportional assist ventilation (PAV) (145), and 
neurally adjusted ventilatory assist (NAVA) (56). The reported patient 
response among these studies, shows similar responses in fR and VT as 
shown in the studies of this thesis (figure 6-1 A-B). However, these previous 
studies did not evaluate the acid-base response to changes in ventilation, 
neither in terms of FECO2 or arterial blood, neither have they described 
patient response using a set of models including relevant physiological 
systems. In addition, the clinical studies conducted for presenting this work, 
have shown that patients respond to changes in VT and PS even when they 
are relatively small (i.e. 50 ml or 2 cm H2O), and patients’ responses to these 
changes are measurable in terms of fR, pHa and FECO2. Interestingly, a 
significant shift in blood acid-base status due to either decrease or increase 
of V̇Apat can be suspected only by noting an increase or decrease in FECO2 
higher than 0.25%. Other studies have described patients’ response to 
increased FICO2 (i.e. a hypercapnic challenge). The purpose of such studies 
was to identify difficult to wean patients by measuring the increase in airway 
occlusion pressure (P0.1) during the hypercapnic challenge (150,151). These 
studies did not describe the relationship between ventilation, pulmonary gas-
exchange and blood acid-base status. The clinical studies and data have 
shown that instead of hypercapnic challenges, relatively small reductions in 
the level of ventilator support are enough to increase the respiratory 
response. The results from the work presented here can therefore be seen 
as novel when compared to previously performed studies. 
7.2. SECONDARY FINDINGS 
In addition to adequately describing patients’ response to changes in the level 
of ventilator support, there were several interesting additional findings, these 
being presented in the following sub-sections. Sub-section 7.2.1 presents the 
two patient-specific respiratory control model parameters. Subsection 7.2.2 
presents the level of model-input complexity required to describe patient 
response. Section 7.2.3 presents different V̇O2, and V̇CO2 responses on 
reducing VT and PS. Finally, in subsection 7.2.4, Vds calculated with the 
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method presented in section 3.3 is shown to correlate with an alternative 
method tp estimation of serial dead space considering re-breathed CO2.  
7.2.1. PATIENT-SPECIFIC RESPIRATORY CONTROL MODEL 
PARAMETERS 
In order to describe and simulate patients’ response to changes in ventilator 
support, all model parameters must be tuned to individual patients’ 
conditions. For the set of models previously included in INVENT, all patient-
specific model parameters (fs, fA2, f2, BE, DPG) have been characterized, 
estimated and shown to describe patients’ response. However, patient-
specific parameters of the respiratory control model (SIDcsf and TC) were 
estimated, characterized, and proven to describe patients’ respiratory 
response with the two studies conducted for this work.  
The respiratory control model has two components, CSF acid-base model 
(figure 3-4 D) and chemoreflex respiratory control equations (figure 3-4 E). 
These components can be described with parameters SIDcsf and TC, 
respectively. According to the results of the two conducted studies, it has 
been shown that both parameters can be tuned and are uniquely identified 
for individual patients. Tuning parameter SIDcsf was possible with the 
addition of equation 11 to the CSF acid-base model, assuming that CSF 
bicarbonate can be determined from mixed venous blood bicarbonate. Tuning 
parameter TC was possible with equation 21, assuming adequate muscle 
function (fM=1), and determining V̇Apat from clinical data, as described in 
section 4.3. Both parameters have an effect on respiratory control, SIDcsf 
modulates [H+csf] and Dc (108,109), while TC is determined by the current 
pHa. 
7.2.2. MODEL-INPUT COMPLEXITY REQUIRED TO DESCRIBE PATIENT 
RESPONSE 
In addition to identifying patient-specific parameters, the set of models 
requires inputs to describe and simulate patients’ response. Identifying the 
minimum number of model-inputs to adequately describe patients’s response 
is required as part of the characterization and evaluation of the set of models. 
For that purpose, the set of models was firstly evaluated in a study conducted 
with patients ventilated in ACV (fixed levels of VT) in order to isolate patients’ 
response to changes in fR as VT was modified (20). In this way, the model-
input complexity necessary to evaluate patients’ response was determined 
without influence of patient effort. Figures 5-1 and 5-2, illustrate that the 
model-input complexity for adequately describe and simulate fR, pHa and 
FECO2, includes changes in Vds, V̇CO2, and fM, as shown in table 5-2. The 
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same model-input complexity was also required to describe patients at 
ventilated at different levels of PS, with the addition of Ceff. 
7.2.3. DIFFERENT V̇O2 AND V̇CO2 RESPONSES ON REDUCING VT AND 
PS 
The studies conducted gave interesting results in relation to patients’ 
metabolic response on changing ventilator support. Patients’ response in 
terms of V̇O2 and V̇CO2 was different in modification of VT or PS. 50% of the 
patients ventilated in ACV (patients 1, 5, 6, 8, 9, 10) presented a systematic 
increase in V̇O2 and V̇CO2 as VT changed, in contrast patients ventilated in 
PSV did not present changes in V̇O2 and V̇CO2 as PS changed. The lack of 
a systematic change in V̇O2 or V̇CO2 in PSV contrasts with a previous study 
performed in PSV where systematic increases in V̇O2 were observed on 
decreasing PS (21). This difference in V̇O2 response between the studies 
may be due to the smaller PS step-changes and range of PS modification 
used in the PSV study, which were about the half of those used by (21). The 
larger increases in V̇O2, and V̇CO2 on VT reduction may be consistent with 
the increased work of breathing and reduced synchrony during ACV in 
comparison to PS (20,41,144). 
7.2.4. CORRELATION BETWEEN TWO SERIAL DEAD SPACE 
CALCULATIONS 
The values of serial dead-space estimated in the studies were particularly 
interesting in the PSV study. Here patients occasionally presented with high 
values of Vds (figure 6.3). To confirm whether these estimates were correct 
these values were compared to calculations performed using Fowler’s 
method (Vdf) (152), and taking re-inspired CO2 into account as described 
previously (153,154). Figure 7-1 A illustrates the relationship between VT and 
Vds. The grey symbols in figure 7-1 A represent values of Vds calculated 
using the method presented in this thesis. The black symbols in figure 7-1 A 
represent Vdf. Both, Vds and Vdf increase linearly as VT increases. The r-
values for the correlation between VT and serial dead space calculations 
were r-value=0.79 (p<0.001) for Vds, and r-value=0.87 (p<0.001) for Vdf. 
Figure 7-1 B illustrates Bland-Altman analysis for both calculations of serial 
dead space showing bias of -17 ml and limits of agreement of ±70 ml. 
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Figure 7-1. Serial dead space estimated at each PS level. A) Serial dead space is 
plotted against VT for each patient at each PS level. Grey symbols illustrate serial 
dead space calculated with equation 15 (Vds) and black symbols illustrate serial dead 
space calculated with Fowler’s method corrected to rebreathed CO2 (Vdf). The grey 
and black lines illustrate the correlation between each serial dead space calculation 
and VT. Vds=0.48*VT-0.01 l, r-value=0.79 (p<0.001) and Vdf=0.53*VT-0.04 l, r-
value=0.87 (p<0.001). B) The agreement between Vds and Vdf is shown with a Bland-
Altman plot. The solid line illustrates the bias between Vds and corrected Fowler’s 
dead space, the dashed lines illustrate the limits of agreement. Each symbol illustrates 
a single patient i.e. right-pointing triangle (patient 1), vertical cross (patient 2), upwards 
triangle (patient 3), hexagram (patient 4), square (patient 5), diamond (patient 6), circle 
(patient 7), downwards triangle (patient 8), diagonal cross (patient 9), left-pointing 
triangle (patient 10), dot (patient 11) and pentagram (patient 12). 
  
7.3. LIMITATIONS OF THE SET OF MODELS DESCRIBING 
RESPIRATORY CONTROL  
The set of models describing the respiratory drive developed and evaluated 
in this thesis was designed to be tuned with clinically available data, thus 
several assumptions were necessary to simplify the models such that 
parameter values could be estimated uniquely. In addition, to the model 
assumptions, the clinical studies for evaluating of the set of models were 
limited due to practical problems when perfoming the clinical studies. Sub-
section 7.3.1 presents model assumptions and sub-section 7.3.2 presents 
limitations of the evaluations.  
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7.3.1. RESPIRATORY CONTROL MODEL ASSUMPTIONS  
The advantage of using simple models for describing physiological processes 
is that they can be tuned with clinically available data. The purpose of doing 
so is to allow these models to be used at the bedside without the need for 
complex measurement technology, to describe and simulate patients’ 
response. However, using simple models requires uniquely identifiable model 
parameters. The respiratory control model requires arterial and CSF [H+], 
PaCO2, and PaO2 to simulate ventilation (103). However, factors like cerebral 
blood flow (CBF), afferent neural inputs and sedation or/and state of 
consciousness may influence the respiratory control model. Thus, the set of 
models was used to perform simulations of patient response under the 
following assumptions: steady state ventilation; constant cerebral blood flow; 
no influence from afferent neural inputs; constant state of consciousness; and 
ventilation at baseline conditions is adequate. 
 Steady state ventilation. The set of models was used to perform 
steady state simulations describing fR, pHa and FeCO2 on changing 
VT or PS, and assuming steady state conditions of Vds, V̇CO2, and 
fM. The differences between patients’ response simulations for each 
level of ventilator support are due to changes between steady state 
conditions upon the corresponding level of ventilator support, as 
illustrated in figures 5-1, 5-2, and in appendices A and B. Substantial 
information representing dynamic state is present in data measured 
following changes in VT or PS, however, this has not been exploited. 
 Constant cerebral blood flow (CBF). Fluctuations in CBF are 
induced by changes in PaCO2 or [HCO3a-] (11,134). For instance, 
increased CBF generates a sudden reduction of PcsfCO2, which may 
reduce [H+csf] and Dc. Reduced Dc may down-regulate Dp 
producing central apnea during unconscious breathing (i.e. Dw=0 
l/min). Thus, fluctuations in CBF may generate an intermittent 
mismatch between Dc and Dp, triggering the Cheyne-Stokes 
breathing pattern i.e. alternating periods of apnea followed by periods 
of high fR (110,118,120,122). The effects of changes in CBF were 
not considered, assuming CBF as a constant (table 3-1). 
Consideration of changes in CBF may result in conditions that 
perhaps do not reach steady state ventilation. 
 Afferent neural inputs. The effect of afferent neural inputs from 
pulmonary stretch receptors on ventilation is an increase of the 
neural expiratory time in conditions of high inspiratory flow, so that, 
fR is reduced. This effect is also known as the Hering-Breuer reflex 
(155). The effect of afferent neural inputs were not considered in the 
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models, however, this effect might be identified as a reduction of fR 
on increasing the level of ventilator support. 
 Constant state of consciousness. Steady state ventilation is 
affected by the state of consciousness and administration of 
sedatives. For example, administration of opioids can shift the 
respiratory response to CO2 by increasing TC, and consequently 
reducing the central chemoreflex respiratory drive (Dc) (135,156). In 
this way, TC may include the effects of sedation. Changes in patients’ 
state of consciousness over a longer time period, e.g. following 
modification of opioid therapy, would require re-estimation of TC. 
 Ventilation at baseline conditions is adequate. The parameter 
describing patient’s muscle function (fM), indicates whether patients 
respond inadequately to changes VT or PS. However, to calculate 
this parameter, baseline ventilation was considered as adequate. 
Inadequate response to changes the level of ventilator support was 
assumed as the mismatch between calculated V̇Apat and model 
simulated V̇Aexp. Accordingly, fM=1 describes patients’ ability to 
generate V̇Aexp on modification of ventilator support. fM is only 
estimated as different from 1 when the absolute difference between 
model simulated and measured values of FECO2 is greater than 
0.25%, i.e. the standard deviation of FECO2 in healthy subjects (141). 
The causes of inadequate patient response or respiratory muscles 
failure cannot be determined with the set of models, so it is unknown 
whether fM<1 represents fatigue, reduced strength or endurance, or 
poor muscle firing (17,21,31). On the contrary, fM>1 may indicate an 
improvement in ventilation, as V̇Apat is higher than V̇Aexp. In case 
of fM>1 on increasing PS,  increased V̇Apat may be related to 
respiratory alkalosis due to over-support (42), thus the interpretation 
of fM>1 should be complemented among Ceff and changes in fR. 
7.3.2. LIMITATIONS OF CLINICAL STUDIES  
Evaluating the set of models in the clinical practice requires taking into 
account several limitations due to practical problems when performing the 
protocols. These limitations are in relation to: time; type and number of 
enrolled patients; and availability of measurements. 
 Time-related limitations. The clinical studies were performed in 
patients in assisted ventilation. The protocols were designed to 
evaluate patients’ response to changes in ventilator support, thus, 
only 15 minutes per level of support were considered, in order to 
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allow the patient to reach steady state ventilation. The evaluation 
time was therefore limited to 60 to 75 minutes. During this period of 
time the set of models described adequately patients’ response. 
However, this time is less than typical ICU stay. The model evaluation 
was limited to a short period of time, so that, the time required for re-
estimating the set of models parameters has not been determined. 
 Patient-related limitations. The number of patients enrolled into the 
two clinical studies was limited to 15 patients per study. In addition, 
the enrolled patients presented different diagnoses and physiological 
conditions. The evaluation of the set of models was therefore limited 
to a relatively small sample size, and heterogeneous patient group. 
Nevertheless, the models provided adequate description of patients’ 
response, and hence showed the capability of describing general ICU 
patients in assisted ventilation modes. 
 Measurement-availability limitations related to tuning model 
parameters. In order to describe patients’ response to changes in 
ventilator support, models parameters require to be tuned to 
individual patients’ conditions. For that purpose, a number of 
measurements are required. These requirements are: determining 
cardiac output (Q̇); measurements of V̇O2 and V̇CO2; performance of 
an experimental procedure involving 3-5 step changes in FIO2; and 
a single measurement of arterial blood gases (ABG). Q̇ is necessary 
to determine high and low V̇/Q̇ ratios describing the pulmonary gas-
exchange (40). Q̇ is seldom measured in ICU, thus it is estimated 
from the body surface area (BSA) and a fixed cardiac index (4). This 
calculation has been shown to be an adequate approximation for 
describing pulmonary gas-exchange (4). Measurements of V̇O2 and 
V̇CO2 are also required to tune the pulmonary gas-exchange, blood 
acid-base and respiratory control models parameters. These 
measurements are performed with indirect calorimetry, which is not 
widely used in ICU. In addition, tuning the pulmonary gas-exchange 
model requires an experimental procedure in which the patient is 
subjected to 3-5 levels of FIO2. Despite this process is semi-
automatic requiring from the physician to perform changes in the 
level of FIO2 in the ventilator, the experiment is performed in about 
10-15 minutes (61,62). The model parameters of blood acid-base 
and respiratory control can be determined from a single ABG, which 
is measured at the beginning of the experimental procedure. 
 Measurement-availability limitations related to lung mechanics. 
Measuring lung mechanics and work of breathing may provide a 
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complete description of patients’ response. However, measuring 
work of breathing requires the use of an esophageal catheter to 
measure esophageal pressure (Peso). Peso is however seldom used 
in ICU. Accordingly, during the clinical studies performed to evaluate 
the set of models describing respiratory drive, Peso, was not 
performed. As such, measurements of airway pressure and flow were 
used to determine Ceff. The interpretation of Ceff was limited due to 
lack of measurements of Peso and work of breathing (57,58).  
Studies are required to evaluate whether the calculation of Ceff 
provides information compatable with that available from esophageal 
measurements. 
7.4. FUTURE WORK 
Through this thesis, the need of developing a set of models describing the 
respiratory drive that can be used at the bedside was explicit. The clinical 
application of the set of models is therefore a logical future development. 
There are however several interesting modelling issues that can be 
addressed in the future, these being: evaluation considering larger periods of 
time; evaluations considering specific patient groups; determining whether 
TC can quantify the degree of sedation; and determine whether Ceff can be 
used to quantify patients’ effort on reduction of PS, and hence be used as a 
surrogate measurement of work of breathing. 
So far, the set of models was evaluated over a relatively short time-period. It 
is not therefore known how often it is necessary to re-estimate model 
parameters, or how model parameters might change with time as the patient’s 
condition varies. A long-period evaluation of the models may provide insight 
as to how often patients’ conditions change, and what is a significant change 
necessary to re-tune the parameters. 
Evaluating the set of models in patient specific group may provide insight into 
patients’ progress during mechanical ventilation. In doing so, it might be 
possible to identify patterns of response and changes in model parameters 
within different patient groups e.g. ARDS, or postsurgical patients. 
Long-period evaluations combined with different levels of sedation and 
analgesia may determine whether TC changes during sedation. If TC 
changes with sedation, it may be possible to use TC to determine the degree 
of respiratory drive depression due to e.g. opioid administration. 
Determining whether Ceff can be used as a surrogate measurement of 
patient effort may require a study with simultaneous measurement of 
esophageal pressure to determine work of breathing and patient effort. In 
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doing so, the calculated portion of VT explained by patient effort can be 
calculated with both, esophageal pressure and Ceff. The comparison 
between both measurements will determine whether Ceff can be a surrogate 
measure of patient effort. 
The set of models describing respiratory drive has been incorporated into the 
INVENT system, now commercialized as the Beacon Caresystem (Mermaid 
Care A/S, Nr. Sundby, Denmark). As such, the set of physiological models 
developed in this thesis is currently being used at the bedside, and several of 
the studies outlined above are now underway. 
7.5. FINAL CONCLUSIONS 
This PhD thesis has shown that the respiratory response of patients 
ventilated in ACV or PSV to changes in the level of ventilator support can be 
described with a set of physiological models including: pulmonary gas-
exchange; blood acid-base status; body buffering; CSF acid-base status; 
chemoreflex respiratory control; and descriptions of muscle function and 
effective compliance. The model parameters required to describe respiratory 
control are SIDcsf and TC, at least for normal oxygenation. The set of models 
describing respiratory drive requires measurements of Vds, V̇CO2, fM and 
Ceff to adequately describe patients’ response in terms of fR, pHa and FECO2 
on changing VT or PS. The set of models provided an adequate description 
of patients’ response to changes in VT and PS, suggesting that the set of 
models may be appropriate for describing the effects of modifying ventilator 
support in ACV and PSV at the bedside. 
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Appendix A. Patients’ measured and 
model simulated response to step 
changes in VT 
Figures A-1 – A-6 illustrate patients’ response to different levels of VT. Blank 
symbols and error bars represent measurements taken at different levels of 
VT. Grey symbols illustrate model simulated values considering changes in 
serial dead space (VD), CO2 production (V̇CO2) and muscle function (fM). 
Each symbol represents a different VT level, i.e. baseline (upward triangles), 
first (circles), second (squares), third (diamonds), fourth (hexagrams) and fifth 
(downward triangles).  
For each of the twelve patients included for data analysis (table 5-1), six plots 
are presented, arranged in two rows and three columns. The three plots of 
rows A in figures A-1 to A-6 illustrate the patients’ measured and model 
simulated values of fR, pHa, and FECO2 as VT was modified. The three plots 
of rows B illustrate the patients’ measured changes in VD, V̇CO2 and muscle 
function (fM) as VT was modified.  
For all patients, solid lines in row A, column 1 illustrate constant V̇A, 
calculated assuming constant VD (dotted line in figures B1), constant V̇CO2 
(dotted line in figures B2), and fM=1 (dotted line in figures B3). Values of fM 
lower than 1 indicate may inadequate patient response to reduction in 
ventilator support. 
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Figure A-1. Measured and model simulated patient response to changes in VT. 
Patients 1 and 2. 
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Figure A-2. Measured and model simulated patient response to changes in VT. 
Patients 3 and 4. 
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Figure A-3. Measured and model simulated patient response to changes in VT. 
Patients 5 and 6. 
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Figure A-4. Measured and model simulated patient response to changes in VT. 
Patients 7 and 8. 
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Figure A-5. Measured and model simulated patient response to changes in VT. 
Patients 9 and 10. 
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Figure A-6. Measured and model simulated patient response to changes in VT. 
Patients 11 and 12. 
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Appendix B. Patients’ measured and 
model simulated response to step 
changes in PS 
Figures B-1 – B-12 illustrate patients’ response to different levels of PS. Blank 
symbols and error bars represent measurements taken at different levels of 
PS. Grey symbols illustrate model simulated values considering changes in 
serial dead space (VD), CO2 production (V̇CO2) and muscle function (fM). 
Each symbol represents a different PS level i.e. baseline (upward triangles), 
first (circles), second (squares), third (diamonds), fourth (hexagrams) and fifth 
(downward triangles).  
For each of the twelve patients included for data analysis (table 6-1), nine 
plots are presented, arranged in three rows and three columns. The three 
plots of rows A in figures B-1 to B-12 illustrate the patients’ measured and 
model simulated values of fR, pHa, and FECO2 as PS was modified. The 
three plots of rows B illustrate measured changes in VT, V̇A and Ceff at each 
PS level. Thre three plots of rows C illustrate the patients’ measured changes 
in VD, V̇CO2 and muscle function (fM) as PS was modified.  
For all patients, solid lines in row A, column 1 illustrate constant V̇A calculated 
assuming constant VD (dotted line in figures C1), constant V̇CO2 (dotted line 
in figures C2), and fM=1 (dotted line in figures C3). Values of fM lower than 1 
may indicate inadequate patient response to reduction in ventilator support. 
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Figure B-1. Measured and model simulated patient response to changes in PS. 
Patient 1. 
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Figure B-2. Measured and model simulated patient response to changes in PS. 
Patient 2. 
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Figure B-3. Measured and model simulated patient response to changes in PS. 
Patient 3. 
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Figure B-4. Measured and model simulated patient response to changes in PS. 
Patient 4. 
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Figure B-5. Measured and model simulated patient response to changes in PS. 
Patient 5. 
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Figure B-6. Measured and model simulated patient response to changes in PS. 
Patient 6. 
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Figure B-7. Measured and model simulated patient response to changes in PS. 
Patient 7. 
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Figure B-8. Measured and model simulated patient response to changes in PS. 
Patient 8. 
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Figure B-9. Measured and model simulated patient response to changes in PS. 
Patient 9. 
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Figure B-10. Measured and model simulated patient response to changes in PS. 
Patient 10. 
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Figure B-11. Measured and model simulated patient response to changes in PS. 
Patient 11. 
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Figure B-12. Measured and model simulated patient response to changes in PS. 
Patient 12. 
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